{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "9b261c7c",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 46\r\n",
      "Original :  assist primary care providers in determining if an opioid taper is necessary for a specific patient, in performing the taper, and in providing follow-up and support during the taper\r\n",
      "Extracted:  assist primary care providers in determining if an opioid taper is necessary for a specific patient, in performing the taper, and in providing follow-up and support during the taper\r\n",
      "1 64\r\n",
      "Original :  establish treatment goals\r\n",
      "Extracted:  establish treatment goals\r\n",
      "2 127\r\n",
      "Original :  plan\r\n",
      "Extracted:  plan\r\n",
      "3 181\r\n",
      "Original :  if there is clinically meaningful improvement in pain and function\r\n",
      "Extracted:  if there is clinically meaningful improvement in pain and function\r\n",
      "4 257\r\n",
      "Original :  risks, benefits and responsibilities for managing therapy\r\n",
      "Extracted:  risks, benefits and responsibilities for managing therapy\r\n",
      "5 257\r\n",
      "Original :  risks, benefits and responsibilities for managing therapy\r\n",
      "Extracted:  risks, benefits and responsibilities for managing therapy\r\n",
      "6 0\r\n",
      "Original :  opioids\r\n",
      "Extracted:  opioids\r\n",
      "7 4\r\n",
      "Original :  immediate-release\r\n",
      "Extracted:  immediate-release\r\n",
      "8 72\r\n",
      "Original :  lowest\r\n",
      "Extracted:  lowest\r\n",
      "9 198\r\n",
      "Original :  benefits and risks\r\n",
      "Extracted:  benefits and risks\r\n",
      "10 198\r\n",
      "Original :  benefits and risks\r\n",
      "Extracted:  benefits and risks\r\n",
      "11 253\r\n",
      "Original :  if benefits do not outweigh harms\r\n",
      "Extracted:  if benefits do not outweigh harms\r\n",
      "12 253\r\n",
      "Original :  if benefits do not outweigh harms\r\n",
      "Extracted:  if benefits do not outweigh harms\r\n",
      "13 0\r\n",
      "Original :  offer risk mitigation strategies, including naloxone\r\n",
      "Extracted:  offer risk mitigation strategies, including naloxone\r\n",
      "14 145\r\n",
      "Original :  at least every 3 months\r\n",
      "Extracted:  at least every 3 months\r\n",
      "15 206\r\n",
      "Original :  at least annually\r\n",
      "Extracted:  at least annually\r\n",
      "16 145\r\n",
      "Original :  at least every 3 months\r\n",
      "Extracted:  at least every 3 months\r\n",
      "17 206\r\n",
      "Original :  at least annually\r\n",
      "Extracted:  at least annually\r\n",
      "18 0\r\n",
      "Original :  offer risk mitigation strategies, including naloxone\r\n",
      "Extracted:  offer risk mitigation strategies, including naloxone\r\n",
      "19 243\r\n",
      "Original :  opioid and benzodiazepines\r\n",
      "Extracted:  opioid and benzodiazepines\r\n",
      "20 333\r\n",
      "Original :  mat (medication-assisted treatment)\r\n",
      "Extracted:  mat (medication-assisted treatment)\r\n",
      "21 333\r\n",
      "Original :  mat (medication-assisted treatment)\r\n",
      "Extracted:  mat (medication-assisted treatment)\r\n",
      "22 333\r\n",
      "Original :  mat (medication-assisted treatment)\r\n",
      "Extracted:  mat (medication-assisted treatment)\r\n",
      "23 373\r\n",
      "Original :  patients with oud (opioid use disorder)\r\n",
      "Extracted:  patients with oud (opioid use disorder)\r\n",
      "24 373\r\n",
      "Original :  patients with oud (opioid use disorder)\r\n",
      "Extracted:  patients with oud (opioid use disorder)\r\n",
      "25 216\r\n",
      "Original :  no pain reduction, no improvement in function or patient requests to discontinue therapy, severe unmanageable adverse effects, dosage indicates high risk of adverse events, concerns related to an increased risk of sud (substance use disorder) (e.g., behaviors, age < 30, family history, personal history of sud), an overdose event involving opioids, non-adherence to the treatment plan or unsafe behaviors\r\n",
      "Extracted:  no pain reduction, no improvement in function or patient requests to discontinue therapy, severe unmanageable adverse effects, dosage indicates high risk of adverse events, concerns related to an increased risk of sud (substance use disorder) (e.g., behaviors, age < 30, family history, personal history of sud), an overdose event involving opioids, non-adherence to the treatment plan or unsafe behaviors\r\n",
      "26 675\r\n",
      "Original :  drowsiness, constipation, and cognitive impairment\r\n",
      "Extracted:  drowsiness, constipation, and cognitive impairment\r\n",
      "27 792\r\n",
      "Original :  doses of 90 medd (morphine equivalent daily dose) and higher\r\n",
      "Extracted:  doses of 90 medd (morphine equivalent daily dose) and higher\r\n",
      "28 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "29 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "30 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "31 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "32 675\r\n",
      "Original :  drowsiness, constipation, and cognitive impairment\r\n",
      "Extracted:  drowsiness, constipation, and cognitive impairment\r\n",
      "33 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "34 792\r\n",
      "Original :  doses of 90 medd (morphine equivalent daily dose) and higher\r\n",
      "Extracted:  doses of 90 medd (morphine equivalent daily dose) and higher\r\n",
      "35 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "36 887\r\n",
      "Original :  early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant udt\r\n",
      "Extracted:  early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant udt\r\n",
      "37 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "38 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "39 466\r\n",
      "Original :  behaviors, age < 30, family history, personal history of sud\r\n",
      "Extracted:  behaviors, age < 30, family history, personal history of sud\r\n",
      "40 887\r\n",
      "Original :  early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant udt\r\n",
      "Extracted:  early refills, lost/stolen prescription, buying or borrowing opioids, failure to obtain or aberrant udt\r\n",
      "41 138\r\n",
      "Original :  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "Extracted:  re-evaluate the risks and benefits of continuing opioid therapy\r\n",
      "42 49\r\n",
      "Original :  lung disease, sleep apnea, liver disease, renal disease, fall risk, advanced age\r\n",
      "Extracted:  lung disease, sleep apnea, liver disease, renal disease, fall risk, advanced age\r\n",
      "43 131\r\n",
      "Original :  consider tapering opioids\r\n",
      "Extracted:  consider tapering opioids\r\n",
      "44 314\r\n",
      "Original :  ptsd, depression, anxiety\r\n",
      "Extracted:  ptsd, depression, anxiety\r\n",
      "45 382\r\n",
      "Original :  the risks of continued use, along with possible benefits\r\n",
      "Extracted:  the risks of continued use, along with possible benefits\r\n",
      "46 619\r\n",
      "Original :  alcohol use disorder (aud), opioid use disorder (oud), and/or a use disorder involving other substances\r\n",
      "Extracted:  alcohol use disorder (aud), opioid use disorder (oud), and/or a use disorder involving other substances\r\n",
      "47 228\r\n",
      "Original :  benzodiazepines\r\n",
      "Extracted:  benzodiazepines\r\n",
      "48 46\r\n",
      "Original :  conditions that may warrant evaluation\r\n",
      "Extracted:  conditions that may warrant evaluation\r\n",
      "49 271\r\n",
      "Original :  before deciding to change therapy, look for “red flags”. the red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.\r\n",
      "Extracted:  before deciding to change therapy, look for “red flags”. the red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.\r\n",
      "50 271\r\n",
      "Original :  before deciding to change therapy, look for “red flags”. the red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.\r\n",
      "Extracted:  before deciding to change therapy, look for “red flags”. the red flags are progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection.\r\n",
      "51 346\r\n",
      "Original :  progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection\r\n",
      "Extracted:  progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, history of internal malignancy that has not been re-staged, signs of/risk factors for infection\r\n",
      "52 587\r\n",
      "Original :  when there is progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, a history of internal malignancy that has not been re-staged, signs of/risk factors for infection such as fever, recent skin or urinary infection, immunosuppression, iv drug use\r\n",
      "Extracted:  when there is progressive numbness or weakness, progressive changes in bowel or bladder function, unexplained weight loss, a history of internal malignancy that has not been re-staged, signs of/risk factors for infection such as fever, recent skin or urinary infection, immunosuppression, iv drug use\r\n",
      "53 552\r\n",
      "Original :  an urgent evaluation\r\n",
      "Extracted:  an urgent evaluation\r\n",
      "54 552\r\n",
      "Original :  an urgent evaluation\r\n",
      "Extracted:  an urgent evaluation\r\n",
      "55 552\r\n",
      "Original :  an urgent evaluation\r\n",
      "Extracted:  an urgent evaluation\r\n",
      "56 552\r\n",
      "Original :  an urgent evaluation\r\n",
      "Extracted:  an urgent evaluation\r\n",
      "57 552\r\n",
      "Original :  an urgent evaluation\r\n",
      "Extracted:  an urgent evaluation\r\n",
      "58 816\r\n",
      "Original :  fever, recent skin or urinary infection, immunosuppression, iv drug use\r\n",
      "Extracted:  fever, recent skin or urinary infection, immunosuppression, iv drug use\r\n",
      "59 7\r\n",
      "Original :  screening and treatment is offered for conditions that can complicate pain management\r\n",
      "Extracted:  screening and treatment is offered for conditions that can complicate pain management\r\n",
      "60 179\r\n",
      "Original :  mental health disorders, oud and other sud, moral injury, central sensitization, medical complications, sleep disorders\r\n",
      "Extracted:  mental health disorders, oud and other sud, moral injury, central sensitization, medical complications, sleep disorders\r\n",
      "61 332\r\n",
      "Original :  ptsd, anxiety disorders, depressive disorders\r\n",
      "Extracted:  ptsd, anxiety disorders, depressive disorders\r\n",
      "62 379\r\n",
      "Original :  if suicidal, then activate suicide prevention plan. if high suicide risk or actively suicidal, consult with mental health provider before beginning taper.\r\n",
      "Extracted:  if suicidal, then activate suicide prevention plan. if high suicide risk or actively suicidal, consult with mental health provider before beginning taper.\r\n",
      "63 397\r\n",
      "Original :  activate suicide prevention plan\r\n",
      "Extracted:  activate suicide prevention plan\r\n",
      "64 474\r\n",
      "Original :  consult with mental health provider before beginning taper\r\n",
      "Extracted:  consult with mental health provider before beginning taper\r\n",
      "65 474\r\n",
      "Original :  consult with mental health provider before beginning taper\r\n",
      "Extracted:  consult with mental health provider before beginning taper\r\n",
      "66 635\r\n",
      "Original :  about 41%: approximately 28% for mild symptoms, 10% for moderate symptoms and 3.5% for severe symptoms of oud\r\n",
      "Extracted:  about 41%: approximately 28% for mild symptoms, 10% for moderate symptoms and 3.5% for severe symptoms of oud\r\n",
      "67 646\r\n",
      "Original :  approximately 28%\r\n",
      "Extracted:  approximately 28%\r\n",
      "68 683\r\n",
      "Original :  10%\r\n",
      "Extracted:  10%\r\n",
      "69 713\r\n",
      "Original :  3.5%\r\n",
      "Extracted:  3.5%\r\n",
      "70 746\r\n",
      "Original :  patients with chronic pain who develop oud from opioid analgesic therapy\r\n",
      "Extracted:  patients with chronic pain who develop oud from opioid analgesic therapy\r\n",
      "71 832\r\n",
      "Original :  both pain and oud\r\n",
      "Extracted:  both pain and oud\r\n",
      "72 861\r\n",
      "Original :  either tapering the opioid analgesic or continuing to prescribe the opioid without providing oud treatment\r\n",
      "Extracted:  either tapering the opioid analgesic or continuing to prescribe the opioid without providing oud treatment\r\n",
      "73 993\r\n",
      "Original :  overdose and other adverse events\r\n",
      "Extracted:  overdose and other adverse events\r\n",
      "74 993\r\n",
      "Original :  overdose and other adverse events\r\n",
      "Extracted:  overdose and other adverse events\r\n",
      "75 6\r\n",
      "Original :  shared decision-making\r\n",
      "Extracted:  shared decision-making\r\n",
      "76 76\r\n",
      "Original :  medication-assisted therapy (mat)\r\n",
      "Extracted:  medication-assisted therapy (mat)\r\n",
      "77 178\r\n",
      "Original :  opioid agonist therapy (oat)\r\n",
      "Extracted:  opioid agonist therapy (oat)\r\n",
      "78 242\r\n",
      "Original :  taking opioid agonist medications such as buprenorphine/naloxone (suboxone) or methadone\r\n",
      "Extracted:  taking opioid agonist medications such as buprenorphine/naloxone (suboxone) or methadone\r\n",
      "79 284\r\n",
      "Original :  buprenorphine/naloxone (suboxone) or methadone\r\n",
      "Extracted:  buprenorphine/naloxone (suboxone) or methadone\r\n",
      "80 359\r\n",
      "Original :  through a federally regulated opioid treatment program for oud therapy\r\n",
      "Extracted:  through a federally regulated opioid treatment program for oud therapy\r\n",
      "81 464\r\n",
      "Original :  extended-release (er) injectable naltrexone (vivitrol)\r\n",
      "Extracted:  extended-release (er) injectable naltrexone (vivitrol)\r\n",
      "82 585\r\n",
      "Original :  residential sud treatment, intensive outpatient sud treatment, regular sud specialty care clinic, primary care or general mental health clinic, or federally regulated opioid treatment program\r\n",
      "Extracted:  residential sud treatment, intensive outpatient sud treatment, regular sud specialty care clinic, primary care or general mental health clinic, or federally regulated opioid treatment program\r\n",
      "83 794\r\n",
      "Original :  an act of transgression that leads to serious inner conflict typically brought on by betrayal, disproportionate violence, incidents involving civilians, within-rank violence\r\n",
      "Extracted:  an act of transgression that leads to serious inner conflict typically brought on by betrayal, disproportionate violence, incidents involving civilians, within-rank violence\r\n",
      "84 879\r\n",
      "Original :  betrayal, disproportionate violence, incidents involving civilians, within-rank violence\r\n",
      "Extracted:  betrayal, disproportionate violence, incidents involving civilians, within-rank violence\r\n",
      "85 997\r\n",
      "Original :  via psychologists or chaplains\r\n",
      "Extracted:  via psychologists or chaplains\r\n",
      "86 1262\r\n",
      "Original :  sleep apnea\r\n",
      "Extracted:  sleep apnea\r\n",
      "87 34\r\n",
      "Original :  special attention must be given to ensure that the veteran does not feel abandoned\r\n",
      "Extracted:  special attention must be given to ensure that the veteran does not feel abandoned\r\n",
      "88 0\r\n",
      "Original :  when a decision is made to taper\r\n",
      "Extracted:  when a decision is made to taper\r\n",
      "89 173\r\n",
      "Original :  a discussion should occur between the veteran, family members/caregivers, and the provider either during a face-to-face appointment or on the telephone\r\n",
      "Extracted:  a discussion should occur between the veteran, family members/caregivers, and the provider either during a face-to-face appointment or on the telephone\r\n",
      "90 207\r\n",
      "Original :  the veteran, family members/caregivers, and the provider\r\n",
      "Extracted:  the veteran, family members/caregivers, and the provider\r\n",
      "91 127\r\n",
      "Original :  any changes being made in opioid prescribing\r\n",
      "Extracted:  any changes being made in opioid prescribing\r\n",
      "92 378\r\n",
      "Original :  discussion, asking about goals, educating the veteran\r\n",
      "Extracted:  discussion, asking about goals, educating the veteran\r\n",
      "93 453\r\n",
      "Original :  listening to the veteran’s story, letting the veteran know that you believe that their pain is real, using motivational interviewing (mi) techniques to acknowledge the veteran’s fears about tapering\r\n",
      "Extracted:  listening to the veteran’s story, letting the veteran know that you believe that their pain is real, using motivational interviewing (mi) techniques to acknowledge the veteran’s fears about tapering\r\n",
      "94 661\r\n",
      "Original :  family members or other supporters\r\n",
      "Extracted:  family members or other supporters\r\n",
      "95 560\r\n",
      "Original :  motivational interviewing (mi)\r\n",
      "Extracted:  motivational interviewing (mi)\r\n",
      "96 602\r\n",
      "Original :  to acknowledge the veteran’s fears about tapering\r\n",
      "Extracted:  to acknowledge the veteran’s fears about tapering\r\n",
      "97 902\r\n",
      "Original :  just being pain-free\r\n",
      "Extracted:  just being pain-free\r\n",
      "98 935\r\n",
      "Original :  personal health inventory\r\n",
      "Extracted:  personal health inventory\r\n",
      "99 29\r\n",
      "Original :  bio-psycho-social model e.g., phi’s “whole health” approach\r\n",
      "Extracted:  bio-psycho-social model e.g., phi’s “whole health” approach\r\n",
      "100 59\r\n",
      "Original :  phi’s “whole health” approach\r\n",
      "Extracted:  phi’s “whole health” approach\r\n",
      "101 139\r\n",
      "Original :  cognitive behavioral therapy (cbt) or acceptance and commitment therapy (act) for pain\r\n",
      "Extracted:  cognitive behavioral therapy (cbt) or acceptance and commitment therapy (act) for pain\r\n",
      "102 352\r\n",
      "Original :  acupuncture, meditation, yoga\r\n",
      "Extracted:  acupuncture, meditation, yoga\r\n",
      "103 287\r\n",
      "Original :  complementary and integrative health\r\n",
      "Extracted:  complementary and integrative health\r\n",
      "104 407\r\n",
      "Original :  slow tapering of opioids to reduce opioid risks while not “cutting off” the veteran\r\n",
      "Extracted:  slow tapering of opioids to reduce opioid risks while not “cutting off” the veteran\r\n",
      "105 74\r\n",
      "Original :  dose reduction or complete discontinuation\r\n",
      "Extracted:  dose reduction or complete discontinuation\r\n",
      "106 176\r\n",
      "Original :  subsequent regular reassessment\r\n",
      "Extracted:  subsequent regular reassessment\r\n",
      "107 326\r\n",
      "Original :  slower, more gradual tapers\r\n",
      "Extracted:  slower, more gradual tapers\r\n",
      "108 326\r\n",
      "Original :  slower, more gradual tapers\r\n",
      "Extracted:  slower, more gradual tapers\r\n",
      "109 409\r\n",
      "Original :  several months to years\r\n",
      "Extracted:  several months to years\r\n",
      "110 442\r\n",
      "Original :  the opioid dose\r\n",
      "Extracted:  the opioid dose\r\n",
      "111 597\r\n",
      "Original :  5% to 20%\r\n",
      "Extracted:  5% to 20%\r\n",
      "112 597\r\n",
      "Original :  5% to 20% every 4 weeks\r\n",
      "Extracted:  5% to 20% every 4 weeks\r\n",
      "113 682\r\n",
      "Original :  drug diversion, illegal activities, or situations where the risks of continuing the opioid outweigh the risks of a rapid taper\r\n",
      "Extracted:  drug diversion, illegal activities, or situations where the risks of continuing the opioid outweigh the risks of a rapid taper\r\n",
      "114 622\r\n",
      "Original :  more rapid tapers\r\n",
      "Extracted:  more rapid tapers\r\n",
      "115 622\r\n",
      "Original :  more rapid tapers\r\n",
      "Extracted:  more rapid tapers\r\n",
      "116 622\r\n",
      "Original :  more rapid tapers\r\n",
      "Extracted:  more rapid tapers\r\n",
      "117 622\r\n",
      "Original :  more rapid tapers\r\n",
      "Extracted:  more rapid tapers\r\n",
      "118 622\r\n",
      "Original :  more rapid tapers\r\n",
      "Extracted:  more rapid tapers\r\n",
      "119 819\r\n",
      "Original :  the rationale for the opioid taper and the opioid taper schedule\r\n",
      "Extracted:  the rationale for the opioid taper and the opioid taper schedule\r\n",
      "120 925\r\n",
      "Original :  opioid overdose education\r\n",
      "Extracted:  opioid overdose education\r\n",
      "121 965\r\n",
      "Original :  naloxone\r\n",
      "Extracted:  naloxone\r\n",
      "122 977\r\n",
      "Original :  patients at increased risk of overdose\r\n",
      "Extracted:  patients at increased risk of overdose\r\n",
      "123 977\r\n",
      "Original :  patients at increased risk of overdose\r\n",
      "Extracted:  patients at increased risk of overdose\r\n",
      "124 1057\r\n",
      "Original :  as little as a week\r\n",
      "Extracted:  as little as a week\r\n",
      "125 1130\r\n",
      "Original :  an overdose\r\n",
      "Extracted:  an overdose\r\n",
      "126 22\r\n",
      "Original :  over years\r\n",
      "Extracted:  over years\r\n",
      "127 73\r\n",
      "Original :  2 to 10% every 4 to 8 weeks with pauses in taper as needed\r\n",
      "Extracted:  2 to 10% every 4 to 8 weeks with pauses in taper as needed\r\n",
      "128 164\r\n",
      "Original :  patients taking high doses of long-acting opioids for many years\r\n",
      "Extracted:  patients taking high doses of long-acting opioids for many years\r\n",
      "129 384\r\n",
      "Original :  90 mg sr qam, 75 mg for noon, 90 mg qpm\r\n",
      "Extracted:  90 mg sr qam, 75 mg for noon, 90 mg qpm\r\n",
      "130 453\r\n",
      "Original :  veteran response\r\n",
      "Extracted:  veteran response\r\n",
      "131 471\r\n",
      "Original :  pauses in the taper\r\n",
      "Extracted:  pauses in the taper\r\n",
      "132 495\r\n",
      "Original :  allow the patient time to acquire new skills for management of pain and emotional distress while allowing for neurobiological equilibration\r\n",
      "Extracted:  allow the patient time to acquire new skills for management of pain and emotional distress while allowing for neurobiological equilibration\r\n",
      "133 691\r\n",
      "Original :  75 mg sr qam, 75 mg noon, 90 mg qpm\r\n",
      "Extracted:  75 mg sr qam, 75 mg noon, 90 mg qpm\r\n",
      "134 740\r\n",
      "Original :  75 mg sr (60 mg+15 mg) q8h\r\n",
      "Extracted:  75 mg sr (60 mg+15 mg) q8h\r\n",
      "135 780\r\n",
      "Original :  75 mg sr qam, 60 mg noon, 75 mg qpm\r\n",
      "Extracted:  75 mg sr qam, 60 mg noon, 75 mg qpm\r\n",
      "136 829\r\n",
      "Original :  60 mg sr qam, 60 mg noon, 75 mg qpm\r\n",
      "Extracted:  60 mg sr qam, 60 mg noon, 75 mg qpm\r\n",
      "137 878\r\n",
      "Original :  60 mg sr q8h\r\n",
      "Extracted:  60 mg sr q8h\r\n",
      "138 904\r\n",
      "Original :  60 mg sr qam, 45 mg noon, 60 mg qpm\r\n",
      "Extracted:  60 mg sr qam, 45 mg noon, 60 mg qpm\r\n",
      "139 953\r\n",
      "Original :  45 mg sr qam, 45 mg noon, 60 mg qpm\r\n",
      "Extracted:  45 mg sr qam, 45 mg noon, 60 mg qpm\r\n",
      "140 1002\r\n",
      "Original :  45 mg sr q8h\r\n",
      "Extracted:  45 mg sr q8h\r\n",
      "141 1066\r\n",
      "Original :  until off the morphine or the desired dose of opioid is reached\r\n",
      "Extracted:  until off the morphine or the desired dose of opioid is reached\r\n",
      "142 21\r\n",
      "Original :  over months or years\r\n",
      "Extracted:  over months or years\r\n",
      "143 81\r\n",
      "Original :  5 to 20% every 4 weeks with pauses in taper as needed\r\n",
      "Extracted:  5 to 20% every 4 weeks with pauses in taper as needed\r\n",
      "144 0\r\n",
      "Original :  slower taper\r\n",
      "Extracted:  slower taper\r\n",
      "145 336\r\n",
      "Original :  75 mg (60 mg+15 mg)sr q8h\r\n",
      "Extracted:  75 mg (60 mg+15 mg)sr q8h\r\n",
      "146 417\r\n",
      "Original :  60 mg sr q8h\r\n",
      "Extracted:  60 mg sr q8h\r\n",
      "147 443\r\n",
      "Original :  45 mg sr q8h\r\n",
      "Extracted:  45 mg sr q8h\r\n",
      "148 469\r\n",
      "Original :  30 mg sr q8h\r\n",
      "Extracted:  30 mg sr q8h\r\n",
      "149 495\r\n",
      "Original :  15 mg sr q8h\r\n",
      "Extracted:  15 mg sr q8h\r\n",
      "150 521\r\n",
      "Original :  15 mg sr q12h\r\n",
      "Extracted:  15 mg sr q12h\r\n",
      "151 548\r\n",
      "Original :  15mg sr qhs\r\n",
      "Extracted:  15mg sr qhs\r\n",
      "152 594\r\n",
      "Original :  after month 7\r\n",
      "Extracted:  after month 7\r\n",
      "153 625\r\n",
      "Original :  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "Extracted:  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "154 21\r\n",
      "Original :  over weeks\r\n",
      "Extracted:  over weeks\r\n",
      "155 67\r\n",
      "Original :  10 to 20% every week\r\n",
      "Extracted:  10 to 20% every week\r\n",
      "156 242\r\n",
      "Original :  75 mg sr q8h\r\n",
      "Extracted:  75 mg sr q8h\r\n",
      "157 309\r\n",
      "Original :  60 mg sr (15 mg x 4) q8h\r\n",
      "Extracted:  60 mg sr (15 mg x 4) q8h\r\n",
      "158 346\r\n",
      "Original :  45 mg sr (15 mg x 3) q8h\r\n",
      "Extracted:  45 mg sr (15 mg x 3) q8h\r\n",
      "159 383\r\n",
      "Original :  30 mg sr (15 mg x 2) q8h\r\n",
      "Extracted:  30 mg sr (15 mg x 2) q8h\r\n",
      "160 420\r\n",
      "Original :  15 mg sr q8h\r\n",
      "Extracted:  15 mg sr q8h\r\n",
      "161 445\r\n",
      "Original :  15 mg sr q12h\r\n",
      "Extracted:  15 mg sr q12h\r\n",
      "162 471\r\n",
      "Original :  15 mg sr qhs x 7 days\r\n",
      "Extracted:  15 mg sr qhs x 7 days\r\n",
      "163 526\r\n",
      "Original :  after week 7\r\n",
      "Extracted:  after week 7\r\n",
      "164 556\r\n",
      "Original :  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "Extracted:  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "165 20\r\n",
      "Original :  over days\r\n",
      "Extracted:  over days\r\n",
      "166 551\r\n",
      "Original :  by 20 to 50% of first dose if needed, then reduce by 10 to 20% every day\r\n",
      "Extracted:  by 20 to 50% of first dose if needed, then reduce by 10 to 20% every day\r\n",
      "167 774\r\n",
      "Original :  60 mg sr (15 mg x 4) q8h\r\n",
      "Extracted:  60 mg sr (15 mg x 4) q8h\r\n",
      "168 851\r\n",
      "Original :  45 mg sr (15 mg x 3) q8h\r\n",
      "Extracted:  45 mg sr (15 mg x 3) q8h\r\n",
      "169 887\r\n",
      "Original :  30 mg sr (15 mg x 2) q8h\r\n",
      "Extracted:  30 mg sr (15 mg x 2) q8h\r\n",
      "170 923\r\n",
      "Original :  15 mg sr q8h\r\n",
      "Extracted:  15 mg sr q8h\r\n",
      "171 947\r\n",
      "Original :  15 mg sr q12h\r\n",
      "Extracted:  15 mg sr q12h\r\n",
      "172 947\r\n",
      "Original :  15 mg sr q12h\r\n",
      "Extracted:  15 mg sr q12h\r\n",
      "173 947\r\n",
      "Original :  15 mg sr q12h\r\n",
      "Extracted:  15 mg sr q12h\r\n",
      "174 974\r\n",
      "Original :  15 mg sr qhs\r\n",
      "Extracted:  15 mg sr qhs\r\n",
      "175 974\r\n",
      "Original :  15 mg sr qhs\r\n",
      "Extracted:  15 mg sr qhs\r\n",
      "176 974\r\n",
      "Original :  15 mg sr qhs\r\n",
      "Extracted:  15 mg sr qhs\r\n",
      "177 974\r\n",
      "Original :  15 mg sr qhs\r\n",
      "Extracted:  15 mg sr qhs\r\n",
      "178 1021\r\n",
      "Original :  after day 11\r\n",
      "Extracted:  after day 11\r\n",
      "179 1051\r\n",
      "Original :  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "Extracted:  morphine ir 15 mg ½ tablet (7.5 mg) twice daily\r\n",
      "180 31\r\n",
      "Original :  rapid tapers\r\n",
      "Extracted:  rapid tapers\r\n",
      "181 54\r\n",
      "Original :  withdrawal effects\r\n",
      "Extracted:  withdrawal effects\r\n",
      "182 77\r\n",
      "Original :  patients should be treated with adjunctive medications\r\n",
      "Extracted:  patients should be treated with adjunctive medications\r\n",
      "183 180\r\n",
      "Original :  admitting the patient for inpatient care\r\n",
      "Extracted:  admitting the patient for inpatient care\r\n",
      "184 383\r\n",
      "Original :  medical history, mental health diagnoses, and patient preference\r\n",
      "Extracted:  medical history, mental health diagnoses, and patient preference\r\n",
      "185 222\r\n",
      "Original :  if patients are prescribed both long-acting and short-acting opioids\r\n",
      "Extracted:  if patients are prescribed both long-acting and short-acting opioids\r\n",
      "186 238\r\n",
      "Original :  15 mg every 10 days\r\n",
      "Extracted:  15 mg every 10 days\r\n",
      "187 343\r\n",
      "Original :  4 tablets = 60 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening\r\n",
      "Extracted:  4 tablets = 60 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening\r\n",
      "188 472\r\n",
      "Original :  3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening\r\n",
      "Extracted:  3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 4 tablets = 60 mg in the evening\r\n",
      "189 601\r\n",
      "Original :  3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 3 tablets = 45 mg in the evening\r\n",
      "Extracted:  3 tablets = 45 mg in the morning, 3 tablets = 45 mg in the afternoon, 3 tablets = 45 mg in the evening\r\n",
      "190 113\r\n",
      "Original :  continue the strategy of reducing to morphine sr 30 mg every 8 hours, follow up in 1 to 4 weeks to determine the next step in the taper\r\n",
      "Extracted:  continue the strategy of reducing to morphine sr 30 mg every 8 hours, follow up in 1 to 4 weeks to determine the next step in the taper\r\n",
      "191 294\r\n",
      "Original :  request mental health support and consider the possibility of oud\r\n",
      "Extracted:  request mental health support and consider the possibility of oud\r\n",
      "192 414\r\n",
      "Original :  explore the reason for the reluctance\r\n",
      "Extracted:  explore the reason for the reluctance\r\n",
      "193 491\r\n",
      "Original :  medical (increased pain), mental health (worsening depression, anxiety, etc.), and substance use disorder (sud)/opioid use disorder (oud)\r\n",
      "Extracted:  medical (increased pain), mental health (worsening depression, anxiety, etc.), and substance use disorder (sud)/opioid use disorder (oud)\r\n",
      "194 797\r\n",
      "Original :  remain at morphine sr 45 mg every 8 hours for 1 to 2 months then reassess\r\n",
      "Extracted:  remain at morphine sr 45 mg every 8 hours for 1 to 2 months then reassess\r\n",
      "195 928\r\n",
      "Original :  skills training and/or have a comprehensive pain care plan\r\n",
      "Extracted:  skills training and/or have a comprehensive pain care plan\r\n",
      "196 1015\r\n",
      "Original :  review the risk of the taper vs. the benefit of remaining at the current dose\r\n",
      "Extracted:  review the risk of the taper vs. the benefit of remaining at the current dose\r\n",
      "197 1015\r\n",
      "Original :  review the risk of the taper vs. the benefit of remaining at the current dose, and if necessary, adjust the speed of the taper according to the response of the veteran\r\n",
      "Extracted:  review the risk of the taper vs. the benefit of remaining at the current dose, and if necessary, adjust the speed of the taper according to the response of the veteran\r\n",
      "198 43\r\n",
      "Original :  pact team\r\n",
      "Extracted:  pact team\r\n",
      "199 98\r\n",
      "Original :  a team function with various team members taking on roles in which they have demonstrated specific competencies\r\n",
      "Extracted:  a team function with various team members taking on roles in which they have demonstrated specific competencies\r\n",
      "200 0\r\n",
      "Original :  follow-up for tapering\r\n",
      "Extracted:  follow-up for tapering\r\n",
      "201 211\r\n",
      "Original :  mental health practitioners\r\n",
      "Extracted:  mental health practitioners\r\n",
      "202 339\r\n",
      "Original :  1 to 4 weeks after starting taper then monthly before each reduction\r\n",
      "Extracted:  1 to 4 weeks after starting taper then monthly before each reduction\r\n",
      "203 339\r\n",
      "Original :  1 to 4 weeks after starting taper then monthly before each reduction\r\n",
      "Extracted:  1 to 4 weeks after starting taper then monthly before each reduction\r\n",
      "204 583\r\n",
      "Original :  weekly before each dose reduction\r\n",
      "Extracted:  weekly before each dose reduction\r\n",
      "205 669\r\n",
      "Original :  daily before each dose reduction or if available offer inpatient admission\r\n",
      "Extracted:  daily before each dose reduction or if available offer inpatient admission\r\n",
      "206 819\r\n",
      "Original :  in the clinic and/or over telephone\r\n",
      "Extracted:  in the clinic and/or over telephone\r\n",
      "207 819\r\n",
      "Original :  in the clinic and/or over telephone\r\n",
      "Extracted:  in the clinic and/or over telephone\r\n",
      "208 819\r\n",
      "Original :  in the clinic and/or over telephone\r\n",
      "Extracted:  in the clinic and/or over telephone\r\n",
      "209 908\r\n",
      "Original :  in the hospital, clinic or over telephone\r\n",
      "Extracted:  in the hospital, clinic or over telephone\r\n",
      "210 1053\r\n",
      "Original :  the risk category of the veteran\r\n",
      "Extracted:  the risk category of the veteran\r\n",
      "211 951\r\n",
      "Original :  providers\r\n",
      "Extracted:  providers\r\n",
      "212 1087\r\n",
      "Original :  a veteran with high risk due to a medical condition\r\n",
      "Extracted:  a veteran with high risk due to a medical condition\r\n",
      "213 1087\r\n",
      "Original :  a veteran with high risk due to a medical condition\r\n",
      "Extracted:  a veteran with high risk due to a medical condition\r\n",
      "214 1372\r\n",
      "Original :  providing follow-up in a clinic visit may be more optimal than a telephone visit\r\n",
      "Extracted:  providing follow-up in a clinic visit may be more optimal than a telephone visit\r\n",
      "215 1372\r\n",
      "Original :  providing follow-up in a clinic visit may be more optimal than a telephone visit\r\n",
      "Extracted:  providing follow-up in a clinic visit may be more optimal than a telephone visit\r\n",
      "216 1467\r\n",
      "Original :  patient function, pain intensity, sleep, physical activity, personal goals, and stress level\r\n",
      "Extracted:  patient function, pain intensity, sleep, physical activity, personal goals, and stress level\r\n",
      "217 0\r\n",
      "Original :  short-term oral medications\r\n",
      "Extracted:  short-term oral medications\r\n",
      "218 172\r\n",
      "Original :  an opioid or benzodiazepine\r\n",
      "Extracted:  an opioid or benzodiazepine\r\n",
      "219 266\r\n",
      "Original :  with a gradual taper\r\n",
      "Extracted:  with a gradual taper\r\n",
      "220 308\r\n",
      "Original :  hours to days\r\n",
      "Extracted:  hours to days\r\n",
      "221 498\r\n",
      "Original :  days to weeks\r\n",
      "Extracted:  days to weeks\r\n",
      "222 785\r\n",
      "Original :  weeks to months\r\n",
      "Extracted:  weeks to months\r\n",
      "223 356\r\n",
      "Original :  anxiety/restlessness, rapid short respirations, runny nose, tearing eyes, sweating, insomnia, and dilated reactive pupils\r\n",
      "Extracted:  anxiety/restlessness, rapid short respirations, runny nose, tearing eyes, sweating, insomnia, and dilated reactive pupils\r\n",
      "224 545\r\n",
      "Original :  runny nose, tearing eyes, rapid breathing, yawning, tremor, diffuse muscle spasms/aches, piloerection, nausea, vomiting, and diarrhea, abdominal pain, fever, chills, increased white blood cells if sudden withdrawal\r\n",
      "Extracted:  runny nose, tearing eyes, rapid breathing, yawning, tremor, diffuse muscle spasms/aches, piloerection, nausea, vomiting, and diarrhea, abdominal pain, fever, chills, increased white blood cells if sudden withdrawal\r\n",
      "225 839\r\n",
      "Original :  irritability, fatigue, bradycardia, decreased body temperature, craving, insomnia\r\n",
      "Extracted:  irritability, fatigue, bradycardia, decreased body temperature, craving, insomnia\r\n",
      "226 955\r\n",
      "Original :  5 to 10 days following opioid dose reduction/cessation but may take longer depending on the half-life of the opioid (e.g., methadone)\r\n",
      "Extracted:  5 to 10 days following opioid dose reduction/cessation but may take longer depending on the half-life of the opioid (e.g., methadone)\r\n",
      "227 1126\r\n",
      "Original :  dysphoria, insomnia\r\n",
      "Extracted:  dysphoria, insomnia\r\n",
      "228 1244\r\n",
      "Original :  fatigue, mental functioning, pain, and well-being\r\n",
      "Extracted:  fatigue, mental functioning, pain, and well-being\r\n",
      "229 9\r\n",
      "Original :  use of adjuvant medications\r\n",
      "Extracted:  use of adjuvant medications\r\n",
      "230 184\r\n",
      "Original :  clonidine 0.1 to 0.2 mg oral every 6 to 8 hours\r\n",
      "Extracted:  clonidine 0.1 to 0.2 mg oral every 6 to 8 hours\r\n",
      "231 243\r\n",
      "Original :  if blood pressure <90/60 mmhg (0.1 to 0.2 mg 2 to 4 times daily is commonly used in the outpatient setting)\r\n",
      "Extracted:  if blood pressure <90/60 mmhg (0.1 to 0.2 mg 2 to 4 times daily is commonly used in the outpatient setting)\r\n",
      "232 373\r\n",
      "Original :  0.1 mg oral\r\n",
      "Extracted:  0.1 mg oral\r\n",
      "233 148\r\n",
      "Original :  sweating, tachycardia, myoclonus\r\n",
      "Extracted:  sweating, tachycardia, myoclonus\r\n",
      "234 661\r\n",
      "Original :  baclofen, gabapentin, tizanidine\r\n",
      "Extracted:  baclofen, gabapentin, tizanidine\r\n",
      "235 781\r\n",
      "Original :  5 mg 3 times daily; may increase to 40 mg total daily dose; re-evaluate in 3 to 7 days; average duration 15 days; may continue after acute withdrawal to help decrease cravings; should be tapered when it is discontinued\r\n",
      "Extracted:  5 mg 3 times daily; may increase to 40 mg total daily dose; re-evaluate in 3 to 7 days; average duration 15 days; may continue after acute withdrawal to help decrease cravings; should be tapered when it is discontinued\r\n",
      "236 1089\r\n",
      "Original :  start at 100 to 300 mg and titrate to 1800 to 2100 mg divided in 2 to 3 daily doses; adjust dose if renal impairment\r\n",
      "Extracted:  start at 100 to 300 mg and titrate to 1800 to 2100 mg divided in 2 to 3 daily doses; adjust dose if renal impairment\r\n",
      "237 671\r\n",
      "Original :  gabapentin\r\n",
      "Extracted:  gabapentin\r\n",
      "238 671\r\n",
      "Original :  gabapentin\r\n",
      "Extracted:  gabapentin\r\n",
      "239 671\r\n",
      "Original :  gabapentin\r\n",
      "Extracted:  gabapentin\r\n",
      "240 1234\r\n",
      "Original :  withdrawal symptoms and help with pain, anxiety, and sleep\r\n",
      "Extracted:  withdrawal symptoms and help with pain, anxiety, and sleep\r\n",
      "241 1382\r\n",
      "Original :  4 mg three times daily, can increase to 8 mg three times daily\r\n",
      "Extracted:  4 mg three times daily, can increase to 8 mg three times daily\r\n",
      "242 78\r\n",
      "Original :  hydroxyzine 25 to 50 mg three times a day as needed, diphenhydramine 25 mg every 6 hours as needed\r\n",
      "Extracted:  hydroxyzine 25 to 50 mg three times a day as needed, diphenhydramine 25 mg every 6 hours as needed\r\n",
      "243 200\r\n",
      "Original :  for veterans older than 65 years\r\n",
      "Extracted:  for veterans older than 65 years\r\n",
      "244 273\r\n",
      "Original :  nsaids (e.g., naproxen 375 to 500 mg twice daily or ibuprofen 400 to 600 mg four times daily), acetaminophen 650 mg every 6 hours as needed, topical medications like menthol/methylsalicylate cream, lidocaine cream/ointment\r\n",
      "Extracted:  nsaids (e.g., naproxen 375 to 500 mg twice daily or ibuprofen 400 to 600 mg four times daily), acetaminophen 650 mg every 6 hours as needed, topical medications like menthol/methylsalicylate cream, lidocaine cream/ointment\r\n",
      "245 525\r\n",
      "Original :  patients with risk of gi bleed, renal compromise, cardiac disease\r\n",
      "Extracted:  patients with risk of gi bleed, renal compromise, cardiac disease\r\n",
      "246 638\r\n",
      "Original :  trazodone 25 to 300 mg orally at bedtime\r\n",
      "Extracted:  trazodone 25 to 300 mg orally at bedtime\r\n",
      "247 37\r\n",
      "Original :  prochlorperazine 5 to 10 mg every 4 hours as needed, promethazine 25 mg orally or rectally every 6 hours as needed, ondansetron 4 mg every 6 hours as needed\r\n",
      "Extracted:  prochlorperazine 5 to 10 mg every 4 hours as needed, promethazine 25 mg orally or rectally every 6 hours as needed, ondansetron 4 mg every 6 hours as needed\r\n",
      "248 242\r\n",
      "Original :  dicyclomine 20 mg every 6 to 8 hours as needed\r\n",
      "Extracted:  dicyclomine 20 mg every 6 to 8 hours as needed\r\n",
      "249 329\r\n",
      "Original :  loperamide 4 mg orally initially, then 2 mg with each loose stool, not to exceed 16 mg daily; bismuth subsalicylate 524 mg every 0.5 to 1 hour orally, not to exceed 4192 mg/day\r\n",
      "Extracted:  loperamide 4 mg orally initially, then 2 mg with each loose stool, not to exceed 16 mg daily; bismuth subsalicylate 524 mg every 0.5 to 1 hour orally, not to exceed 4192 mg/day\r\n",
      "250 91\r\n",
      "Original :  the best information available at the time of publication\r\n",
      "Extracted:  the best information available at the time of publication\r\n",
      "251 171\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Original :  provide information and assist decision making\r\n",
      "Extracted:  provide information and assist decision making\r\n",
      "252 244\r\n",
      "Original :  define a standard of care \r\n",
      "Extracted:  define a standard of care \r\n",
      "253 251\r\n",
      "Original :  a standard of care\r\n",
      "Extracted:  a standard of care\r\n",
      "254 341\r\n",
      "Original :  as prescribing an exclusive course of management\r\n",
      "Extracted:  as prescribing an exclusive course of management\r\n",
      "255 46\r\n",
      "Original :  a systematic review of both clinical and epidemiological evidence\r\n",
      "Extracted:  a systematic review of both clinical and epidemiological evidence\r\n",
      "256 126\r\n",
      "Original :  a panel of multidisciplinary experts\r\n",
      "Extracted:  a panel of multidisciplinary experts\r\n",
      "257 167\r\n",
      "Original :  provides a clear explanation of the logical relationships between various care options and health outcomes while rating both the quality of the evidence and the strength of the recommendation\r\n",
      "Extracted:  provides a clear explanation of the logical relationships between various care options and health outcomes while rating both the quality of the evidence and the strength of the recommendation\r\n",
      "258 63\r\n",
      "Original :  when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice\r\n",
      "Extracted:  when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice\r\n",
      "259 214\r\n",
      "Original :  every healthcare professional making use of these guidelines\r\n",
      "Extracted:  every healthcare professional making use of these guidelines\r\n",
      "260 294\r\n",
      "Original :  evaluating the appropriateness of applying them in the setting of any particular clinical situation\r\n",
      "Extracted:  evaluating the appropriateness of applying them in the setting of any particular clinical situation\r\n",
      "261 72\r\n",
      "Original :  inclusion of recommendations for specific testing and/or therapeutic interventions within these guidelines\r\n",
      "Extracted:  inclusion of recommendations for specific testing and/or therapeutic interventions within these guidelines\r\n",
      "262 154\r\n",
      "Original :  2004\r\n",
      "Extracted:  2004\r\n",
      "263 72\r\n",
      "Original :  evidence-based practice work group\r\n",
      "Extracted:  evidence-based practice work group\r\n",
      "264 175\r\n",
      "Original :  to advise the “…health executive council on the use of clinical and epidemiological evidence to improve the health of the population across the veterans health administration and military health system,” by facilitating the development of clinical practice guidelines (cpgs) for the va and dod populations\r\n",
      "Extracted:  to advise the “…health executive council on the use of clinical and epidemiological evidence to improve the health of the population across the veterans health administration and military health system,” by facilitating the development of clinical practice guidelines (cpgs) for the va and dod populations\r\n",
      "265 379\r\n",
      "Original :  by facilitating the development of clinical practice guidelines (cpgs) for the va and dod populations\r\n",
      "Extracted:  by facilitating the development of clinical practice guidelines (cpgs) for the va and dod populations\r\n",
      "266 414\r\n",
      "Original :  clinical practice guidelines\r\n",
      "Extracted:  clinical practice guidelines\r\n",
      "267 506\r\n",
      "Original :  provide healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with chronic pain who are on or being considered for long-term opioid therapy (lot)\r\n",
      "Extracted:  provide healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with chronic pain who are on or being considered for long-term opioid therapy (lot)\r\n",
      "268 694\r\n",
      "Original :  long-term opioid therapy\r\n",
      "Extracted:  long-term opioid therapy\r\n",
      "269 3\r\n",
      "Original :  2010\r\n",
      "Extracted:  2010\r\n",
      "270 9\r\n",
      "Original :  the va and dod\r\n",
      "Extracted:  the va and dod\r\n",
      "271 150\r\n",
      "Original :  evidence reviewed through march 2009\r\n",
      "Extracted:  evidence reviewed through march 2009\r\n",
      "272 194\r\n",
      "Original :  the release of that guideline\r\n",
      "Extracted:  the release of that guideline\r\n",
      "273 194\r\n",
      "Original :  the release of that guideline\r\n",
      "Extracted:  the release of that guideline\r\n",
      "274 263\r\n",
      "Original :  an epidemic of opioid misuse and opioid use disorder (oud) in america, including among america’s veterans\r\n",
      "Extracted:  an epidemic of opioid misuse and opioid use disorder (oud) in america, including among america’s veterans\r\n",
      "275 71\r\n",
      "Original :  in 2015\r\n",
      "Extracted:  in 2015\r\n",
      "276 187\r\n",
      "Original :  objective, evidence-based information on the management of chronic pain\r\n",
      "Extracted:  objective, evidence-based information on the management of chronic pain\r\n",
      "277 275\r\n",
      "Original :  to assist healthcare providers in all aspects of patient care, including, but not limited to, diagnosis, treatment, and follow-up\r\n",
      "Extracted:  to assist healthcare providers in all aspects of patient care, including, but not limited to, diagnosis, treatment, and follow-up\r\n",
      "278 42\r\n",
      "Original :  to improve the patient’s health and well-being by providing evidence-based guidance to providers who are taking care of patients on or being considered for lot\r\n",
      "Extracted:  to improve the patient’s health and well-being by providing evidence-based guidance to providers who are taking care of patients on or being considered for lot\r\n",
      "279 89\r\n",
      "Original :  by providing evidence-based guidance to providers who are taking care of patients on or being considered for lot\r\n",
      "Extracted:  by providing evidence-based guidance to providers who are taking care of patients on or being considered for lot\r\n",
      "280 274\r\n",
      "Original :  to assess the patient’s condition, provide education, and determine the best treatment methods in collaboration with the patient and a multidisciplinary care team, optimize the patient’s health outcomes and function and improve quality of life, minimize preventable complications and morbidity, emphasize the use of patient-centered care\r\n",
      "Extracted:  to assess the patient’s condition, provide education, and determine the best treatment methods in collaboration with the patient and a multidisciplinary care team, optimize the patient’s health outcomes and function and improve quality of life, minimize preventable complications and morbidity, emphasize the use of patient-centered care\r\n",
      "281 79\r\n",
      "Original :  general clinicians or specialists\r\n",
      "Extracted:  general clinicians or specialists\r\n",
      "282 113\r\n",
      "Original :  to study and consider the latest information on opioid therapy (ot) and how and whether to incorporate that information or recommendations into their practice\r\n",
      "Extracted:  to study and consider the latest information on opioid therapy (ot) and how and whether to incorporate that information or recommendations into their practice\r\n",
      "283 0\r\n",
      "Original :  this guideline\r\n",
      "Extracted:  this guideline\r\n",
      "284 291\r\n",
      "Original :  provide specific information\r\n",
      "Extracted:  provide specific information\r\n",
      "285 358\r\n",
      "Original :  looking up the dosing of a medication used less frequently or the meaning of the urine drug testing (udt) result\r\n",
      "Extracted:  looking up the dosing of a medication used less frequently or the meaning of the urine drug testing (udt) result\r\n",
      "286 476\r\n",
      "Original :  section on tapering and its accompanying appendix\r\n",
      "Extracted:  section on tapering and its accompanying appendix\r\n",
      "287 703\r\n",
      "Original :  to educate themselves and better understand their care\r\n",
      "Extracted:  to educate themselves and better understand their care\r\n",
      "288 796\r\n",
      "Original :  to assure that its clinicians and patients have the resources available to compassionately, effectively, and safely evaluate and deliver lot in a timely, culturally sensitive manner\r\n",
      "Extracted:  to assure that its clinicians and patients have the resources available to compassionately, effectively, and safely evaluate and deliver lot in a timely, culturally sensitive manner\r\n",
      "289 118\r\n",
      "Original :  on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advances and patterns evolve\r\n",
      "Extracted:  on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advances and patterns evolve\r\n",
      "290 364\r\n",
      "Original :  the variety of ever-changing state regulations that may be pertinent\r\n",
      "Extracted:  the variety of ever-changing state regulations that may be pertinent\r\n",
      "291 535\r\n",
      "Original :  the individual clinician\r\n",
      "Extracted:  the individual clinician\r\n",
      "292 573\r\n",
      "Original :  the patient’s clinical presentation, patient preferences, and the available diagnostic and treatment options\r\n",
      "Extracted:  the patient’s clinical presentation, patient preferences, and the available diagnostic and treatment options\r\n",
      "293 795\r\n",
      "Original :  a recommendation, within the context of a provider’s clinical judgment and patient values and preferences, in the care for an individual patient.\r\n",
      "Extracted:  a recommendation, within the context of a provider’s clinical judgment and patient values and preferences, in the care for an individual patient.\r\n",
      "294 46\r\n",
      "Original :  a systematic approach considering four domains as per the grading of recommendations assessment, development and evaluation (grade) approach\r\n",
      "Extracted:  a systematic approach considering four domains as per the grading of recommendations assessment, development and evaluation (grade) approach\r\n",
      "295 104\r\n",
      "Original :  grading of recommendations assessment, development and evaluation\r\n",
      "Extracted:  grading of recommendations assessment, development and evaluation\r\n",
      "296 211\r\n",
      "Original :  confidence in the quality of the evidence, balance of desirable and undesirable outcomes (i.e., benefits and harms), patient or provider values and preferences, and other implications, as appropriate (e.g., resource use, equity, acceptability)\r\n",
      "Extracted:  confidence in the quality of the evidence, balance of desirable and undesirable outcomes (i.e., benefits and harms), patient or provider values and preferences, and other implications, as appropriate (e.g., resource use, equity, acceptability)\r\n",
      "297 95\r\n",
      "Original :  multiple instances in which confidence in the quality of the evidence was low or very low, while there was marked imbalance of benefits and harms, as well as certain other important considerations arising from the domains of values and preferences and/or other implications\r\n",
      "Extracted:  multiple instances in which confidence in the quality of the evidence was low or very low, while there was marked imbalance of benefits and harms, as well as certain other important considerations arising from the domains of values and preferences and/or other implications\r\n",
      "298 385\r\n",
      "Original :  the harms due to the potential for severe adverse events associated with opioids, particularly overdose and oud\r\n",
      "Extracted:  the harms due to the potential for severe adverse events associated with opioids, particularly overdose and oud\r\n",
      "299 586\r\n",
      "Original :  these factors\r\n",
      "Extracted:  these factors\r\n",
      "300 139\r\n",
      "Original :  self-management strategies and other non-pharmacological treatments\r\n",
      "Extracted:  self-management strategies and other non-pharmacological treatments\r\n",
      "301 54\r\n",
      "Original :  opioid therapy\r\n",
      "Extracted:  opioid therapy\r\n",
      "302 208\r\n",
      "Original :  when pharmacologic therapies are used\r\n",
      "Extracted:  when pharmacologic therapies are used\r\n",
      "303 260\r\n",
      "Original :  non-opioids over opioids\r\n",
      "Extracted:  non-opioids over opioids\r\n",
      "304 3\r\n",
      "Original :  strongly recommend against\r\n",
      "Extracted:  strongly recommend against\r\n",
      "305 361\r\n",
      "Original :  a short duration\r\n",
      "Extracted:  a short duration\r\n",
      "306 286\r\n",
      "Original :  if prescribing opioid therapy for patients with chronic pain\r\n",
      "Extracted:  if prescribing opioid therapy for patients with chronic pain\r\n",
      "307 385\r\n",
      "Original :  consideration of opioid therapy beyond 90 days\r\n",
      "Extracted:  consideration of opioid therapy beyond 90 days\r\n",
      "308 441\r\n",
      "Original :  reevaluation and discussion with patient of risks and benefits\r\n",
      "Extracted:  reevaluation and discussion with patient of risks and benefits\r\n",
      "309 65\r\n",
      "Original :  ongoing risk mitigation strategies, assessment for opioid use disorder, and consideration for tapering when risks exceed benefits\r\n",
      "Extracted:  ongoing risk mitigation strategies, assessment for opioid use disorder, and consideration for tapering when risks exceed benefits\r\n",
      "310 199\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "311 417\r\n",
      "Original :  close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering\r\n",
      "Extracted:  close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering\r\n",
      "312 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "313 150\r\n",
      "Original :  consider tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate\r\n",
      "Extracted:  consider tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate\r\n",
      "314 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "315 498\r\n",
      "Original :  close monitoring and consideration for tapering when risks exceed benefits\r\n",
      "Extracted:  close monitoring and consideration for tapering when risks exceed benefits\r\n",
      "316 13\r\n",
      "Original :  implementing risk mitigation strategies\r\n",
      "Extracted:  implementing risk mitigation strategies\r\n",
      "317 98\r\n",
      "Original :  starting with an informed consent conversation covering the risks and benefits of opioid therapy as well as alternative therapies\r\n",
      "Extracted:  starting with an informed consent conversation covering the risks and benefits of opioid therapy as well as alternative therapies\r\n",
      "318 229\r\n",
      "Original :  the strategies and their frequency\r\n",
      "Extracted:  the strategies and their frequency\r\n",
      "319 317\r\n",
      "Original :  ongoing, random urine drug testing (including appropriate confirmatory testing), checking state prescription drug monitoring programs, monitoring for overdose potential and suicidality, providing overdose education, prescribing of naloxone rescue and accompanying education\r\n",
      "Extracted:  ongoing, random urine drug testing (including appropriate confirmatory testing), checking state prescription drug monitoring programs, monitoring for overdose potential and suicidality, providing overdose education, prescribing of naloxone rescue and accompanying education\r\n",
      "320 13\r\n",
      "Original :  assessing suicide risk and intervening when necessary\r\n",
      "Extracted:  assessing suicide risk and intervening when necessary\r\n",
      "321 67\r\n",
      "Original :  when considering initiating or continuing long-term opioid therapy\r\n",
      "Extracted:  when considering initiating or continuing long-term opioid therapy\r\n",
      "322 239\r\n",
      "Original :  at least every three months\r\n",
      "Extracted:  at least every three months\r\n",
      "323 148\r\n",
      "Original :  evaluating benefits of continued opioid therapy and risk for opioid-related adverse events\r\n",
      "Extracted:  evaluating benefits of continued opioid therapy and risk for opioid-related adverse events\r\n",
      "324 200\r\n",
      "Original :  risk for opioid-related adverse events\r\n",
      "Extracted:  risk for opioid-related adverse events\r\n",
      "325 159\r\n",
      "Original :  benefits of continued opioid therapy\r\n",
      "Extracted:  benefits of continued opioid therapy\r\n",
      "326 321\r\n",
      "Original :  lowest dose of opioids as indicated by patient-specific risks and benefits\r\n",
      "Extracted:  lowest dose of opioids as indicated by patient-specific risks and benefits\r\n",
      "327 360\r\n",
      "Original :  patient-specific risks and benefits\r\n",
      "Extracted:  patient-specific risks and benefits\r\n",
      "328 415\r\n",
      "Original :  absolutely safe\r\n",
      "Extracted:  absolutely safe\r\n",
      "329 49\r\n",
      "Original :  more frequent monitoring for adverse events including opioid use disorder and overdose\r\n",
      "Extracted:  more frequent monitoring for adverse events including opioid use disorder and overdose\r\n",
      "330 0\r\n",
      "Original :  as opioid dosage and risk increase\r\n",
      "Extracted:  as opioid dosage and risk increase\r\n",
      "331 179\r\n",
      "Original :  at any dose\r\n",
      "Extracted:  at any dose\r\n",
      "332 204\r\n",
      "Original :  in a dose dependent manner\r\n",
      "Extracted:  in a dose dependent manner\r\n",
      "333 298\r\n",
      "Original :  20- 50 mg morphine equivalent daily dose\r\n",
      "Extracted:  20- 50 mg morphine equivalent daily dose\r\n",
      "334 232\r\n",
      "Original :  risks for overdose and death\r\n",
      "Extracted:  risks for overdose and death\r\n",
      "335 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "336 200\r\n",
      "Original :  evaluate for tapering to reduced dose or to discontinuation\r\n",
      "Extracted:  evaluate for tapering to reduced dose or to discontinuation\r\n",
      "337 113\r\n",
      "Original :  patients who are currently prescribed doses over 90 mg morphine equivalent daily dose\r\n",
      "Extracted:  patients who are currently prescribed doses over 90 mg morphine equivalent daily dose\r\n",
      "338 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "339 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "340 13\r\n",
      "Original :  tapering to reduced dose or to discontinuation of long-term opioid therapy\r\n",
      "Extracted:  tapering to reduced dose or to discontinuation of long-term opioid therapy\r\n",
      "341 88\r\n",
      "Original :  when risks of long-term opioid therapy outweigh benefits\r\n",
      "Extracted:  when risks of long-term opioid therapy outweigh benefits\r\n",
      "342 152\r\n",
      "Original :  abrupt discontinuation\r\n",
      "Extracted:  abrupt discontinuation\r\n",
      "343 294\r\n",
      "Original :  risk assessment and patient needs and characteristics\r\n",
      "Extracted:  risk assessment and patient needs and characteristics\r\n",
      "344 13\r\n",
      "Original :  interdisciplinary\r\n",
      "Extracted:  interdisciplinary\r\n",
      "345 41\r\n",
      "Original :  addresses pain, substance use disorders, and/or mental health problems for patients presenting with high risk and/or aberrant behavior\r\n",
      "Extracted:  addresses pain, substance use disorders, and/or mental health problems for patients presenting with high risk and/or aberrant behavior\r\n",
      "346 199\r\n",
      "Original :  medication assisted treatment\r\n",
      "Extracted:  medication assisted treatment\r\n",
      "347 256\r\n",
      "Original :  patients with chronic pain and opioid use disorder\r\n",
      "Extracted:  patients with chronic pain and opioid use disorder\r\n",
      "348 233\r\n",
      "Original :  opioid use disorder\r\n",
      "Extracted:  opioid use disorder\r\n",
      "349 322\r\n",
      "Original :  va/dod clinical practice guideline\r\n",
      "Extracted:  va/dod clinical practice guideline\r\n",
      "350 13\r\n",
      "Original :  alternatives to opioids\r\n",
      "Extracted:  alternatives to opioids\r\n",
      "351 41\r\n",
      "Original :  mild-to-moderate acute pain\r\n",
      "Extracted:  mild-to-moderate acute pain\r\n",
      "352 155\r\n",
      "Original :  when opioids are used for acute pain\r\n",
      "Extracted:  when opioids are used for acute pain\r\n",
      "353 88\r\n",
      "Original :  multimodal pain care including non-opioid medications as indicated\r\n",
      "Extracted:  multimodal pain care including non-opioid medications as indicated\r\n",
      "354 248\r\n",
      "Original :  immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if adjustments or continuing opioid therapy is indicated\r\n",
      "Extracted:  immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if adjustments or continuing opioid therapy is indicated\r\n",
      "355 290\r\n",
      "Original :  lowest effective\r\n",
      "Extracted:  lowest effective\r\n",
      "356 345\r\n",
      "Original :  no later than 3-5 days\r\n",
      "Extracted:  no later than 3-5 days\r\n",
      "357 368\r\n",
      "Original :  to determine if adjustments or continuing opioid therapy is indicated\r\n",
      "Extracted:  to determine if adjustments or continuing opioid therapy is indicated\r\n",
      "358 453\r\n",
      "Original :  education about opioid risks and alternatives to opioid therapy\r\n",
      "Extracted:  education about opioid risks and alternatives to opioid therapy\r\n",
      "359 50\r\n",
      "Original :  facilitate understanding of the clinical pathway and decision making process used in management of lot\r\n",
      "Extracted:  facilitate understanding of the clinical pathway and decision making process used in management of lot\r\n",
      "360 247\r\n",
      "Original :  the understanding that such a format may promote more efficient diagnostic and therapeutic decision making and has the potential to change patterns of resource use\r\n",
      "Extracted:  the understanding that such a format may promote more efficient diagnostic and therapeutic decision making and has the potential to change patterns of resource use\r\n",
      "361 452\r\n",
      "Original :  not all clinical practices are linear\r\n",
      "Extracted:  not all clinical practices are linear\r\n",
      "362 588\r\n",
      "Original :  to assess the critical information needed at the major decision points in the clinical process\r\n",
      "Extracted:  to assess the critical information needed at the major decision points in the clinical process\r\n",
      "363 575\r\n",
      "Original :  the provider\r\n",
      "Extracted:  the provider\r\n",
      "364 696\r\n",
      "Original :  an ordered sequence of steps of care, recommended observations and examinations, decisions to be considered, actions to be taken\r\n",
      "Extracted:  an ordered sequence of steps of care, recommended observations and examinations, decisions to be considered, actions to be taken\r\n",
      "365 18\r\n",
      "Original :  determination of appropriateness for opioid therapy\r\n",
      "Extracted:  determination of appropriateness for opioid therapy\r\n",
      "366 77\r\n",
      "Original :  non-pharmacologic and non-opioid pharmacologic\r\n",
      "Extracted:  non-pharmacologic and non-opioid pharmacologic\r\n",
      "367 263\r\n",
      "Original :  proceed to module d\r\n",
      "Extracted:  proceed to module d\r\n",
      "368 385\r\n",
      "Original :  obtain biopsychosocial assessment. then educate or re-educate on non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment. then implement and optimize non-opioid treatments for chronic pain (e.g., physical, psychological, and complementary and integrative treatments).\r\n",
      "Extracted:  obtain biopsychosocial assessment. then educate or re-educate on non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment. then implement and optimize non-opioid treatments for chronic pain (e.g., physical, psychological, and complementary and integrative treatments).\r\n",
      "369 450\r\n",
      "Original :  non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment\r\n",
      "Extracted:  non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment\r\n",
      "370 619\r\n",
      "Original :  non-opioid treatments for chronic pain\r\n",
      "Extracted:  non-opioid treatments for chronic pain\r\n",
      "371 816\r\n",
      "Original :  exit algorithm; manage with non-opioid modalities\r\n",
      "Extracted:  exit algorithm; manage with non-opioid modalities\r\n",
      "372 950\r\n",
      "Original :  complete opioid risk assessment and see if patient risks outweigh benefits by considering strength and number of risk factors and patient preference\r\n",
      "Extracted:  complete opioid risk assessment and see if patient risks outweigh benefits by considering strength and number of risk factors and patient preference\r\n",
      "373 1025\r\n",
      "Original :  by considering strength and number of risk factors and patient preference\r\n",
      "Extracted:  by considering strength and number of risk factors and patient preference\r\n",
      "374 1141\r\n",
      "Original :  see whether referral/consultation for evaluation and treatment is indicated (e.g., mental health, sud, more intensive interdisciplinary care)\r\n",
      "Extracted:  see whether referral/consultation for evaluation and treatment is indicated (e.g., mental health, sud, more intensive interdisciplinary care)\r\n",
      "375 1357\r\n",
      "Original :  refer/consult with appropriate interdisciplinary treatments. then after referral/consultation with appropriate interdisciplinary treatments, see if the patient is willing to engage in a comprehensive pain care plan.\r\n",
      "Extracted:  refer/consult with appropriate interdisciplinary treatments. then after referral/consultation with appropriate interdisciplinary treatments, see if the patient is willing to engage in a comprehensive pain care plan.\r\n",
      "376 1498\r\n",
      "Original :  see if the patient is willing to engage in a comprehensive pain care plan\r\n",
      "Extracted:  see if the patient is willing to engage in a comprehensive pain care plan\r\n",
      "377 816\r\n",
      "Original :  exit algorithm; manage with non-opioid modalities\r\n",
      "Extracted:  exit algorithm; manage with non-opioid modalities\r\n",
      "378 1932\r\n",
      "Original :  educate the patient and family about treatment options, including education on known risks and unknown long-term benefits of ot, risks of sud and overdose, need for risk mitigation strategies, naloxone rescue. then see if adding ot to comprehensive pain therapy is indicated at this time.\r\n",
      "Extracted:  educate the patient and family about treatment options, including education on known risks and unknown long-term benefits of ot, risks of sud and overdose, need for risk mitigation strategies, naloxone rescue. then see if adding ot to comprehensive pain therapy is indicated at this time.\r\n",
      "379 1969\r\n",
      "Original :  treatment options, including education on known risks and unknown long-term benefits of ot, risks of sud and overdose, need for risk mitigation strategies, naloxone rescue\r\n",
      "Extracted:  treatment options, including education on known risks and unknown long-term benefits of ot, risks of sud and overdose, need for risk mitigation strategies, naloxone rescue\r\n",
      "380 2296\r\n",
      "Original :  see if the patient is prepared to accept responsibilities and the provider is prepared to implement risk mitigation strategies\r\n",
      "Extracted:  see if the patient is prepared to accept responsibilities and the provider is prepared to implement risk mitigation strategies\r\n",
      "381 816\r\n",
      "Original :  exit algorithm; manage with non-opioid modalities\r\n",
      "Extracted:  exit algorithm; manage with non-opioid modalities\r\n",
      "382 2683\r\n",
      "Original :  discuss and complete written informed consent with patient and family, determine and document treatment plan, and proceed to module b\r\n",
      "Extracted:  discuss and complete written informed consent with patient and family, determine and document treatment plan, and proceed to module b\r\n",
      "383 816\r\n",
      "Original :  exit algorithm; manage with non-opioid modalities\r\n",
      "Extracted:  exit algorithm; manage with non-opioid modalities\r\n",
      "384 49\r\n",
      "Original :  pain assessment, patient functional goals, impact of pain on family, work, life, review of previous diagnostic studies, additional consultations and referrals, coexisting illness and treatments and effect on pain, significant psychological, social, or behavioral factors that may affect treatment, family history of chronic pain, collateral of family involvement, patient beliefs/knowledge of the cause of their pain and their treatment preferences along with the perceived efficacy of various treatment options\r\n",
      "Extracted:  pain assessment, patient functional goals, impact of pain on family, work, life, review of previous diagnostic studies, additional consultations and referrals, coexisting illness and treatments and effect on pain, significant psychological, social, or behavioral factors that may affect treatment, family history of chronic pain, collateral of family involvement, patient beliefs/knowledge of the cause of their pain and their treatment preferences along with the perceived efficacy of various treatment options\r\n",
      "385 612\r\n",
      "Original :  psychological factors related to continuing vs. tapering ot\r\n",
      "Extracted:  psychological factors related to continuing vs. tapering ot\r\n",
      "386 758\r\n",
      "Original :  history, physical exam, comorbidities, previous treatment and medications, duration of symptoms, onset and triggers\r\n",
      "Extracted:  history, physical exam, comorbidities, previous treatment and medications, duration of symptoms, onset and triggers\r\n",
      "387 703\r\n",
      "Original :  beliefs, expectations, fears\r\n",
      "Extracted:  beliefs, expectations, fears\r\n",
      "388 964\r\n",
      "Original :  true life-threatening allergy to opioids, active sud, elevated suicide risk, concomitant use of benzodiazepines\r\n",
      "Extracted:  true life-threatening allergy to opioids, active sud, elevated suicide risk, concomitant use of benzodiazepines\r\n",
      "389 1091\r\n",
      "Original :  long-term opioid therapy\r\n",
      "Extracted:  long-term opioid therapy\r\n",
      "390 928\r\n",
      "Original :  opioid therapy\r\n",
      "Extracted:  opioid therapy\r\n",
      "391 1161\r\n",
      "Original :  prescription drug monitoring program\r\n",
      "Extracted:  prescription drug monitoring program\r\n",
      "392 1213\r\n",
      "Original :  substance use disorder\r\n",
      "Extracted:  substance use disorder\r\n",
      "393 1251\r\n",
      "Original :  urine drug test\r\n",
      "Extracted:  urine drug test\r\n",
      "394 1297\r\n",
      "Original :  va/dod clinical practice guideline for the assessment and management of patients at risk for suicide\r\n",
      "Extracted:  va/dod clinical practice guideline for the assessment and management of patients at risk for suicide\r\n",
      "395 18\r\n",
      "Original :  treatment with opioid therapy\r\n",
      "Extracted:  treatment with opioid therapy\r\n",
      "396 96\r\n",
      "Original :  the candidate for trial of ot with consent (in conjunction with a comprehensive pain care plan)\r\n",
      "Extracted:  the candidate for trial of ot with consent (in conjunction with a comprehensive pain care plan)\r\n",
      "397 235\r\n",
      "Original :  short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe, long-acting opioids should not be prescribed for opioid-naive individuals, consider alternatives to methadone and transdermal fentanyl, assessment of improvement in pain and functional status and adverse effects, offer overdose education and naloxone distribution (oend)\r\n",
      "Extracted:  short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe, long-acting opioids should not be prescribed for opioid-naive individuals, consider alternatives to methadone and transdermal fentanyl, assessment of improvement in pain and functional status and adverse effects, offer overdose education and naloxone distribution (oend)\r\n",
      "398 235\r\n",
      "Original :  short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe\r\n",
      "Extracted:  short duration (e.g., 1 week initial prescription; no more than 3 months total), use the lowest effective dose recognizing that no dose is completely safe\r\n",
      "399 663\r\n",
      "Original :  a strategy of escalating dose to achieve benefit increases risk and has not been shown to improve function.\r\n",
      "Extracted:  a strategy of escalating dose to achieve benefit increases risk and has not been shown to improve function.\r\n",
      "400 787\r\n",
      "Original :  above 20-50 mg medd\r\n",
      "Extracted:  above 20-50 mg medd\r\n",
      "401 440\r\n",
      "Original :  opioid-naive individuals\r\n",
      "Extracted:  opioid-naive individuals\r\n",
      "402 391\r\n",
      "Original :  long-acting opioids should not be prescribed for opioid-naive individuals\r\n",
      "Extracted:  long-acting opioids should not be prescribed for opioid-naive individuals\r\n",
      "403 491\r\n",
      "Original :  methadone and transdermal fentanyl\r\n",
      "Extracted:  methadone and transdermal fentanyl\r\n",
      "404 925\r\n",
      "Original :  admit/provide medical and psychiatric treatment to stabilize as indicated\r\n",
      "Extracted:  admit/provide medical and psychiatric treatment to stabilize as indicated\r\n",
      "405 1064\r\n",
      "Original :  see if there is a clinically meaningful improvement in function in the absence of significant risk factors\r\n",
      "Extracted:  see if there is a clinically meaningful improvement in function in the absence of significant risk factors\r\n",
      "406 1281\r\n",
      "Original :  review and optimize comprehensive pain care plan (e.g., non-opioid treatments, self-management strategies)\r\n",
      "Extracted:  review and optimize comprehensive pain care plan (e.g., non-opioid treatments, self-management strategies)\r\n",
      "407 1337\r\n",
      "Original :  non-opioid treatments, self-management strategies\r\n",
      "Extracted:  non-opioid treatments, self-management strategies\r\n",
      "408 1499\r\n",
      "Original :  taper to discontinuation (consult module c if needed), exit algorithm and manage with non-opioid modalities\r\n",
      "Extracted:  taper to discontinuation (consult module c if needed), exit algorithm and manage with non-opioid modalities\r\n",
      "409 1638\r\n",
      "Original :  patient risk factors (e.g., 1-4 weeks with any dose change; up to every 3 months without dose change if clinically and functionally stable)\r\n",
      "Extracted:  patient risk factors (e.g., 1-4 weeks with any dose change; up to every 3 months without dose change if clinically and functionally stable)\r\n",
      "410 1799\r\n",
      "Original :  assess function, risks, and benefits of ot, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or sud); complete risk mitigation strategies; review and optimize comprehensive pain care plan\r\n",
      "Extracted:  assess function, risks, and benefits of ot, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or sud); complete risk mitigation strategies; review and optimize comprehensive pain care plan\r\n",
      "411 1806\r\n",
      "Original :  function, risks, and benefits of ot, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or sud)\r\n",
      "Extracted:  function, risks, and benefits of ot, progress toward functional treatment goals, adverse effects, adherence to treatment plan, complications or co-occurring conditions (e.g., medical, mental health, and/or sud)\r\n",
      "412 162\r\n",
      "Original :  comprehensive pain care plan\r\n",
      "Extracted:  comprehensive pain care plan\r\n",
      "413 2147\r\n",
      "Original :  non-adherence, co-occurring conditions, behaviors suggesting oud, indications for referral\r\n",
      "Extracted:  non-adherence, co-occurring conditions, behaviors suggesting oud, indications for referral\r\n",
      "414 2274\r\n",
      "Original :  consider one or more of the following: shortening prescribing interval, intensifying risk mitigation strategies, increasing intensity of monitoring, referring to interdisciplinary care and consulting with or referring to specialty care\r\n",
      "Extracted:  consider one or more of the following: shortening prescribing interval, intensifying risk mitigation strategies, increasing intensity of monitoring, referring to interdisciplinary care and consulting with or referring to specialty care\r\n",
      "415 2574\r\n",
      "Original :  see if there are indications to discontinue or taper\r\n",
      "Extracted:  see if there are indications to discontinue or taper\r\n",
      "416 2683\r\n",
      "Original :  taper to reduced dose or taper to discontinuation\r\n",
      "Extracted:  taper to reduced dose or taper to discontinuation\r\n",
      "417 2792\r\n",
      "Original :  reassess in 1-3 months or more frequently as determined by patient risk factors\r\n",
      "Extracted:  reassess in 1-3 months or more frequently as determined by patient risk factors\r\n",
      "418 41\r\n",
      "Original :  oend, udt, pdmp, face-to-face follow-up with frequency determined by risk\r\n",
      "Extracted:  oend, udt, pdmp, face-to-face follow-up with frequency determined by risk\r\n",
      "419 177\r\n",
      "Original :  risks of ot outweigh benefits, patient preference, diversion\r\n",
      "Extracted:  risks of ot outweigh benefits, patient preference, diversion\r\n",
      "420 316\r\n",
      "Original :  lack of clinically meaningful improvement in function, concomitant use of medications that increase risk of overdose, co-occurring medical or mental health conditions that increase risk, concerns about oud or other sud, patient non-compliance with opioid safety measures and opioid risk mitigation strategies, patient non-participation in a comprehensive pain care plan, prescribed dose higher than the maximal recommended dose, pain condition not effectively treated with opioids (e.g., back pain with normal mri; fibromyalgia), medical or mental health comorbidities that increase risk, improvement in the underlying pain condition being treated, unmanageable side effects\r\n",
      "Extracted:  lack of clinically meaningful improvement in function, concomitant use of medications that increase risk of overdose, co-occurring medical or mental health conditions that increase risk, concerns about oud or other sud, patient non-compliance with opioid safety measures and opioid risk mitigation strategies, patient non-participation in a comprehensive pain care plan, prescribed dose higher than the maximal recommended dose, pain condition not effectively treated with opioids (e.g., back pain with normal mri; fibromyalgia), medical or mental health comorbidities that increase risk, improvement in the underlying pain condition being treated, unmanageable side effects\r\n",
      "421 1055\r\n",
      "Original :  non-adherence to comprehensive pain care plan (e.g., attendance at appointment), unexpected udt and pdmp results, non-adherence to opioid prescription (e.g., using more than prescribed and/or running out early), higher risk medication characteristics (e.g., high-dose opioids, combination of opioids and benzodiazepines), patients with mental health, medical, or sud comorbidities that increase risk for adverse outcomes\r\n",
      "Extracted:  non-adherence to comprehensive pain care plan (e.g., attendance at appointment), unexpected udt and pdmp results, non-adherence to opioid prescription (e.g., using more than prescribed and/or running out early), higher risk medication characteristics (e.g., high-dose opioids, combination of opioids and benzodiazepines), patients with mental health, medical, or sud comorbidities that increase risk for adverse outcomes\r\n",
      "422 1108\r\n",
      "Original :  attendance at appointment\r\n",
      "Extracted:  attendance at appointment\r\n",
      "423 1213\r\n",
      "Original :  using more than prescribed and/or running out early\r\n",
      "Extracted:  using more than prescribed and/or running out early\r\n",
      "424 1313\r\n",
      "Original :  high-dose opioids, combination of opioids and benzodiazepines\r\n",
      "Extracted:  high-dose opioids, combination of opioids and benzodiazepines\r\n",
      "425 1492\r\n",
      "Original :  morphine equivalent daily dose\r\n",
      "Extracted:  morphine equivalent daily dose\r\n",
      "426 1581\r\n",
      "Original :  overdose education and naloxone distribution\r\n",
      "Extracted:  overdose education and naloxone distribution\r\n",
      "427 15\r\n",
      "Original :  tapering or discontinuation of opioid therapy\r\n",
      "Extracted:  tapering or discontinuation of opioid therapy\r\n",
      "428 139\r\n",
      "Original :  repeat comprehensive biopsychosocial assessment. then see if the patient demonstrates signs or symptoms of sud.\r\n",
      "Extracted:  repeat comprehensive biopsychosocial assessment. then see if the patient demonstrates signs or symptoms of sud.\r\n",
      "429 310\r\n",
      "Original :  see whether the patient is willing to engage in sud therapy\r\n",
      "Extracted:  see whether the patient is willing to engage in sud therapy\r\n",
      "430 428\r\n",
      "Original :  access specialized sud care with monitoring and follow-up appropriate for the patient’s needs (e.g., mat, treatment for comorbidities), see va/dod sud cpg, exit algorithms and manage with non-opioid modalities\r\n",
      "Extracted:  access specialized sud care with monitoring and follow-up appropriate for the patient’s needs (e.g., mat, treatment for comorbidities), see va/dod sud cpg, exit algorithms and manage with non-opioid modalities\r\n",
      "431 706\r\n",
      "Original :  look for evidence of diversion\r\n",
      "Extracted:  look for evidence of diversion\r\n",
      "432 778\r\n",
      "Original :  immediately discontinue opioid therapy\r\n",
      "Extracted:  immediately discontinue opioid therapy\r\n",
      "433 861\r\n",
      "Original :  look for high-risk or dangerous behavior (e.g., overdose event, accidents, and threatening provider)\r\n",
      "Extracted:  look for high-risk or dangerous behavior (e.g., overdose event, accidents, and threatening provider)\r\n",
      "434 909\r\n",
      "Original :  overdose event, accidents, and threatening provider\r\n",
      "Extracted:  overdose event, accidents, and threatening provider\r\n",
      "435 1106\r\n",
      "Original :  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "Extracted:  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "436 1106\r\n",
      "Original :  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "Extracted:  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "437 1106\r\n",
      "Original :  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "Extracted:  address safety and misuse, assess for withdrawal symptoms and offer expedited taper, immediate discontinuation or detox as indicated, continue to monitor for sud and mental health comorbidities and offer treatment as indicated (see va/dod sud cpg and academic detailing tapering document), exit algorithm and manage with non-opioid modalities\r\n",
      "438 1503\r\n",
      "Original :  develop an individualized tapering treatment plan (including pace of tapering, setting of care) based on patient and treatment characteristics\r\n",
      "Extracted:  develop an individualized tapering treatment plan (including pace of tapering, setting of care) based on patient and treatment characteristics\r\n",
      "439 1657\r\n",
      "Original :  1 week to 1 month\r\n",
      "Extracted:  1 week to 1 month\r\n",
      "440 1657\r\n",
      "Original :  1 week to 1 month\r\n",
      "Extracted:  1 week to 1 month\r\n",
      "441 1608\r\n",
      "Original :  patient and treatment characteristics\r\n",
      "Extracted:  patient and treatment characteristics\r\n",
      "442 1839\r\n",
      "Original :  educate on self-management and risks of ot, optimize whole person approach to pain care, optimize treatment of co-occurring mental health conditions, optimize non-opioid pain treatment modalities, reassess for oud and readiness for oud treatment as indicated\r\n",
      "Extracted:  educate on self-management and risks of ot, optimize whole person approach to pain care, optimize treatment of co-occurring mental health conditions, optimize non-opioid pain treatment modalities, reassess for oud and readiness for oud treatment as indicated\r\n",
      "443 2231\r\n",
      "Original :  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "Extracted:  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "444 2231\r\n",
      "Original :  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "Extracted:  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "445 2231\r\n",
      "Original :  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "Extracted:  repeat comprehensive biopsychosocial assessment and see if an sud is identified\r\n",
      "446 2342\r\n",
      "Original :  find out if the patient is willing to engage in sud therapy\r\n",
      "Extracted:  find out if the patient is willing to engage in sud therapy\r\n",
      "447 2437\r\n",
      "Original :  identify the followings: use of opioids to modulate emotions (i.e., “chemical coping”), untreated or undertreated psychiatric disorder\r\n",
      "Extracted:  identify the followings: use of opioids to modulate emotions (i.e., “chemical coping”), untreated or undertreated psychiatric disorder\r\n",
      "448 2709\r\n",
      "Original :  engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training\r\n",
      "Extracted:  engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training\r\n",
      "449 2709\r\n",
      "Original :  engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training\r\n",
      "Extracted:  engage the patient in appropriate behavioral and/or psychiatric treatment, ideally in an interdisciplinary setting, consider reduced rate of taper or pause in taper for patients actively engaged in skills training\r\n",
      "450 2462\r\n",
      "Original :  use of opioids to modulate emotions\r\n",
      "Extracted:  use of opioids to modulate emotions\r\n",
      "451 2834\r\n",
      "Original :  reduced rate of taper or pause in taper\r\n",
      "Extracted:  reduced rate of taper or pause in taper\r\n",
      "452 3040\r\n",
      "Original :  provide additional education about whole person pain care and lot and reassurance that the patient will not be abandoned, consider more frequent follow-up using the expanded care team (registered nurse, clinical pharmacist, health coach, mental health provider), consider reduced rate of taper or pause in taper for patients actively engaged in skills training, reassess for oud throughout the taper\r\n",
      "Extracted:  provide additional education about whole person pain care and lot and reassurance that the patient will not be abandoned, consider more frequent follow-up using the expanded care team (registered nurse, clinical pharmacist, health coach, mental health provider), consider reduced rate of taper or pause in taper for patients actively engaged in skills training, reassess for oud throughout the taper\r\n",
      "453 3201\r\n",
      "Original :  the expanded care team\r\n",
      "Extracted:  the expanded care team\r\n",
      "454 3225\r\n",
      "Original :  registered nurse, clinical pharmacist, health coach, mental health provider\r\n",
      "Extracted:  registered nurse, clinical pharmacist, health coach, mental health provider\r\n",
      "455 778\r\n",
      "Original :  immediately discontinue opioid therapy\r\n",
      "Extracted:  immediately discontinue opioid therapy\r\n",
      "456 1647\r\n",
      "Original :  follow-up 1 week to 1 month after each change in dosage and after discontinuation considering patient and treatment characteristics\r\n",
      "Extracted:  follow-up 1 week to 1 month after each change in dosage and after discontinuation considering patient and treatment characteristics\r\n",
      "457 20\r\n",
      "Original :  a gradual taper rate (5-10% reduction every 4 weeks) allows time for neurobiological, psychological, and behavioral adaptations\r\n",
      "Extracted:  a gradual taper rate (5-10% reduction every 4 weeks) allows time for neurobiological, psychological, and behavioral adaptations\r\n",
      "458 42\r\n",
      "Original :  5-10% reduction every 4 weeks\r\n",
      "Extracted:  5-10% reduction every 4 weeks\r\n",
      "459 80\r\n",
      "Original :  time for neurobiological, psychological, and behavioral adaptations\r\n",
      "Extracted:  time for neurobiological, psychological, and behavioral adaptations\r\n",
      "460 276\r\n",
      "Original :  consider interdisciplinary services that may include mental health, sud, primary care, and specialty pain care\r\n",
      "Extracted:  consider interdisciplinary services that may include mental health, sud, primary care, and specialty pain care\r\n",
      "461 208\r\n",
      "Original :  unmasked oud, exacerbation of underlying mental health conditions\r\n",
      "Extracted:  unmasked oud, exacerbation of underlying mental health conditions\r\n",
      "462 329\r\n",
      "Original :  mental health, sud, primary care, and specialty pain care\r\n",
      "Extracted:  mental health, sud, primary care, and specialty pain care\r\n",
      "463 396\r\n",
      "Original :  concerns that may negatively impact taper (e.g., inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and sud)\r\n",
      "Extracted:  concerns that may negatively impact taper (e.g., inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and sud)\r\n",
      "464 445\r\n",
      "Original :  inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and sud\r\n",
      "Extracted:  inability for adequate follow-up, inability to provide adequate treatment for co-occurring medical and mental health conditions and sud\r\n",
      "465 684\r\n",
      "Original :  opioid dose, duration of therapy, type of opioid formulation, psychiatric, medical and sud comorbidities and other patient risk factors (e.g., non-adherence, high-risk medication-related behavior, strength of social support, and coping)\r\n",
      "Extracted:  opioid dose, duration of therapy, type of opioid formulation, psychiatric, medical and sud comorbidities and other patient risk factors (e.g., non-adherence, high-risk medication-related behavior, strength of social support, and coping)\r\n",
      "466 16\r\n",
      "Original :  patients currently on opioid therapy\r\n",
      "Extracted:  patients currently on opioid therapy\r\n",
      "467 84\r\n",
      "Original :  look for factors that would require immediate attention and possible discontinuation of ot due to unacceptable risk\r\n",
      "Extracted:  look for factors that would require immediate attention and possible discontinuation of ot due to unacceptable risk\r\n",
      "468 267\r\n",
      "Original :  admit/provide treatment to stabilize, including opioid tapering or sud treatment as indicated\r\n",
      "Extracted:  admit/provide treatment to stabilize, including opioid tapering or sud treatment as indicated\r\n",
      "469 431\r\n",
      "Original :  obtain a biopsychosocial assessment\r\n",
      "Extracted:  obtain a biopsychosocial assessment\r\n",
      "470 582\r\n",
      "Original :  review data and re-assess risks and benefits of continuing ot and consider strength and number of risk factors\r\n",
      "Extracted:  review data and re-assess risks and benefits of continuing ot and consider strength and number of risk factors\r\n",
      "471 503\r\n",
      "Original :  current prescriber, prior and current udt, pdmp\r\n",
      "Extracted:  current prescriber, prior and current udt, pdmp\r\n",
      "472 715\r\n",
      "Original :  address factors related to incomplete data prior to prescribing. then review data and re-assess risks and benefits of continuing ot and consider strength and number of risk factors.\r\n",
      "Extracted:  address factors related to incomplete data prior to prescribing. then review data and re-assess risks and benefits of continuing ot and consider strength and number of risk factors.\r\n",
      "473 947\r\n",
      "Original :  proceed to module c\r\n",
      "Extracted:  proceed to module c\r\n",
      "474 1025\r\n",
      "Original :  educate/re-educate on the following: non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment options, preferred treatment methods being non-pharmacotherapy and non-opioid pharmacotherapy, new information on risks and lack of benefits of long-term ot\r\n",
      "Extracted:  educate/re-educate on the following: non-opioid management, self-management to improve function and quality of life, realistic expectations and limitations of medical treatment options, preferred treatment methods being non-pharmacotherapy and non-opioid pharmacotherapy, new information on risks and lack of benefits of long-term ot\r\n",
      "475 1402\r\n",
      "Original :  identify if there is presence of prescribed opioid dose>90 mg medd or combined sedating medication that increases risk of adverse events (e.g., benzodiazepine) or patient non-participation in a comprehensive pain care plan or other indications for tapering\r\n",
      "Extracted:  identify if there is presence of prescribed opioid dose>90 mg medd or combined sedating medication that increases risk of adverse events (e.g., benzodiazepine) or patient non-participation in a comprehensive pain care plan or other indications for tapering\r\n",
      "476 1726\r\n",
      "Original :  reassess and optimize preferred non-opioid treatments for chronic pain (e.g., physical and psychological treatments) recognizing that the patient is willing to continue to engage in a comprehensive treatment plan including non-opioid treatments\r\n",
      "Extracted:  reassess and optimize preferred non-opioid treatments for chronic pain (e.g., physical and psychological treatments) recognizing that the patient is willing to continue to engage in a comprehensive treatment plan including non-opioid treatments\r\n",
      "477 1804\r\n",
      "Original :  physical and psychological treatments\r\n",
      "Extracted:  physical and psychological treatments\r\n",
      "478 2056\r\n",
      "Original :  continue ot using the following approach: shortest duration, using lowest effective dose (recognizing that no dose is completely safe and overdose risk increases at doses > 20-50 mg medd), continual assessment of improvement in pain and functional status and adverse effects\r\n",
      "Extracted:  continue ot using the following approach: shortest duration, using lowest effective dose (recognizing that no dose is completely safe and overdose risk increases at doses > 20-50 mg medd), continual assessment of improvement in pain and functional status and adverse effects\r\n",
      "479 2378\r\n",
      "Original :  patient risk factors\r\n",
      "Extracted:  patient risk factors\r\n",
      "480 947\r\n",
      "Original :  proceed to module c\r\n",
      "Extracted:  proceed to module c\r\n",
      "481 947\r\n",
      "Original :  proceed to module c\r\n",
      "Extracted:  proceed to module c\r\n",
      "482 947\r\n",
      "Original :  proceed to module c\r\n",
      "Extracted:  proceed to module c\r\n",
      "483 83\r\n",
      "Original :  untreated sud, unstable mental health disorder, medical condition that acutely increases opioid risks (e.g., compromised or worsening cognitive or cardiopulmonary status), other factors that acutely increase risk of overdose (recent overdose, current sedation, recent motor vehicle accident), acutely elevated suicide risk\r\n",
      "Extracted:  untreated sud, unstable mental health disorder, medical condition that acutely increases opioid risks (e.g., compromised or worsening cognitive or cardiopulmonary status), other factors that acutely increase risk of overdose (recent overdose, current sedation, recent motor vehicle accident), acutely elevated suicide risk\r\n",
      "484 309\r\n",
      "Original :  recent overdose, current sedation, recent motor vehicle accident\r\n",
      "Extracted:  recent overdose, current sedation, recent motor vehicle accident\r\n",
      "485 462\r\n",
      "Original :  increase in all-cause mortality, increase risk of unintentional overdose death, increase risk of developing oud, risk of developing or worsening - depression, falls, fractures, sleep disordered breathing, worsening pain, motor vehicle accidents hypogonadism, prolonged pain, nausea, constipation, dry mouth, sedation, cognitive dysfunction, immune system dysfunction, reduction in function, reduction in quality of life\r\n",
      "Extracted:  increase in all-cause mortality, increase risk of unintentional overdose death, increase risk of developing oud, risk of developing or worsening - depression, falls, fractures, sleep disordered breathing, worsening pain, motor vehicle accidents hypogonadism, prolonged pain, nausea, constipation, dry mouth, sedation, cognitive dysfunction, immune system dysfunction, reduction in function, reduction in quality of life\r\n",
      "486 929\r\n",
      "Original :  modest short-term improvement in pain, possible short-term improvement in function\r\n",
      "Extracted:  modest short-term improvement in pain, possible short-term improvement in function\r\n",
      "487 1097\r\n",
      "Original :  “doctors used to think that opioids were safe and effective when used for long periods of time to treat chronic pain.”, “new information has taught us that long-term opioid use can lead to multiple problems including loss of pain relieving effects, increased pain, unintentional death, oud, and problems with sleep, mood, hormonal dysfunction, and immune dysfunction,”, “we now know that the best treatments for chronic pain are not opioids. the best treatments for chronic pain are non-drug treatments such as psychological therapies and rehabilitation therapies and non-opioid medications.”\r\n",
      "Extracted:  “doctors used to think that opioids were safe and effective when used for long periods of time to treat chronic pain.”, “new information has taught us that long-term opioid use can lead to multiple problems including loss of pain relieving effects, increased pain, unintentional death, oud, and problems with sleep, mood, hormonal dysfunction, and immune dysfunction,”, “we now know that the best treatments for chronic pain are not opioids. the best treatments for chronic pain are non-drug treatments such as psychological therapies and rehabilitation therapies and non-opioid medications.”\r\n",
      "488 0\r\n",
      "Original :  chronic pain\r\n",
      "Extracted:  chronic pain\r\n",
      "489 127\r\n",
      "Original :  the institute of medicine [iom]\r\n",
      "Extracted:  the institute of medicine [iom]\r\n",
      "490 161\r\n",
      "Original :  at least 100 million\r\n",
      "Extracted:  at least 100 million\r\n",
      "491 247\r\n",
      "Original :  the treatment of chronic pain with opioids\r\n",
      "Extracted:  the treatment of chronic pain with opioids\r\n",
      "492 401\r\n",
      "Original :  an epidemic of opioid-related adverse events\r\n",
      "Extracted:  an epidemic of opioid-related adverse events\r\n",
      "493 139\r\n",
      "Original :  from 11.3% to 19.6%\r\n",
      "Extracted:  from 11.3% to 19.6%\r\n",
      "494 163\r\n",
      "Original :  from 26% to 29%\r\n",
      "Extracted:  from 26% to 29%\r\n",
      "495 254\r\n",
      "Original :  82.5\r\n",
      "Extracted:  82.5\r\n",
      "496 284\r\n",
      "Original :  37.6\r\n",
      "Extracted:  37.6\r\n",
      "497 385\r\n",
      "Original :  at least 17%\r\n",
      "Extracted:  at least 17%\r\n",
      "498 15\r\n",
      "Original :  limited\r\n",
      "Extracted:  limited\r\n",
      "499 168\r\n",
      "Original :  increased mortality, oud, overdose, sexual dysfunction, fractures, myocardial infarction, constipation, and sleep-disordered breathing\r\n",
      "Extracted:  increased mortality, oud, overdose, sexual dysfunction, fractures, myocardial infarction, constipation, and sleep-disordered breathing\r\n",
      "500 364\r\n",
      "Original :  259 million\r\n",
      "Extracted:  259 million\r\n",
      "501 72\r\n",
      "Original :  morbidity, mortality, opioid-related  overdose death rates, and substance use disorders (sud) treatment admissions\r\n",
      "Extracted:  morbidity, mortality, opioid-related  overdose death rates, and substance use disorders (sud) treatment admissions\r\n",
      "502 216\r\n",
      "Original :  drug overdose\r\n",
      "Extracted:  drug overdose\r\n",
      "503 343\r\n",
      "Original :  1.9 million americans were affected by an oud related to non-medical  use of prescription pain relievers, and in the same year, 18,893 individuals died as a result of a  prescription drug overdose\r\n",
      "Extracted:  1.9 million americans were affected by an oud related to non-medical  use of prescription pain relievers, and in the same year, 18,893 individuals died as a result of a  prescription drug overdose\r\n",
      "504 343\r\n",
      "Original :  1.9 million\r\n",
      "Extracted:  1.9 million\r\n",
      "505 471\r\n",
      "Original :  18,893\r\n",
      "Extracted:  18,893\r\n",
      "506 556\r\n",
      "Original :  a four-fold increase\r\n",
      "Extracted:  a four-fold increase\r\n",
      "507 660\r\n",
      "Original :  14% increase\r\n",
      "Extracted:  14% increase\r\n",
      "508 806\r\n",
      "Original :  34%\r\n",
      "Extracted:  34%\r\n",
      "509 806\r\n",
      "Original :  34%\r\n",
      "Extracted:  34%\r\n",
      "510 985\r\n",
      "Original :  22%\r\n",
      "Extracted:  22%\r\n",
      "511 806\r\n",
      "Original :  34% of patients reported that they thought they were “addicted” or “dependent” on opioid pain medication, 34% said that they used the medication for “fun” or to “get high,” while 22% used the medication to relieve day-to-day stress\r\n",
      "Extracted:  34% of patients reported that they thought they were “addicted” or “dependent” on opioid pain medication, 34% said that they used the medication for “fun” or to “get high,” while 22% used the medication to relieve day-to-day stress\r\n",
      "512 749\r\n",
      "Original :  chronic non-cancer pain\r\n",
      "Extracted:  chronic non-cancer pain\r\n",
      "513 57\r\n",
      "Original :  the rate of heroin overdose deaths\r\n",
      "Extracted:  the rate of heroin overdose deaths\r\n",
      "514 103\r\n",
      "Original :  nearly four-fold\r\n",
      "Extracted:  nearly four-fold\r\n",
      "515 333\r\n",
      "Original :  80%\r\n",
      "Extracted:  80%\r\n",
      "516 445\r\n",
      "Original :  75%\r\n",
      "Extracted:  75%\r\n",
      "517 69\r\n",
      "Original :  heroin\r\n",
      "Extracted:  heroin\r\n",
      "518 507\r\n",
      "Original :  prescription opioids\r\n",
      "Extracted:  prescription opioids\r\n",
      "519 556\r\n",
      "Original :  increase in the use of opioids, as well as associated morbidity, mortality, and other adverse outcomes\r\n",
      "Extracted:  increase in the use of opioids, as well as associated morbidity, mortality, and other adverse outcomes\r\n",
      "520 760\r\n",
      "Original :  the va/dod clinical practice guideline for the management of substance use disorders (va/dod sud cpg)\r\n",
      "Extracted:  the va/dod clinical practice guideline for the management of substance use disorders (va/dod sud cpg)\r\n",
      "521 764\r\n",
      "Original :  va/dod clinical practice guideline for the management of substance use disorders\r\n",
      "Extracted:  va/dod clinical practice guideline for the management of substance use disorders\r\n",
      "522 54\r\n",
      "Original :  in the way pain is viewed and treated\r\n",
      "Extracted:  in the way pain is viewed and treated\r\n",
      "523 0\r\n",
      "Original :  the u.s. is in the midst of a cultural transformation in the way pain is viewed and treated\r\n",
      "Extracted:  the u.s. is in the midst of a cultural transformation in the way pain is viewed and treated\r\n",
      "524 137\r\n",
      "Original :  the pain experience is reduced to a pain generator and pain treatment is aimed at fixing or numbing pain with medications, interventions, or surgery\r\n",
      "Extracted:  the pain experience is reduced to a pain generator and pain treatment is aimed at fixing or numbing pain with medications, interventions, or surgery\r\n",
      "525 219\r\n",
      "Original :  fixing or numbing pain with medications, interventions, or surgery\r\n",
      "Extracted:  fixing or numbing pain with medications, interventions, or surgery\r\n",
      "526 297\r\n",
      "Original :  the 1990s and the first decade of the 2000s\r\n",
      "Extracted:  the 1990s and the first decade of the 2000s\r\n",
      "527 342\r\n",
      "Original :  as the cost, potential harm, and limited effectiveness of the approach in the biomedical model of pain care to chronic pain was becoming apparent\r\n",
      "Extracted:  as the cost, potential harm, and limited effectiveness of the approach in the biomedical model of pain care to chronic pain was becoming apparent\r\n",
      "528 575\r\n",
      "Original :  a biopsychosocial, multimodal, interdisciplinary model\r\n",
      "Extracted:  a biopsychosocial, multimodal, interdisciplinary model\r\n",
      "529 0\r\n",
      "Original :  a paradigm shift in the use of ot for chronic non-terminal pain\r\n",
      "Extracted:  a paradigm shift in the use of ot for chronic non-terminal pain\r\n",
      "530 141\r\n",
      "Original :  rarely used outside of severe acute injury or post-surgical pain, primarily due to concern for tolerance, physical dependence, and addiction\r\n",
      "Extracted:  rarely used outside of severe acute injury or post-surgical pain, primarily due to concern for tolerance, physical dependence, and addiction\r\n",
      "531 236\r\n",
      "Original :  tolerance, physical dependence, and addiction\r\n",
      "Extracted:  tolerance, physical dependence, and addiction\r\n",
      "532 283\r\n",
      "Original :  as the hospice and palliative care  movement began defining end-of-life care in the u.s. during the 1980s and emphasizing the importance of  pain relief\r\n",
      "Extracted:  as the hospice and palliative care  movement began defining end-of-life care in the u.s. during the 1980s and emphasizing the importance of  pain relief\r\n",
      "533 504\r\n",
      "Original :  efforts to destigmatize the use of prescription opioids for chronic non-terminal pain\r\n",
      "Extracted:  efforts to destigmatize the use of prescription opioids for chronic non-terminal pain\r\n",
      "534 741\r\n",
      "Original :  chronic pain management\r\n",
      "Extracted:  chronic pain management\r\n",
      "535 792\r\n",
      "Original :  in the 1990s and the first decade of the 2000s\r\n",
      "Extracted:  in the 1990s and the first decade of the 2000s\r\n",
      "536 920\r\n",
      "Original :  absence\r\n",
      "Extracted:  absence\r\n",
      "537 1187\r\n",
      "Original :  in the decade of the 2010s\r\n",
      "Extracted:  in the decade of the 2010s\r\n",
      "538 1038\r\n",
      "Original :  as observational and epidemiologic data of harm from lot accumulated\r\n",
      "Extracted:  as observational and epidemiologic data of harm from lot accumulated\r\n",
      "539 0\r\n",
      "Original :  the accumulation of evidence of harms and the absence of evidence of long-term benefits\r\n",
      "Extracted:  the accumulation of evidence of harms and the absence of evidence of long-term benefits\r\n",
      "540 188\r\n",
      "Original :  the evidence of both the safety and efficacy for non-pharmacologic and non-opioid pharmacologic pain therapies\r\n",
      "Extracted:  the evidence of both the safety and efficacy for non-pharmacologic and non-opioid pharmacologic pain therapies\r\n",
      "541 436\r\n",
      "Original :  as a complex multidimensional experience that requires multimodal and integrated care approaches\r\n",
      "Extracted:  as a complex multidimensional experience that requires multimodal and integrated care approaches\r\n",
      "542 555\r\n",
      "Original :  non-pharmacologic treatments and non-opioid medications\r\n",
      "Extracted:  non-pharmacologic treatments and non-opioid medications\r\n",
      "543 694\r\n",
      "Original :  primarily in the treatment of severe acute pain, post-operative pain, and end-of-life pain\r\n",
      "Extracted:  primarily in the treatment of severe acute pain, post-operative pain, and end-of-life pain\r\n",
      "544 680\r\n",
      "Original :  limited\r\n",
      "Extracted:  limited\r\n",
      "545 0\r\n",
      "Original :  the increasing use of opioids, as well as the accompanying rise in morbidity and mortality associated with opioid use\r\n",
      "Extracted:  the increasing use of opioids, as well as the accompanying rise in morbidity and mortality associated with opioid use\r\n",
      "546 0\r\n",
      "Original :  the increasing use of opioids\r\n",
      "Extracted:  the increasing use of opioids\r\n",
      "547 0\r\n",
      "Original :  the increasing use of opioids\r\n",
      "Extracted:  the increasing use of opioids\r\n",
      "548 444\r\n",
      "Original :  curtailing illicit drug consumption in america and improving the health and safety of the american people by reducing the consequences of drug abuse\r\n",
      "Extracted:  curtailing illicit drug consumption in america and improving the health and safety of the american people by reducing the consequences of drug abuse\r\n",
      "549 723\r\n",
      "Original :  october 2015\r\n",
      "Extracted:  october 2015\r\n",
      "550 633\r\n",
      "Original :  presidential memorandum on preventing prescription drug abuse and heroin use\r\n",
      "Extracted:  presidential memorandum on preventing prescription drug abuse and heroin use\r\n",
      "551 814\r\n",
      "Original :  by calling for change in a number of key areas including preventing drug use in communities, seeking early intervention opportunities, and integrating sud treatment and supporting recovery\r\n",
      "Extracted:  by calling for change in a number of key areas including preventing drug use in communities, seeking early intervention opportunities, and integrating sud treatment and supporting recovery\r\n",
      "552 0\r\n",
      "Original :  with the passage of the patient protection and affordable care act (ppaca) in march 2010\r\n",
      "Extracted:  with the passage of the patient protection and affordable care act (ppaca) in march 2010\r\n",
      "553 159\r\n",
      "Original :  coordinate pain research efforts  throughout federal government agencies\r\n",
      "Extracted:  coordinate pain research efforts  throughout federal government agencies\r\n",
      "554 78\r\n",
      "Original :  march 2010\r\n",
      "Extracted:  march 2010\r\n",
      "555 263\r\n",
      "Original :  summarizing advances in pain  care research, identifying gaps in research, and developing recommendations regarding ways to minimize  duplicative efforts, disseminate pain care information, and expand public/private research partnerships  and collaborations\r\n",
      "Extracted:  summarizing advances in pain  care research, identifying gaps in research, and developing recommendations regarding ways to minimize  duplicative efforts, disseminate pain care information, and expand public/private research partnerships  and collaborations\r\n",
      "556 233\r\n",
      "Original :  the committee\r\n",
      "Extracted:  the committee\r\n",
      "557 576\r\n",
      "Original :  march 2016\r\n",
      "Extracted:  march 2016\r\n",
      "558 587\r\n",
      "Original :  in response to the  call from the national academy of medicine to increase awareness of pain as a significant public health  issue in the u.s.\r\n",
      "Extracted:  in response to the  call from the national academy of medicine to increase awareness of pain as a significant public health  issue in the u.s.\r\n",
      "559 795\r\n",
      "Original :  prevention and  care, professional education and training, and population research\r\n",
      "Extracted:  prevention and  care, professional education and training, and population research\r\n",
      "560 900\r\n",
      "Original :  decreasing the  prevalence of all types of pain (acute and chronic) in the u.s., as well as the disability and morbidity  associated with pain\r\n",
      "Extracted:  decreasing the  prevalence of all types of pain (acute and chronic) in the u.s., as well as the disability and morbidity  associated with pain\r\n",
      "561 35\r\n",
      "Original :  va, dod, and substance abuse and mental health services  administration (samhsa)\r\n",
      "Extracted:  va, dod, and substance abuse and mental health services  administration (samhsa)\r\n",
      "562 48\r\n",
      "Original :  substance abuse and mental health services  administration\r\n",
      "Extracted:  substance abuse and mental health services  administration\r\n",
      "563 274\r\n",
      "Original :  august 2013\r\n",
      "Extracted:  august 2013\r\n",
      "564 421\r\n",
      "Original :  ensuring opioids are used in a safe, effective, and judicious manner.\r\n",
      "Extracted:  ensuring opioids are used in a safe, effective, and judicious manner.\r\n",
      "565 308\r\n",
      "Original :  opioid safety initiative\r\n",
      "Extracted:  opioid safety initiative\r\n",
      "566 359\r\n",
      "Original :  veterans integrated service networks\r\n",
      "Extracted:  veterans integrated service networks\r\n",
      "567 539\r\n",
      "Original :  increased education, monitoring, use of safe and effective prescribing and  management methods, tool development, collaboration, and use of alternative pain treatment\r\n",
      "Extracted:  increased education, monitoring, use of safe and effective prescribing and  management methods, tool development, collaboration, and use of alternative pain treatment\r\n",
      "568 725\r\n",
      "Original :  veterans health administration (vha’s) electronic health record\r\n",
      "Extracted:  veterans health administration (vha’s) electronic health record\r\n",
      "569 725\r\n",
      "Original :  veterans health administration (vha’s) electronic health record\r\n",
      "Extracted:  veterans health administration (vha’s) electronic health record\r\n",
      "570 789\r\n",
      "Original :  to identify patients who may be  high-risk for adverse outcomes with use of opioids and providers whose prescribing practices do not  reflect best evidence so that patient care can be improved\r\n",
      "Extracted:  to identify patients who may be  high-risk for adverse outcomes with use of opioids and providers whose prescribing practices do not  reflect best evidence so that patient care can be improved\r\n",
      "571 1012\r\n",
      "Original :  specific  indicators (e.g., the number of unique pharmacy patients dispensed an opioid, the unique patients on lot who have received udt)\r\n",
      "Extracted:  specific  indicators (e.g., the number of unique pharmacy patients dispensed an opioid, the unique patients on lot who have received udt)\r\n",
      "572 1187\r\n",
      "Original :  the opioid overdose education and  naloxone distribution (oend) program\r\n",
      "Extracted:  the opioid overdose education and  naloxone distribution (oend) program\r\n",
      "573 1270\r\n",
      "Original :  implemented as a risk mitigation strategy aimed at  reducing deaths from opioid overdose\r\n",
      "Extracted:  implemented as a risk mitigation strategy aimed at  reducing deaths from opioid overdose\r\n",
      "574 1392\r\n",
      "Original :  education and training  regarding the following topics: opioid overdose prevention, recognition, and rescue response; risk  mitigation strategies; and issuing naloxone kits, which can be used as an antidote to opioid  overdose\r\n",
      "Extracted:  education and training  regarding the following topics: opioid overdose prevention, recognition, and rescue response; risk  mitigation strategies; and issuing naloxone kits, which can be used as an antidote to opioid  overdose\r\n",
      "575 80\r\n",
      "Original :  osi toolkit and the patient  guide “taking opioids responsibly for your safety and the safety of others: patient information guide on  long-term opioid therapy for chronic pain”\r\n",
      "Extracted:  osi toolkit and the patient  guide “taking opioids responsibly for your safety and the safety of others: patient information guide on  long-term opioid therapy for chronic pain”\r\n",
      "576 292\r\n",
      "Original :  provide clinicians with  materials to inform clinical decision-making regarding opioid therapy and safe opioid prescribing\r\n",
      "Extracted:  provide clinicians with  materials to inform clinical decision-making regarding opioid therapy and safe opioid prescribing\r\n",
      "577 475\r\n",
      "Original :  https://www.va.gov/painmanagement/opioid_safety_initiative_toolkit.asp\r\n",
      "Extracted:  https://www.va.gov/painmanagement/opioid_safety_initiative_toolkit.asp\r\n",
      "578 703\r\n",
      "Original :  providing information to patients as well as their providers regarding the safe use  of opioids\r\n",
      "Extracted:  providing information to patients as well as their providers regarding the safe use  of opioids\r\n",
      "579 853\r\n",
      "Original :  http://www.healthquality.va.gov/guidelines/pain/cot/opiodtheraphyforchronicpainpatienttool20may20 13print.pdf\r\n",
      "Extracted:  http://www.healthquality.va.gov/guidelines/pain/cot/opiodtheraphyforchronicpainpatienttool20may20 13print.pdf\r\n",
      "580 1017\r\n",
      "Original :  the vha\r\n",
      "Extracted:  the vha\r\n",
      "581 964\r\n",
      "Original :  to further promote safety and patient centered care\r\n",
      "Extracted:  to further promote safety and patient centered care\r\n",
      "582 1041\r\n",
      "Original :  in 2014\r\n",
      "Extracted:  in 2014\r\n",
      "583 1060\r\n",
      "Original :  standardized education and signature informed consent for all patients receiving lot for non-cancer  pain\r\n",
      "Extracted:  standardized education and signature informed consent for all patients receiving lot for non-cancer  pain\r\n",
      "584 58\r\n",
      "Original :  executive departments and agencies shall, to the extent permitted by law, provide training on the appropriate and effective prescribing of opioid medications to all employees who are health care professionals and who prescribe controlled substances as part of their federal responsibilities and duties\r\n",
      "Extracted:  executive departments and agencies shall, to the extent permitted by law, provide training on the appropriate and effective prescribing of opioid medications to all employees who are health care professionals and who prescribe controlled substances as part of their federal responsibilities and duties\r\n",
      "585 0\r\n",
      "Original :  the presidential memorandum of october 2015\r\n",
      "Extracted:  the presidential memorandum of october 2015\r\n",
      "586 0\r\n",
      "Original :  the presidential memorandum of october 2015\r\n",
      "Extracted:  the presidential memorandum of october 2015\r\n",
      "587 444\r\n",
      "Original :  modules on pain management and opioid prescribing safety, the recent centers for disease control and prevention (cdc) guideline, and the identification of substance misuse and referral to specialized services\r\n",
      "Extracted:  modules on pain management and opioid prescribing safety, the recent centers for disease control and prevention (cdc) guideline, and the identification of substance misuse and referral to specialized services\r\n",
      "588 365\r\n",
      "Original :  dod opioid prescriber safety  training program\r\n",
      "Extracted:  dod opioid prescriber safety  training program\r\n",
      "589 654\r\n",
      "Original :  defense centers of  excellence for psychological health and traumatic brain injury\r\n",
      "Extracted:  defense centers of  excellence for psychological health and traumatic brain injury\r\n",
      "590 828\r\n",
      "Original :  http://opstp.cds.pesgce.com/hub.php\r\n",
      "Extracted:  http://opstp.cds.pesgce.com/hub.php\r\n",
      "591 89\r\n",
      "Original :  primary care physicians\r\n",
      "Extracted:  primary care physicians\r\n",
      "592 117\r\n",
      "Original :  march 15, 2016\r\n",
      "Extracted:  march 15, 2016\r\n",
      "593 164\r\n",
      "Original :  assist primary care providers in offering safe and effective treatment for patients with chronic pain in the outpatient setting (not including active cancer treatment, palliative care, or end-of-life care). it is also aimed at improving communication between providers and patients and decreasing adverse outcomes associated with lot.\r\n",
      "Extracted:  assist primary care providers in offering safe and effective treatment for patients with chronic pain in the outpatient setting (not including active cancer treatment, palliative care, or end-of-life care). it is also aimed at improving communication between providers and patients and decreasing adverse outcomes associated with lot.\r\n",
      "594 574\r\n",
      "Original :  initiation and continuation of ot, management of  ot, and risk assessment and use of risk mitigation strategies\r\n",
      "Extracted:  initiation and continuation of ot, management of  ot, and risk assessment and use of risk mitigation strategies\r\n",
      "595 704\r\n",
      "Original :  grade system\r\n",
      "Extracted:  grade system\r\n",
      "596 792\r\n",
      "Original :  assessment of the quality of the evidence and consideration of the balance of desirable and undesirable outcomes, patient values and preferences,  and other considerations (e.g., resource use, equity) during recommendation development\r\n",
      "Extracted:  assessment of the quality of the evidence and consideration of the balance of desirable and undesirable outcomes, patient values and preferences,  and other considerations (e.g., resource use, equity) during recommendation development\r\n",
      "597 18\r\n",
      "Original :  the comprehensive addiction and recovery act\r\n",
      "Extracted:  the comprehensive addiction and recovery act\r\n",
      "598 3\r\n",
      "Original :  july 22, 2016\r\n",
      "Extracted:  july 22, 2016\r\n",
      "599 98\r\n",
      "Original :  addressing the epidemic of overdoses from prescription opioids and other prescription drugs and heroin\r\n",
      "Extracted:  addressing the epidemic of overdoses from prescription opioids and other prescription drugs and heroin\r\n",
      "600 242\r\n",
      "Original :  opioid abuse treatment and prevention\r\n",
      "Extracted:  opioid abuse treatment and prevention\r\n",
      "601 75\r\n",
      "Original :  service members,  veterans, and their families—that has unique characteristics and needs related to the military culture and communities to which they return\r\n",
      "Extracted:  service members,  veterans, and their families—that has unique characteristics and needs related to the military culture and communities to which they return\r\n",
      "602 357\r\n",
      "Original :  specific risk factors such as risk for suicide, sud, and other medical and mental health co-occurring conditions that may complicate the management of pain for these patients\r\n",
      "Extracted:  specific risk factors such as risk for suicide, sud, and other medical and mental health co-occurring conditions that may complicate the management of pain for these patients\r\n",
      "603 590\r\n",
      "Original :  the implications they would  have within the va/dod healthcare settings, particularly regarding considerations such as resource use, accessibility, and equity related to each recommendation and the urgent need for rigorous attention to the balance of risks and benefits for patients within the va/dod specifically\r\n",
      "Extracted:  the implications they would  have within the va/dod healthcare settings, particularly regarding considerations such as resource use, accessibility, and equity related to each recommendation and the urgent need for rigorous attention to the balance of risks and benefits for patients within the va/dod specifically\r\n",
      "604 126\r\n",
      "Original :  along with a clinical evidence review, during which the evidence was evaluated using grade, the cdc guideline developers also considered the findings of a contextual evidence review. further, the cdc core expert group, which consisted of subject matter experts,  representatives of primary care professional societies and state agencies, and an expert in guideline methodology, reviewed recommendations drafted by the cdc and evaluated how the evidence was used in the development of the recommendations, rather than developing the recommendations themselves  (as was the va/dod ot work group’s role in the development of the va/dod ot cpg). while experts provided feedback on the cdc recommendations and their development, the cdc determined the final recommendations. cdc also used a review process considering and incorporating feedback from federal partners (e.g., samhsa, va, dod), stakeholders (e.g., professional organizations, delivery systems,  community organizations), and other constituents (e.g., clinicians, prospective patients).\r\n",
      "Extracted:  along with a clinical evidence review, during which the evidence was evaluated using grade, the cdc guideline developers also considered the findings of a contextual evidence review. further, the cdc core expert group, which consisted of subject matter experts,  representatives of primary care professional societies and state agencies, and an expert in guideline methodology, reviewed recommendations drafted by the cdc and evaluated how the evidence was used in the development of the recommendations, rather than developing the recommendations themselves  (as was the va/dod ot work group’s role in the development of the va/dod ot cpg). while experts provided feedback on the cdc recommendations and their development, the cdc determined the final recommendations. cdc also used a review process considering and incorporating feedback from federal partners (e.g., samhsa, va, dod), stakeholders (e.g., professional organizations, delivery systems,  community organizations), and other constituents (e.g., clinicians, prospective patients).\r\n",
      "605 1218\r\n",
      "Original :  notice in the federal register for a public review and comment period as well as peer review\r\n",
      "Extracted:  notice in the federal register for a public review and comment period as well as peer review\r\n",
      "606 1421\r\n",
      "Original :  based on a slightly different evidence base and revised based on the feedback of individuals who were considering a larger group of potential patients relative to the va/dod\r\n",
      "Extracted:  based on a slightly different evidence base and revised based on the feedback of individuals who were considering a larger group of potential patients relative to the va/dod\r\n",
      "607 1896\r\n",
      "Original :  a document that details the process by which va/dod guidelines will be developed, including the use of the  grade methodology\r\n",
      "Extracted:  a document that details the process by which va/dod guidelines will be developed, including the use of the  grade methodology\r\n",
      "608 20\r\n",
      "Original :  an unpleasant sensory and emotional experience associated with actual or potential  tissue damage, or described in terms of such damage…pain is always subjective…it is unquestionably a  sensation in a part or parts of the body, but it is also always unpleasant and therefore also an emotional  experience.\r\n",
      "Extracted:  an unpleasant sensory and emotional experience associated with actual or potential  tissue damage, or described in terms of such damage…pain is always subjective…it is unquestionably a  sensation in a part or parts of the body, but it is also always unpleasant and therefore also an emotional  experience.\r\n",
      "609 476\r\n",
      "Original :  multifaceted\r\n",
      "Extracted:  multifaceted\r\n",
      "610 553\r\n",
      "Original :  quality (e.g., sharp versus dull), intensity, timing, location, and  whether it is associated with position or movement\r\n",
      "Extracted:  quality (e.g., sharp versus dull), intensity, timing, location, and  whether it is associated with position or movement\r\n",
      "611 27\r\n",
      "Original :  pain lasting three months or more. it is often associated with changes in the  central nervous system (cns) known as central sensitization.\r\n",
      "Extracted:  pain lasting three months or more. it is often associated with changes in the  central nervous system (cns) known as central sensitization.\r\n",
      "612 223\r\n",
      "Original :  primarily nociceptive processing areas\r\n",
      "Extracted:  primarily nociceptive processing areas\r\n",
      "613 106\r\n",
      "Original :  central nervous system\r\n",
      "Extracted:  central nervous system\r\n",
      "614 274\r\n",
      "Original :  chronic pain is thought to be  associated with alterations in brain centers involved with emotions, reward, and executive function as well  as central sensitization of nociceptive pathways across several cns areas.\r\n",
      "Extracted:  chronic pain is thought to be  associated with alterations in brain centers involved with emotions, reward, and executive function as well  as central sensitization of nociceptive pathways across several cns areas.\r\n",
      "615 39\r\n",
      "Original :  pain arising from persistent peripheral stimulation could be  mechanical or chemical/inflammatory in nature typically leading to well-localized nociceptive mechanism pain. mechanical or inflammatory pain with a visceral origin may produce a less localized pain.  neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy) may lead to poorly localized symptoms such as diffuse pain,  burning, numbness, or a feeling of skin sensitivity.\r\n",
      "Extracted:  pain arising from persistent peripheral stimulation could be  mechanical or chemical/inflammatory in nature typically leading to well-localized nociceptive mechanism pain. mechanical or inflammatory pain with a visceral origin may produce a less localized pain.  neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy) may lead to poorly localized symptoms such as diffuse pain,  burning, numbness, or a feeling of skin sensitivity.\r\n",
      "616 39\r\n",
      "Original :  pain arising from persistent peripheral stimulation\r\n",
      "Extracted:  pain arising from persistent peripheral stimulation\r\n",
      "617 39\r\n",
      "Original :  pain arising from persistent peripheral stimulation\r\n",
      "Extracted:  pain arising from persistent peripheral stimulation\r\n",
      "618 211\r\n",
      "Original :  mechanical or inflammatory pain with a visceral origin\r\n",
      "Extracted:  mechanical or inflammatory pain with a visceral origin\r\n",
      "619 302\r\n",
      "Original :  neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy)\r\n",
      "Extracted:  neuropathic pain due to injury or disease of the central or peripheral nervous system (e.g., spinal cord  injury, diabetic neuropathy, radiculopathy)\r\n",
      "620 498\r\n",
      "Original :  diffuse pain,  burning, numbness, or a feeling of skin sensitivity\r\n",
      "Extracted:  diffuse pain,  burning, numbness, or a feeling of skin sensitivity\r\n",
      "621 41\r\n",
      "Original :  a biopsychosocial interview and focused physical exam\r\n",
      "Extracted:  a biopsychosocial interview and focused physical exam\r\n",
      "622 151\r\n",
      "Original :  a pain-related history, assessment of pertinent  medical and psychiatric comorbidities including personal and family history of sud, functional status and  functional goals, coping strategies, and a variety of psychosocial factors such as the patient’s beliefs and  expectations about chronic pain and its treatment\r\n",
      "Extracted:  a pain-related history, assessment of pertinent  medical and psychiatric comorbidities including personal and family history of sud, functional status and  functional goals, coping strategies, and a variety of psychosocial factors such as the patient’s beliefs and  expectations about chronic pain and its treatment\r\n",
      "623 516\r\n",
      "Original :  worsened quality of life, mental health, immune system function, physical function, sleep, employment  status, and impaired personal relationships\r\n",
      "Extracted:  worsened quality of life, mental health, immune system function, physical function, sleep, employment  status, and impaired personal relationships\r\n",
      "624 664\r\n",
      "Original :  worsening of some of these factors (e.g., quality of  life, change in employment status)\r\n",
      "Extracted:  worsening of some of these factors (e.g., quality of  life, change in employment status)\r\n",
      "625 468\r\n",
      "Original :  patients with chronic pain\r\n",
      "Extracted:  patients with chronic pain\r\n",
      "626 882\r\n",
      "Original :  psychological complaints (e.g.,  depression, anxiety, poor self-efficacy, poor general emotional functioning)\r\n",
      "Extracted:  psychological complaints (e.g.,  depression, anxiety, poor self-efficacy, poor general emotional functioning)\r\n",
      "627 915\r\n",
      "Original :  depression, anxiety, poor self-efficacy, poor general emotional functioning\r\n",
      "Extracted:  depression, anxiety, poor self-efficacy, poor general emotional functioning\r\n",
      "628 1108\r\n",
      "Original :  decreased  ability to successfully maintain relationship and career roles and increased depression, fear, and anxiety as  a result of pain\r\n",
      "Extracted:  decreased  ability to successfully maintain relationship and career roles and increased depression, fear, and anxiety as  a result of pain\r\n",
      "629 0\r\n",
      "Original :  chronic pain\r\n",
      "Extracted:  chronic pain\r\n",
      "630 0\r\n",
      "Original :  chronic pain\r\n",
      "Extracted:  chronic pain\r\n",
      "631 0\r\n",
      "Original :  chronic pain\r\n",
      "Extracted:  chronic pain\r\n",
      "632 113\r\n",
      "Original :  approximately 100 million\r\n",
      "Extracted:  approximately 100 million\r\n",
      "633 273\r\n",
      "Original :  the late 1990s and early 2000s\r\n",
      "Extracted:  the late 1990s and early 2000s\r\n",
      "634 273\r\n",
      "Original :  the late 1990s and early 2000s\r\n",
      "Extracted:  the late 1990s and early 2000s\r\n",
      "635 496\r\n",
      "Original :  approximately one in five\r\n",
      "Extracted:  approximately one in five\r\n",
      "636 684\r\n",
      "Original :  quadrupled\r\n",
      "Extracted:  quadrupled\r\n",
      "637 791\r\n",
      "Original :  four-fold\r\n",
      "Extracted:  four-fold\r\n",
      "638 826\r\n",
      "Original :  14%\r\n",
      "Extracted:  14%\r\n",
      "639 879\r\n",
      "Original :  more than 183,000\r\n",
      "Extracted:  more than 183,000\r\n",
      "640 96\r\n",
      "Original :  from  18.9% to 33.4%, an increase of 76.7%\r\n",
      "Extracted:  from  18.9% to 33.4%, an increase of 76.7%\r\n",
      "641 198\r\n",
      "Original :  women and young adults (i.e., 18-34 years old)\r\n",
      "Extracted:  women and young adults (i.e., 18-34 years old)\r\n",
      "642 379\r\n",
      "Original :  44%\r\n",
      "Extracted:  44%\r\n",
      "643 410\r\n",
      "Original :  15%\r\n",
      "Extracted:  15%\r\n",
      "644 531\r\n",
      "Original :  poorer physical function, independent of comorbid mental health concerns\r\n",
      "Extracted:  poorer physical function, independent of comorbid mental health concerns\r\n",
      "645 766\r\n",
      "Original :  over 90%\r\n",
      "Extracted:  over 90%\r\n",
      "646 819\r\n",
      "Original :  nearly 80%\r\n",
      "Extracted:  nearly 80%\r\n",
      "647 992\r\n",
      "Original :  approximately 65%\r\n",
      "Extracted:  approximately 65%\r\n",
      "648 1151\r\n",
      "Original :  age, marital status, race,  geography, mental health comorbidity, and dosage\r\n",
      "Extracted:  age, marital status, race,  geography, mental health comorbidity, and dosage\r\n",
      "649 1249\r\n",
      "Original :  those who were aged 50-65 years,  were married, were of a race other than african american, and who lived in a rural setting\r\n",
      "Extracted:  those who were aged 50-65 years,  were married, were of a race other than african american, and who lived in a rural setting\r\n",
      "650 1418\r\n",
      "Original :  veterans on higher doses of opioids\r\n",
      "Extracted:  veterans on higher doses of opioids\r\n",
      "651 1504\r\n",
      "Original :  those with mental health diagnoses\r\n",
      "Extracted:  those with mental health diagnoses\r\n",
      "652 0\r\n",
      "Original :  individuals with conditions that result in or co-occur with chronic pain\r\n",
      "Extracted:  individuals with conditions that result in or co-occur with chronic pain\r\n",
      "653 176\r\n",
      "Original :  many different physical and psychological conditions have a pain component\r\n",
      "Extracted:  many different physical and psychological conditions have a pain component\r\n",
      "654 98\r\n",
      "Original :  the duration and dose of opioid analgesic use\r\n",
      "Extracted:  the duration and dose of opioid analgesic use\r\n",
      "655 297\r\n",
      "Original :  given the insufficient evidence of benefit for lot\r\n",
      "Extracted:  given the insufficient evidence of benefit for lot\r\n",
      "656 505\r\n",
      "Original :  as patient values and preferences may be impacted by other clinical considerations, some patients with one or more risk factors for adverse outcomes may differ with the clinician’s assessment that the risks of ot  outweigh the potential for modest short-term benefits.\r\n",
      "Extracted:  as patient values and preferences may be impacted by other clinical considerations, some patients with one or more risk factors for adverse outcomes may differ with the clinician’s assessment that the risks of ot  outweigh the potential for modest short-term benefits.\r\n",
      "657 1148\r\n",
      "Original :  should be carefully monitored, and ongoing assessment of risk should be performed with vigilance for the development of additional risk factors and adverse outcomes\r\n",
      "Extracted:  should be carefully monitored, and ongoing assessment of risk should be performed with vigilance for the development of additional risk factors and adverse outcomes\r\n",
      "658 1341\r\n",
      "Original :  consider consultation with appropriate specialty care providers\r\n",
      "Extracted:  consider consultation with appropriate specialty care providers\r\n",
      "659 81\r\n",
      "Original :  duration and dose of ot, severe respiratory instability or sleep disordered breathing, acute psychiatric instability or intermediate to high acute suicide risk, mental health disorders, history of drug overdose, under 30 years of age, co-administration of a drug capable of inducing fatal drug-drug interactions, qtc interval >450 ms for using methadone, evidence for or history of diversion of controlled substances, intolerance, serious adverse effects, or a history of inadequate beneficial response to opioids, impaired bowel motility unresponsive to therapy, headache not responsive to other pain treatment modalities, traumatic brain injury (tbi), true allergy to opioid agents\r\n",
      "Extracted:  duration and dose of ot, severe respiratory instability or sleep disordered breathing, acute psychiatric instability or intermediate to high acute suicide risk, mental health disorders, history of drug overdose, under 30 years of age, co-administration of a drug capable of inducing fatal drug-drug interactions, qtc interval >450 ms for using methadone, evidence for or history of diversion of controlled substances, intolerance, serious adverse effects, or a history of inadequate beneficial response to opioids, impaired bowel motility unresponsive to therapy, headache not responsive to other pain treatment modalities, traumatic brain injury (tbi), true allergy to opioid agents\r\n",
      "660 224\r\n",
      "Original :  any co-occurring condition that significantly affects respiratory rate or function such as chronic obstructive pulmonary disease (copd), asthma, pneumonia, sleep apnea, or a neuromuscular condition (e.g., amyotrophic lateral sclerosis)\r\n",
      "Extracted:  any co-occurring condition that significantly affects respiratory rate or function such as chronic obstructive pulmonary disease (copd), asthma, pneumonia, sleep apnea, or a neuromuscular condition (e.g., amyotrophic lateral sclerosis)\r\n",
      "661 461\r\n",
      "Original :  two large observational studies of patients with a  history of copd and sleep apnea who were prescribed opioids\r\n",
      "Extracted:  two large observational studies of patients with a  history of copd and sleep apnea who were prescribed opioids\r\n",
      "662 74\r\n",
      "Original :  intermediate to high acute suicide risk, severe depression, unstable bipolar disorder, or unstable psychotic disorder\r\n",
      "Extracted:  intermediate to high acute suicide risk, severe depression, unstable bipolar disorder, or unstable psychotic disorder\r\n",
      "663 285\r\n",
      "Original :  a  diagnosis of a mood disorder\r\n",
      "Extracted:  a  diagnosis of a mood disorder\r\n",
      "664 551\r\n",
      "Original :  those with bipolar disorder\r\n",
      "Extracted:  those with bipolar disorder\r\n",
      "665 583\r\n",
      "Original :  2.9 times\r\n",
      "Extracted:  2.9 times\r\n",
      "666 660\r\n",
      "Original :  3.2  times\r\n",
      "Extracted:  3.2  times\r\n",
      "667 784\r\n",
      "Original :  the va/dod suicide cpg\r\n",
      "Extracted:  the va/dod suicide cpg\r\n",
      "668 849\r\n",
      "Original :  the  va/dod clinical practice guideline for management of bipolar disorder in adults (va/dod bd  cpg)\r\n",
      "Extracted:  the  va/dod clinical practice guideline for management of bipolar disorder in adults (va/dod bd  cpg)\r\n",
      "669 1028\r\n",
      "Original :  high dose chronic opioid therapy for pain\r\n",
      "Extracted:  high dose chronic opioid therapy for pain\r\n",
      "670 1110\r\n",
      "Original :  treatment for chronic pain with movement, exercise, and cognitive-behavioral therapy for pain\r\n",
      "Extracted:  treatment for chronic pain with movement, exercise, and cognitive-behavioral therapy for pain\r\n",
      "671 139\r\n",
      "Original :  frequent requests for early refills or atypically large quantities required to control pain\r\n",
      "Extracted:  frequent requests for early refills or atypically large quantities required to control pain\r\n",
      "672 242\r\n",
      "Original :  an emerging sud as well as  diversion\r\n",
      "Extracted:  an emerging sud as well as  diversion\r\n",
      "673 242\r\n",
      "Original :  an emerging sud as well as  diversion\r\n",
      "Extracted:  an emerging sud as well as  diversion\r\n",
      "674 518\r\n",
      "Original :  a history of depression\r\n",
      "Extracted:  a history of depression\r\n",
      "675 577\r\n",
      "Original :  opioid-related toxicity/overdose\r\n",
      "Extracted:  opioid-related toxicity/overdose\r\n",
      "676 653\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "677 682\r\n",
      "Original :  worsening depressive symptoms\r\n",
      "Extracted:  worsening depressive symptoms\r\n",
      "678 883\r\n",
      "Original :  patients with a history of ptsd (with or  without other mental health diagnoses) as compared to patients with other (or no) mental  health diagnoses\r\n",
      "Extracted:  patients with a history of ptsd (with or  without other mental health diagnoses) as compared to patients with other (or no) mental  health diagnoses\r\n",
      "679 812\r\n",
      "Original :  a prevalence of self inflicted injuries\r\n",
      "Extracted:  a prevalence of self inflicted injuries\r\n",
      "680 1067\r\n",
      "Original :  va/dod ptsd cpg\r\n",
      "Extracted:  va/dod ptsd cpg\r\n",
      "681 1111\r\n",
      "Original :  a history of overdose\r\n",
      "Extracted:  a history of overdose\r\n",
      "682 124\r\n",
      "Original :  potential drug interactions prior to initiating lot\r\n",
      "Extracted:  potential drug interactions prior to initiating lot\r\n",
      "683 236\r\n",
      "Original :  i)opioids with benzodiazepines (compared to patients with no prescription, the odds ratio [or] and 95% confidence interval [ci] for drug-related death was or: 14.92, 95% ci: 7.00- 31.77 for patients who filled a prescription for opioids and benzodiazepines; or: 3.40, 95%  ci: 1.60-7.21 for patients who filled only an opioid prescription, and 7.21, 95% ci: 3.33-15.60 for patients who filled only a benzodiazepine prescription) (see recommendation 5) [66,67], ii)fentanyl with cyp3a4 inhibitors, iii) methadone with drugs that can prolong the qt interval (the heart rate’s corrected time  interval from the start of the q wave to the end of the t wave) (e.g., cyp450 2b6 inhibitors)\r\n",
      "Extracted:  i)opioids with benzodiazepines (compared to patients with no prescription, the odds ratio [or] and 95% confidence interval [ci] for drug-related death was or: 14.92, 95% ci: 7.00- 31.77 for patients who filled a prescription for opioids and benzodiazepines; or: 3.40, 95%  ci: 1.60-7.21 for patients who filled only an opioid prescription, and 7.21, 95% ci: 3.33-15.60 for patients who filled only a benzodiazepine prescription) (see recommendation 5) [66,67], ii)fentanyl with cyp3a4 inhibitors, iii) methadone with drugs that can prolong the qt interval (the heart rate’s corrected time  interval from the start of the q wave to the end of the t wave) (e.g., cyp450 2b6 inhibitors)\r\n",
      "684 31\r\n",
      "Original :  methadone\r\n",
      "Extracted:  methadone\r\n",
      "685 166\r\n",
      "Original :  the heart rate’s corrected time interval from the start of the q wave to the end of the t wave\r\n",
      "Extracted:  the heart rate’s corrected time interval from the start of the q wave to the end of the t wave\r\n",
      "686 299\r\n",
      "Original :  a dangerous or fatal cardiac arrhythmia\r\n",
      "Extracted:  a dangerous or fatal cardiac arrhythmia\r\n",
      "687 278\r\n",
      "Original :  torsades de pointes\r\n",
      "Extracted:  torsades de pointes\r\n",
      "688 97\r\n",
      "Original :  unique pharmacodynamic properties that can prolong the qtc interval (the heart rate’s corrected time interval from the start of the q wave to the end of the t wave) and precipitate torsades de pointes, a dangerous or fatal cardiac arrhythmia\r\n",
      "Extracted:  unique pharmacodynamic properties that can prolong the qtc interval (the heart rate’s corrected time interval from the start of the q wave to the end of the t wave) and precipitate torsades de pointes, a dangerous or fatal cardiac arrhythmia\r\n",
      "689 340\r\n",
      "Original :  patients who may be at risk include those with other risk factors for qtc prolongation, current or prior electrocardiograms (ecgs) with a prolonged qtc >450 ms, or a history of syncope.\r\n",
      "Extracted:  patients who may be at risk include those with other risk factors for qtc prolongation, current or prior electrocardiograms (ecgs) with a prolonged qtc >450 ms, or a history of syncope.\r\n",
      "690 376\r\n",
      "Original :  those with other risk factors for qtc prolongation, current or prior electrocardiograms (ecgs) with a prolonged qtc >450 ms, or a history of syncope\r\n",
      "Extracted:  those with other risk factors for qtc prolongation, current or prior electrocardiograms (ecgs) with a prolonged qtc >450 ms, or a history of syncope\r\n",
      "691 108\r\n",
      "Original :  that drug diversion is a crime and constitutes an absolute contraindication to prescribing additional medications\r\n",
      "Extracted:  that drug diversion is a crime and constitutes an absolute contraindication to prescribing additional medications\r\n",
      "692 113\r\n",
      "Original :  drug diversion\r\n",
      "Extracted:  drug diversion\r\n",
      "693 223\r\n",
      "Original :  because suspicion is subjective and may be based on impression, bias, or prejudice\r\n",
      "Extracted:  because suspicion is subjective and may be based on impression, bias, or prejudice\r\n",
      "694 384\r\n",
      "Original :  objective\r\n",
      "Extracted:  objective\r\n",
      "695 432\r\n",
      "Original :  by a negative mass spectrometry/liquid chromatography udt for the substance being prescribed in the absence of withdrawal symptoms in someone who is receiving opioids\r\n",
      "Extracted:  by a negative mass spectrometry/liquid chromatography udt for the substance being prescribed in the absence of withdrawal symptoms in someone who is receiving opioids\r\n",
      "696 600\r\n",
      "Original :  a negative udt for the prescribed opioid\r\n",
      "Extracted:  a negative udt for the prescribed opioid\r\n",
      "697 815\r\n",
      "Original :  routine udt\r\n",
      "Extracted:  routine udt\r\n",
      "698 886\r\n",
      "Original :  methadone, fentanyl, tramadol\r\n",
      "Extracted:  methadone, fentanyl, tramadol\r\n",
      "699 950\r\n",
      "Original :  oxycodone, hydrocodone, hydromorphone\r\n",
      "Extracted:  oxycodone, hydrocodone, hydromorphone\r\n",
      "700 1052\r\n",
      "Original :  discontinue opioids according to recommendations 14 and 15 and assess for underlying oud and/or psychiatric comorbidities\r\n",
      "Extracted:  discontinue opioids according to recommendations 14 and 15 and assess for underlying oud and/or psychiatric comorbidities\r\n",
      "701 990\r\n",
      "Original :  when there is evidence that the patient is diverting opioids\r\n",
      "Extracted:  when there is evidence that the patient is diverting opioids\r\n",
      "702 990\r\n",
      "Original :  when there is evidence that the patient is diverting opioids\r\n",
      "Extracted:  when there is evidence that the patient is diverting opioids\r\n",
      "703 1373\r\n",
      "Original :  sudden discontinuation of opioids due to suspected diversion may place them at high risk for illicit opioid use and resulting opioid overdose (see recommendation 17)\r\n",
      "Extracted:  sudden discontinuation of opioids due to suspected diversion may place them at high risk for illicit opioid use and resulting opioid overdose (see recommendation 17)\r\n",
      "704 120\r\n",
      "Original :  should patients be prescribed additional (or different) opioids if prior administration of opioids led to serious adverse effects or was not tolerated\r\n",
      "Extracted:  should patients be prescribed additional (or different) opioids if prior administration of opioids led to serious adverse effects or was not tolerated\r\n",
      "705 319\r\n",
      "Original :  patients who already have had an adequate opioid trial (of sufficient dose and duration to determine whether or not it will optimize benefit) without a  positive response\r\n",
      "Extracted:  patients who already have had an adequate opioid trial (of sufficient dose and duration to determine whether or not it will optimize benefit) without a  positive response\r\n",
      "706 57\r\n",
      "Original :  inhibit bowel peristalsis\r\n",
      "Extracted:  inhibit bowel peristalsis\r\n",
      "707 137\r\n",
      "Original :  can increase the risk of severe constipation/impaction or possible obstruction\r\n",
      "Extracted:  can increase the risk of severe constipation/impaction or possible obstruction\r\n",
      "708 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "709 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "710 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "711 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "712 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "713 120\r\n",
      "Original :  migraine headaches (with or without aura), tension-type headaches,  occipital neuralgia, or myofascial pain\r\n",
      "Extracted:  migraine headaches (with or without aura), tension-type headaches,  occipital neuralgia, or myofascial pain\r\n",
      "714 232\r\n",
      "Original :  may result in worsening of the underlying headache  condition through factors such as central sensitization and withdrawal\r\n",
      "Extracted:  may result in worsening of the underlying headache  condition through factors such as central sensitization and withdrawal\r\n",
      "715 60\r\n",
      "Original :  lot\r\n",
      "Extracted:  lot\r\n",
      "716 30\r\n",
      "Original :  patients with a history of tbi who use chronic short-acting and  long-acting opioids\r\n",
      "Extracted:  patients with a history of tbi who use chronic short-acting and  long-acting opioids\r\n",
      "717 31\r\n",
      "Original :  morphine causes a release of histamine\r\n",
      "Extracted:  morphine causes a release of histamine\r\n",
      "718 196\r\n",
      "Original :  anaphylaxis\r\n",
      "Extracted:  anaphylaxis\r\n",
      "719 392\r\n",
      "Original :  when an opioid allergy is present and ot is being considered\r\n",
      "Extracted:  when an opioid allergy is present and ot is being considered\r\n",
      "720 454\r\n",
      "Original :  consultation with an allergist may be helpful\r\n",
      "Extracted:  consultation with an allergist may be helpful\r\n",
      "721 6\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "722 6\r\n",
      "Original :  recommend\r\n",
      "Extracted:  recommend\r\n",
      "723 238\r\n",
      "Original :  when pharmacologic therapies are used\r\n",
      "Extracted:  when pharmacologic therapies are used\r\n",
      "724 153\r\n",
      "Original :  self-management strategies and other non-pharmacological treatments\r\n",
      "Extracted:  self-management strategies and other non-pharmacological treatments\r\n",
      "725 486\r\n",
      "Original :  given the lack of evidence  showing sustained functional benefit of lot and moderate evidence outlining harms\r\n",
      "Extracted:  given the lack of evidence  showing sustained functional benefit of lot and moderate evidence outlining harms\r\n",
      "726 188\r\n",
      "Original :  no\r\n",
      "Extracted:  no\r\n",
      "727 652\r\n",
      "Original :  patient values, goals, concerns, and preferences\r\n",
      "Extracted:  patient values, goals, concerns, and preferences\r\n",
      "728 850\r\n",
      "Original :  consider whether lot will result in clinically meaningful  improvements in function such as readiness to return to work/duty and/or measurable improvement in  other areas of function, such that the benefits outweigh the potential harms\r\n",
      "Extracted:  consider whether lot will result in clinically meaningful  improvements in function such as readiness to return to work/duty and/or measurable improvement in  other areas of function, such that the benefits outweigh the potential harms\r\n",
      "729 6\r\n",
      "Original :  there is currently no evidence in the literature documenting the benefit of lot that demonstrates  improvement in pain and function\r\n",
      "Extracted:  there is currently no evidence in the literature documenting the benefit of lot that demonstrates  improvement in pain and function\r\n",
      "730 352\r\n",
      "Original :  a careful assessment of benefits and risks should be made to ensure that  the benefits are expected to outweigh the well-documented risks\r\n",
      "Extracted:  a careful assessment of benefits and risks should be made to ensure that  the benefits are expected to outweigh the well-documented risks\r\n",
      "731 536\r\n",
      "Original :  multimodal\r\n",
      "Extracted:  multimodal\r\n",
      "732 643\r\n",
      "Original :  all opioid risk mitigation strategies outlined in this guideline (see recommendation 7) should be put into  place\r\n",
      "Extracted:  all opioid risk mitigation strategies outlined in this guideline (see recommendation 7) should be put into  place\r\n",
      "733 9\r\n",
      "Original :  in response to the recognition of pain and its management as a public health problem\r\n",
      "Extracted:  in response to the recognition of pain and its management as a public health problem\r\n",
      "734 95\r\n",
      "Original :  the  national academy of medicine\r\n",
      "Extracted:  the  national academy of medicine\r\n",
      "735 158\r\n",
      "Original :  the state of pain research, treatment, and  education in the u.s.\r\n",
      "Extracted:  the state of pain research, treatment, and  education in the u.s.\r\n",
      "736 224\r\n",
      "Original :  the report called for a cultural transformation in the way pain is viewed and  treated.\r\n",
      "Extracted:  the report called for a cultural transformation in the way pain is viewed and  treated.\r\n",
      "737 431\r\n",
      "Original :  a biopsychosocial approach to pain care that is multimodal and  interdisciplinary\r\n",
      "Extracted:  a biopsychosocial approach to pain care that is multimodal and  interdisciplinary\r\n",
      "738 328\r\n",
      "Original :  the u.s. department of health and human services (hhs) national pain strategy  (march 2016)\r\n",
      "Extracted:  the u.s. department of health and human services (hhs) national pain strategy  (march 2016)\r\n",
      "739 602\r\n",
      "Original :  pain perception and its effects on the patient’s function is mediated by multiple factors (e.g., mood, social  support, prior experience, biomechanical factors), not just biology alone\r\n",
      "Extracted:  pain perception and its effects on the patient’s function is mediated by multiple factors (e.g., mood, social  support, prior experience, biomechanical factors), not just biology alone\r\n",
      "740 0\r\n",
      "Original :  psychological therapies (e.g., cognitive behavioral interventions such as cognitive behavioral therapy  [cbt], biofeedback)\r\n",
      "Extracted:  psychological therapies (e.g., cognitive behavioral interventions such as cognitive behavioral therapy  [cbt], biofeedback)\r\n",
      "741 146\r\n",
      "Original :  effective for pain reduction in multiple pain conditions\r\n",
      "Extracted:  effective for pain reduction in multiple pain conditions\r\n",
      "742 31\r\n",
      "Original :  cognitive behavioral interventions such as cognitive behavioral therapy  [cbt], biofeedback\r\n",
      "Extracted:  cognitive behavioral interventions such as cognitive behavioral therapy  [cbt], biofeedback\r\n",
      "743 211\r\n",
      "Original :  exercise treatments, including yoga\r\n",
      "Extracted:  exercise treatments, including yoga\r\n",
      "744 402\r\n",
      "Original :  exercise and  psychological therapies may each exert their influence through multiple mechanisms including but not  limited to the reduction in fear-avoidance, reduction in catastrophizing, and/or enhancing mood.\r\n",
      "Extracted:  exercise and  psychological therapies may each exert their influence through multiple mechanisms including but not  limited to the reduction in fear-avoidance, reduction in catastrophizing, and/or enhancing mood.\r\n",
      "745 631\r\n",
      "Original :  multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)\r\n",
      "Extracted:  multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)\r\n",
      "746 681\r\n",
      "Original :  described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention\r\n",
      "Extracted:  described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention\r\n",
      "747 631\r\n",
      "Original :  multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)\r\n",
      "Extracted:  multidisciplinary biopsychosocial rehabilitation (described as a combination of a physical  intervention such as graded exercise and a psychological, social, or occupational intervention)\r\n",
      "748 1042\r\n",
      "Original :  exercise and psychological therapies\r\n",
      "Extracted:  exercise and psychological therapies\r\n",
      "749 1042\r\n",
      "Original :  exercise and psychological therapies\r\n",
      "Extracted:  exercise and psychological therapies\r\n",
      "750 1000\r\n",
      "Original :  in light of the low harms associated with exercise and psychological therapies when compared with lot\r\n",
      "Extracted:  in light of the low harms associated with exercise and psychological therapies when compared with lot\r\n",
      "751 1000\r\n",
      "Original :  in light of the low harms associated with exercise and psychological therapies when compared with lot\r\n",
      "Extracted:  in light of the low harms associated with exercise and psychological therapies when compared with lot\r\n",
      "752 1250\r\n",
      "Original :  insufficient\r\n",
      "Extracted:  insufficient\r\n",
      "753 1339\r\n",
      "Original :  the choice of which to try first should be individualized based on patient  assessment and a shared decision making process\r\n",
      "Extracted:  the choice of which to try first should be individualized based on patient  assessment and a shared decision making process\r\n",
      "754 68\r\n",
      "Original :  appropriate mechanism and condition specific non-opioid pharmacologic agents\r\n",
      "Extracted:  appropriate mechanism and condition specific non-opioid pharmacologic agents\r\n",
      "755 226\r\n",
      "Original :  gabapentin in neuropathic pain states\r\n",
      "Extracted:  gabapentin in neuropathic pain states\r\n",
      "756 270\r\n",
      "Original :  potential contraindications and long-term  risks of use\r\n",
      "Extracted:  potential contraindications and long-term  risks of use\r\n",
      "757 395\r\n",
      "Original :  these also can carry risk  of harm, depending on the specific patient and chosen medication\r\n",
      "Extracted:  these also can carry risk  of harm, depending on the specific patient and chosen medication\r\n",
      "758 18\r\n",
      "Original :  physical, psychological, and pain rehabilitation modalities\r\n",
      "Extracted:  physical, psychological, and pain rehabilitation modalities\r\n",
      "759 233\r\n",
      "Original :  all avenues for obtaining these treatments (e.g. internet based cbt) and all appropriate non opioid medications\r\n",
      "Extracted:  all avenues for obtaining these treatments (e.g. internet based cbt) and all appropriate non opioid medications\r\n",
      "760 0\r\n",
      "Original :  further studies\r\n",
      "Extracted:  further studies\r\n",
      "761 75\r\n",
      "Original :  a short duration\r\n",
      "Extracted:  a short duration\r\n",
      "762 136\r\n",
      "Original :  consideration of opioid therapy beyond 90 days\r\n",
      "Extracted:  consideration of opioid therapy beyond 90 days\r\n",
      "763 192\r\n",
      "Original :  re-evaluation and discussion with patient of risks and benefits\r\n",
      "Extracted:  re-evaluation and discussion with patient of risks and benefits\r\n",
      "764 322\r\n",
      "Original :  ongoing risk mitigation strategies (see recommendations 7-9), assessment for opioid use disorder, and consideration for tapering when risks exceed benefits (see recommendation 14)\r\n",
      "Extracted:  ongoing risk mitigation strategies (see recommendations 7-9), assessment for opioid use disorder, and consideration for tapering when risks exceed benefits (see recommendation 14)\r\n",
      "765 261\r\n",
      "Original :  patients currently on long-term opioid therapy\r\n",
      "Extracted:  patients currently on long-term opioid therapy\r\n",
      "766 261\r\n",
      "Original :  patients currently on long-term opioid therapy\r\n",
      "Extracted:  patients currently on long-term opioid therapy\r\n",
      "767 261\r\n",
      "Original :  patients currently on long-term opioid therapy\r\n",
      "Extracted:  patients currently on long-term opioid therapy\r\n",
      "768 261\r\n",
      "Original :  patients currently on long-term opioid therapy\r\n",
      "Extracted:  patients currently on long-term opioid therapy\r\n",
      "769 206\r\n",
      "Original :  the heightened risk for developing oud\r\n",
      "Extracted:  the heightened risk for developing oud\r\n",
      "770 31\r\n",
      "Original :  continuing ot beyond 90 days’ duration\r\n",
      "Extracted:  continuing ot beyond 90 days’ duration\r\n",
      "771 134\r\n",
      "Original :  continuing ot for longer than 90 days\r\n",
      "Extracted:  continuing ot for longer than 90 days\r\n",
      "772 217\r\n",
      "Original :  there may be some situations where the benefits of lot clearly outweigh the risks.\r\n",
      "Extracted:  there may be some situations where the benefits of lot clearly outweigh the risks.\r\n",
      "773 325\r\n",
      "Original :  through individual clinical assessment\r\n",
      "Extracted:  through individual clinical assessment\r\n",
      "774 102\r\n",
      "Original :  duration of opioid use as well as dose\r\n",
      "Extracted:  duration of opioid use as well as dose\r\n",
      "775 1097\r\n",
      "Original :  duration of ot\r\n",
      "Extracted:  duration of ot\r\n",
      "776 66\r\n",
      "Original :  when patients have a history of  previous opioid or non-opioid sud\r\n",
      "Extracted:  when patients have a history of  previous opioid or non-opioid sud\r\n",
      "777 33\r\n",
      "Original :  progression from acute to long-term ot is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for oud\r\n",
      "Extracted:  progression from acute to long-term ot is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for oud\r\n",
      "778 33\r\n",
      "Original :  progression from acute to long-term ot\r\n",
      "Extracted:  progression from acute to long-term ot\r\n",
      "779 33\r\n",
      "Original :  progression from acute to long-term ot is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for oud\r\n",
      "Extracted:  progression from acute to long-term ot is associated with little evidence  for sustained analgesic efficacy but a substantial increase in risk for oud\r\n",
      "780 241\r\n",
      "Original :  at initiation of ot and continuously thereafter\r\n",
      "Extracted:  at initiation of ot and continuously thereafter\r\n",
      "781 289\r\n",
      "Original :  to ensure that the patient  understands the associated risks and benefits of lot\r\n",
      "Extracted:  to ensure that the patient  understands the associated risks and benefits of lot\r\n",
      "782 482\r\n",
      "Original :  research\r\n",
      "Extracted:  research\r\n",
      "783 482\r\n",
      "Original :  research\r\n",
      "Extracted:  research\r\n",
      "784 533\r\n",
      "Original :  how long it takes for oud to occur and whether the  nature of the pain is one of the factors that can influence either of this phenomena\r\n",
      "Extracted:  how long it takes for oud to occur and whether the  nature of the pain is one of the factors that can influence either of this phenomena\r\n",
      "785 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "786 127\r\n",
      "Original :  patients currently on long-term opioid therapy with evidence of untreated substance use  disorder\r\n",
      "Extracted:  patients currently on long-term opioid therapy with evidence of untreated substance use  disorder\r\n",
      "787 239\r\n",
      "Original :  close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering\r\n",
      "Extracted:  close monitoring, including engagement in substance use disorder treatment, and discontinuation of opioid therapy for pain with appropriate tapering\r\n",
      "788 37\r\n",
      "Original :  oud, overdose, and death, especially among patients with untreated  sud\r\n",
      "Extracted:  oud, overdose, and death, especially among patients with untreated  sud\r\n",
      "789 0\r\n",
      "Original :  opioids\r\n",
      "Extracted:  opioids\r\n",
      "790 498\r\n",
      "Original :  patients whose sole  sud relates to tobacco misuse\r\n",
      "Extracted:  patients whose sole  sud relates to tobacco misuse\r\n",
      "791 115\r\n",
      "Original :  those diagnosed with cncp and an alcohol use or non-opioid drug use disorder\r\n",
      "Extracted:  those diagnosed with cncp and an alcohol use or non-opioid drug use disorder\r\n",
      "792 516\r\n",
      "Original :  the presence of a lifetime history of sud for patients with cncp\r\n",
      "Extracted:  the presence of a lifetime history of sud for patients with cncp\r\n",
      "793 601\r\n",
      "Original :  28 times increased  odds of therapeutic opioid addiction compared to patients with cncp without a lifetime history of sud\r\n",
      "Extracted:  28 times increased  odds of therapeutic opioid addiction compared to patients with cncp without a lifetime history of sud\r\n",
      "794 0\r\n",
      "Original :  some patients with sud\r\n",
      "Extracted:  some patients with sud\r\n",
      "795 41\r\n",
      "Original :  the recommendation to use non-opioid modalities in lieu of  lot to treat their pain\r\n",
      "Extracted:  the recommendation to use non-opioid modalities in lieu of  lot to treat their pain\r\n",
      "796 135\r\n",
      "Original :  the lack of evidence of efficacy of lot and considerable evidence of  significant harms of overdose, death from overdose, and increased risk of suicide\r\n",
      "Extracted:  the lack of evidence of efficacy of lot and considerable evidence of  significant harms of overdose, death from overdose, and increased risk of suicide\r\n",
      "797 452\r\n",
      "Original :  the va/dod sud cpg\r\n",
      "Extracted:  the va/dod sud cpg\r\n",
      "798 0\r\n",
      "Original :  given the increasing use of cannabis among patients with chronic pain and the lack of rcts comparing  outcomes of prescribing lot versus other therapies for patients with and without cannabis use and  cannabis use disorder\r\n",
      "Extracted:  given the increasing use of cannabis among patients with chronic pain and the lack of rcts comparing  outcomes of prescribing lot versus other therapies for patients with and without cannabis use and  cannabis use disorder\r\n",
      "799 3\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "800 121\r\n",
      "Original :  patients currently on long-term opioid therapy and benzodiazepines\r\n",
      "Extracted:  patients currently on long-term opioid therapy and benzodiazepines\r\n",
      "801 198\r\n",
      "Original :  tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate\r\n",
      "Extracted:  tapering one or both when risks exceed benefits and obtaining specialty consultation as appropriate\r\n",
      "802 0\r\n",
      "Original :  harms may outweigh benefits\r\n",
      "Extracted:  harms may outweigh benefits\r\n",
      "803 119\r\n",
      "Original :  concurrent use of benzodiazepines with prescription opioids\r\n",
      "Extracted:  concurrent use of benzodiazepines with prescription opioids\r\n",
      "804 179\r\n",
      "Original :  increases the risk of  overdose and overdose death\r\n",
      "Extracted:  increases the risk of  overdose and overdose death\r\n",
      "805 268\r\n",
      "Original :  the adjusted odds ratio (aor) for drug  overdose\r\n",
      "Extracted:  the adjusted odds ratio (aor) for drug  overdose\r\n",
      "806 333\r\n",
      "Original :  individuals on lot for chronic pain (without anxiety or ptsd) who also received  concurrent long-term benzodiazepine therapy\r\n",
      "Extracted:  individuals on lot for chronic pain (without anxiety or ptsd) who also received  concurrent long-term benzodiazepine therapy\r\n",
      "807 574\r\n",
      "Original :  veterans receiving both opioids and  benzodiazepines\r\n",
      "Extracted:  veterans receiving both opioids and  benzodiazepines\r\n",
      "808 656\r\n",
      "Original :  death from drug overdose\r\n",
      "Extracted:  death from drug overdose\r\n",
      "809 250\r\n",
      "Original :  concurrent benzodiazepine and lot use\r\n",
      "Extracted:  concurrent benzodiazepine and lot use\r\n",
      "810 318\r\n",
      "Original :  unintentional overdose death\r\n",
      "Extracted:  unintentional overdose death\r\n",
      "811 250\r\n",
      "Original :  concurrent benzodiazepine and lot use\r\n",
      "Extracted:  concurrent benzodiazepine and lot use\r\n",
      "812 81\r\n",
      "Original :  benzodiazepines\r\n",
      "Extracted:  benzodiazepines\r\n",
      "813 526\r\n",
      "Original :  due to symptoms related to benzodiazepine dependence, exacerbations of ptsd, and/or anxiety\r\n",
      "Extracted:  due to symptoms related to benzodiazepine dependence, exacerbations of ptsd, and/or anxiety\r\n",
      "814 634\r\n",
      "Original :  abrupt discontinuation of benzodiazepines\r\n",
      "Extracted:  abrupt discontinuation of benzodiazepines\r\n",
      "815 634\r\n",
      "Original :  abrupt\r\n",
      "Extracted:  abrupt\r\n",
      "816 695\r\n",
      "Original :  as it can lead to serious adverse  effects including seizures and death\r\n",
      "Extracted:  as it can lead to serious adverse  effects including seizures and death\r\n",
      "817 813\r\n",
      "Original :  with caution and  within a team environment when possible (see recommendation 26 in the va/dod sud cpg)\r\n",
      "Extracted:  with caution and  within a team environment when possible (see recommendation 26 in the va/dod sud cpg)\r\n",
      "818 768\r\n",
      "Original :  tapering benzodiazepines\r\n",
      "Extracted:  tapering benzodiazepines\r\n",
      "819 919\r\n",
      "Original :  due to the  difficulty of tapering or discontinuing benzodiazepines\r\n",
      "Extracted:  due to the  difficulty of tapering or discontinuing benzodiazepines\r\n",
      "820 988\r\n",
      "Original :  particular caution should be used\r\n",
      "Extracted:  particular caution should be used\r\n",
      "821 1070\r\n",
      "Original :  veterans with ptsd who have co-occurring chronic pain\r\n",
      "Extracted:  veterans with ptsd who have co-occurring chronic pain\r\n",
      "822 1125\r\n",
      "Original :  the va/dod ptsd  cpg\r\n",
      "Extracted:  the va/dod ptsd  cpg\r\n",
      "823 1146\r\n",
      "Original :  recommends against\r\n",
      "Extracted:  recommends against\r\n",
      "824 1125\r\n",
      "Original :  the va/dod ptsd  cpg\r\n",
      "Extracted:  the va/dod ptsd  cpg\r\n",
      "825 1262\r\n",
      "Original :  benzodiazepines to treat acute anxiety symptoms after trauma\r\n",
      "Extracted:  benzodiazepines to treat acute anxiety symptoms after trauma\r\n",
      "826 1343\r\n",
      "Original :  a  higher incidence of ptsd symptoms\r\n",
      "Extracted:  a  higher incidence of ptsd symptoms\r\n",
      "827 1547\r\n",
      "Original :  although  anxiety may initially improve with benzodiazepines, the improvement is short-lived and may result in  tolerance to increasing doses and eventual failure of the treatment.\r\n",
      "Extracted:  although  anxiety may initially improve with benzodiazepines, the improvement is short-lived and may result in  tolerance to increasing doses and eventual failure of the treatment.\r\n",
      "828 1777\r\n",
      "Original :  exacerbation of severe ptsd symptoms\r\n",
      "Extracted:  exacerbation of severe ptsd symptoms\r\n",
      "829 1733\r\n",
      "Original :  gradual benzodiazepine taper\r\n",
      "Extracted:  gradual benzodiazepine taper\r\n",
      "830 1815\r\n",
      "Original :  concomitant use of benzodiazepines\r\n",
      "Extracted:  concomitant use of benzodiazepines\r\n",
      "831 32\r\n",
      "Original :  the addition of other psychoactive medications to lot\r\n",
      "Extracted:  the addition of other psychoactive medications to lot\r\n",
      "832 120\r\n",
      "Original :  the evidence for harm associated with the combination of opioids and z-drugs (e.g.,  zolpidem, eszopiclone)\r\n",
      "Extracted:  the evidence for harm associated with the combination of opioids and z-drugs (e.g.,  zolpidem, eszopiclone)\r\n",
      "833 446\r\n",
      "Original :  the combination of zolpidem and opioids\r\n",
      "Extracted:  the combination of zolpidem and opioids\r\n",
      "834 496\r\n",
      "Original :  the aor of  overdose\r\n",
      "Extracted:  the aor of  overdose\r\n",
      "835 560\r\n",
      "Original :  potential adverse outcomes (e.g., risk of overdose)\r\n",
      "Extracted:  potential adverse outcomes (e.g., risk of overdose)\r\n",
      "836 618\r\n",
      "Original :  the combined use of antidepressants and opioids\r\n",
      "Extracted:  the combined use of antidepressants and opioids\r\n",
      "837 669\r\n",
      "Original :  patients who do not have depression\r\n",
      "Extracted:  patients who do not have depression\r\n",
      "838 6\r\n",
      "Original :  recommend against\r\n",
      "Extracted:  recommend against\r\n",
      "839 263\r\n",
      "Original :  close monitoring and consideration for tapering when risks exceed benefits\r\n",
      "Extracted:  close monitoring and consideration for tapering when risks exceed benefits\r\n",
      "840 0\r\n",
      "Original :  all patients who take opioids chronically\r\n",
      "Extracted:  all patients who take opioids chronically\r\n",
      "841 91\r\n",
      "Original :  those who are  younger than 30 years of age\r\n",
      "Extracted:  those who are  younger than 30 years of age\r\n",
      "842 58\r\n",
      "Original :  oud and overdose\r\n",
      "Extracted:  oud and overdose\r\n",
      "843 136\r\n",
      "Original :  seven\r\n",
      "Extracted:  seven\r\n",
      "844 0\r\n",
      "Original :  similar to other risk factors, age <30 years\r\n",
      "Extracted:  similar to other risk factors, age <30 years\r\n",
      "845 31\r\n",
      "Original :  age <30 years\r\n",
      "Extracted:  age <30 years\r\n",
      "846 288\r\n",
      "Original :  hospitalized patients  recovering from battlefield injuries\r\n",
      "Extracted:  hospitalized patients  recovering from battlefield injuries\r\n",
      "847 533\r\n",
      "Original :  only if risk mitigation strategies are employed and patients are titrated off lot as soon as it is  appropriate\r\n",
      "Extracted:  only if risk mitigation strategies are employed and patients are titrated off lot as soon as it is  appropriate\r\n",
      "848 20\r\n",
      "Original :  younger patients using opioids\r\n",
      "Extracted:  younger patients using opioids\r\n",
      "849 157\r\n",
      "Original :  patients 18-30 years old\r\n",
      "Extracted:  patients 18-30 years old\r\n",
      "850 133\r\n",
      "Original :  patients ≥65 years old\r\n",
      "Extracted:  patients ≥65 years old\r\n",
      "851 190\r\n",
      "Original :  11\r\n",
      "Extracted:  11\r\n",
      "852 230\r\n",
      "Original :  patients 31-40 years\r\n",
      "Extracted:  patients 31-40 years\r\n",
      "853 312\r\n",
      "Original :  those  ≥65 years old\r\n",
      "Extracted:  those  ≥65 years old\r\n",
      "854 144\r\n",
      "Original :  5\r\n",
      "Extracted:  5\r\n",
      "855 410\r\n",
      "Original :  patients 30-39  years old\r\n",
      "Extracted:  patients 30-39  years old\r\n",
      "856 384\r\n",
      "Original :  subjects 18-29 years old\r\n",
      "Extracted:  subjects 18-29 years old\r\n",
      "857 440\r\n",
      "Original :  roughly half\r\n",
      "Extracted:  roughly half\r\n",
      "858 566\r\n",
      "Original :  patients ≥70 years old\r\n",
      "Extracted:  patients ≥70 years old\r\n",
      "859 384\r\n",
      "Original :  subjects 18-29 years old\r\n",
      "Extracted:  subjects 18-29 years old\r\n",
      "860 595\r\n",
      "Original :  far less risk (nearly 1/17)\r\n",
      "Extracted:  far less risk (nearly 1/17)\r\n",
      "861 0\r\n",
      "Original :  younger patients\r\n",
      "Extracted:  younger patients\r\n",
      "862 46\r\n",
      "Original :  opioid misuse (as suggested by a udt indicating high-risk  medication-related behavior)\r\n",
      "Extracted:  opioid misuse (as suggested by a udt indicating high-risk  medication-related behavior)\r\n",
      "863 168\r\n",
      "Original :  patients in the 45-64 year age group\r\n",
      "Extracted:  patients in the 45-64 year age group\r\n",
      "864 245\r\n",
      "Original :  an aberrant udt (detection of a non-prescribed opioid, non-prescribed  benzodiazepine, illicit drug, or tetrahydrocannabinol [thc])\r\n",
      "Extracted:  an aberrant udt (detection of a non-prescribed opioid, non-prescribed  benzodiazepine, illicit drug, or tetrahydrocannabinol [thc])\r\n",
      "865 394\r\n",
      "Original :  patients in the 20-44 age  group\r\n",
      "Extracted:  patients in the 20-44 age  group\r\n",
      "866 432\r\n",
      "Original :  patients in the 45-64 and ≥65 age groups\r\n",
      "Extracted:  patients in the 45-64 and ≥65 age groups\r\n",
      "867 509\r\n",
      "Original :  20-44 year olds\r\n",
      "Extracted:  20-44 year olds\r\n",
      "868 525\r\n",
      "Original :  to  have non-detection of a prescribed opioid as well (indicating possible diversion)\r\n",
      "Extracted:  to  have non-detection of a prescribed opioid as well (indicating possible diversion)\r\n",
      "869 0\r\n",
      "Original :  an age of 30 years was chosen based on how age was categorized in the six studies that showed an inverse  relationship between age and oud or overdose.\r\n",
      "Extracted:  an age of 30 years was chosen based on how age was categorized in the six studies that showed an inverse  relationship between age and oud or overdose.\r\n",
      "870 155\r\n",
      "Original :  good neurophysiologic rationale\r\n",
      "Extracted:  good neurophysiologic rationale\r\n",
      "871 250\r\n",
      "Original :  studies in other areas (e.g., use of different  substances)\r\n",
      "Extracted:  studies in other areas (e.g., use of different  substances)\r\n",
      "872 324\r\n",
      "Original :  developing brains (age <30 years)\r\n",
      "Extracted:  developing brains (age <30 years)\r\n",
      "873 365\r\n",
      "Original :  increased risk of abnormalities and  addiction\r\n",
      "Extracted:  increased risk of abnormalities and  addiction\r\n",
      "874 94\r\n",
      "Original :  age\r\n",
      "Extracted:  age\r\n",
      "875 13\r\n",
      "Original :  implementing risk mitigation strategies\r\n",
      "Extracted:  implementing risk mitigation strategies\r\n",
      "876 99\r\n",
      "Original :  starting with an informed consent conversation covering the risks and benefits of opioid  therapy as well as alternative therapies\r\n",
      "Extracted:  starting with an informed consent conversation covering the risks and benefits of opioid  therapy as well as alternative therapies\r\n",
      "877 231\r\n",
      "Original :  the strategies and their frequency\r\n",
      "Extracted:  the strategies and their frequency\r\n",
      "878 321\r\n",
      "Original :  ongoing, random urine drug testing (including appropriate confirmatory testing), checking state prescription drug monitoring programs, monitoring for overdose potential and suicidality, providing overdose education, prescribing of naloxone rescue and accompanying education\r\n",
      "Extracted:  ongoing, random urine drug testing (including appropriate confirmatory testing), checking state prescription drug monitoring programs, monitoring for overdose potential and suicidality, providing overdose education, prescribing of naloxone rescue and accompanying education\r\n",
      "879 37\r\n",
      "Original :  before the opioids are prescribed\r\n",
      "Extracted:  before the opioids are prescribed\r\n",
      "880 0\r\n",
      "Original :  risk mitigation for lot should begin\r\n",
      "Extracted:  risk mitigation for lot should begin\r\n",
      "881 72\r\n",
      "Original :  through an informed consent  discussion, reviewing the patient’s history, checking state pdmps, or instructing patients about using drug  take back programs to dispose of unused medication\r\n",
      "Extracted:  through an informed consent  discussion, reviewing the patient’s history, checking state pdmps, or instructing patients about using drug  take back programs to dispose of unused medication\r\n",
      "882 283\r\n",
      "Original :  concurrently with the therapy  (e.g., ongoing udt, oend) and in response to adverse events (e.g., needle exchange programs for those  who develop an intravenous drug use disorder)\r\n",
      "Extracted:  concurrently with the therapy  (e.g., ongoing udt, oend) and in response to adverse events (e.g., needle exchange programs for those  who develop an intravenous drug use disorder)\r\n",
      "883 492\r\n",
      "Original :  use of an opioid pain  care agreement, monitoring for appropriate opioid use, and, with patients’ consent, obtaining a udt\r\n",
      "Extracted:  use of an opioid pain  care agreement, monitoring for appropriate opioid use, and, with patients’ consent, obtaining a udt\r\n",
      "884 834\r\n",
      "Original :  one identified study was a systematic review of 11 studies\r\n",
      "Extracted:  one identified study was a systematic review of 11 studies\r\n",
      "885 1051\r\n",
      "Original :  weak\r\n",
      "Extracted:  weak\r\n",
      "886 904\r\n",
      "Original :  opioid treatment agreements\r\n",
      "Extracted:  opioid treatment agreements\r\n",
      "887 0\r\n",
      "Original :  there may be some variation\r\n",
      "Extracted:  there may be some variation\r\n",
      "888 31\r\n",
      "Original :  patient values and preferences\r\n",
      "Extracted:  patient values and preferences\r\n",
      "889 63\r\n",
      "Original :  an investment of resources\r\n",
      "Extracted:  an investment of resources\r\n",
      "890 151\r\n",
      "Original :  to allow for shared decision making and treatment planning\r\n",
      "Extracted:  to allow for shared decision making and treatment planning\r\n",
      "891 254\r\n",
      "Original :  can affect access to care for all empaneled patients\r\n",
      "Extracted:  can affect access to care for all empaneled patients\r\n",
      "892 340\r\n",
      "Original :  vha policy regarding education and signature informed consent\r\n",
      "Extracted:  vha policy regarding education and signature informed consent\r\n",
      "893 402\r\n",
      "Original :  when  providing lot for patients with non-cancer pain\r\n",
      "Extracted:  when  providing lot for patients with non-cancer pain\r\n",
      "894 309\r\n",
      "Original :  vha providers\r\n",
      "Extracted:  vha providers\r\n",
      "895 198\r\n",
      "Original :  prior  practice of using opioid treatment (or pain care) agreements\r\n",
      "Extracted:  prior  practice of using opioid treatment (or pain care) agreements\r\n",
      "896 292\r\n",
      "Original :  as coercive rather  than therapeutic, lack respect for individual autonomy, can be a barrier to pain care, and may be harmful  to the patient-provider relationship\r\n",
      "Extracted:  as coercive rather  than therapeutic, lack respect for individual autonomy, can be a barrier to pain care, and may be harmful  to the patient-provider relationship\r\n",
      "897 0\r\n",
      "Original :  given the recognized risks of opioid therapy\r\n",
      "Extracted:  given the recognized risks of opioid therapy\r\n",
      "898 89\r\n",
      "Original :  a robust,  signature informed consent process that is patient-centered and provides patients with information about  known benefits and harms of ot and treatment alternatives\r\n",
      "Extracted:  a robust,  signature informed consent process that is patient-centered and provides patients with information about  known benefits and harms of ot and treatment alternatives\r\n",
      "899 46\r\n",
      "Original :  an optimal approach to care\r\n",
      "Extracted:  an optimal approach to care\r\n",
      "900 289\r\n",
      "Original :  a requirement for  signature informed consent, consistent with va policy for other treatments or procedures with a  significant risk of complications or morbidity\r\n",
      "Extracted:  a requirement for  signature informed consent, consistent with va policy for other treatments or procedures with a  significant risk of complications or morbidity\r\n",
      "901 21\r\n",
      "Original :  offered treatments (e.g., ot) and may also decline risk mitigation strategies (e.g.,  udt, pill counts) that are recommended in the course of clinical care\r\n",
      "Extracted:  offered treatments (e.g., ot) and may also decline risk mitigation strategies (e.g.,  udt, pill counts) that are recommended in the course of clinical care\r\n",
      "902 0\r\n",
      "Original :  state database queries\r\n",
      "Extracted:  state database queries\r\n",
      "903 27\r\n",
      "Original :  detection of multi-sourcing of controlled substances\r\n",
      "Extracted:  detection of multi-sourcing of controlled substances\r\n",
      "904 281\r\n",
      "Original :  at least quarterly\r\n",
      "Extracted:  at least quarterly\r\n",
      "905 252\r\n",
      "Original :  the cdc\r\n",
      "Extracted:  the cdc\r\n",
      "906 311\r\n",
      "Original :  the state database system\r\n",
      "Extracted:  the state database system\r\n",
      "907 0\r\n",
      "Original :  as substance misuse in patients on lot is more than 30% in some series\r\n",
      "Extracted:  as substance misuse in patients on lot is more than 30% in some series\r\n",
      "908 258\r\n",
      "Original :  help to address safety, fairness, and trust with ot\r\n",
      "Extracted:  help to address safety, fairness, and trust with ot\r\n",
      "909 312\r\n",
      "Original :  availability of accurate and timely confirmatory testing (e.g., gas chromatography-mass spectrometry  [gcms])\r\n",
      "Extracted:  availability of accurate and timely confirmatory testing (e.g., gas chromatography-mass spectrometry  [gcms])\r\n",
      "910 441\r\n",
      "Original :  the false positive and negative rates associated with udts\r\n",
      "Extracted:  the false positive and negative rates associated with udts\r\n",
      "911 505\r\n",
      "Original :  interpretation of a  udt and confirmatory results\r\n",
      "Extracted:  interpretation of a  udt and confirmatory results\r\n",
      "912 564\r\n",
      "Original :  education and knowledge of the local procedures and clinical  scenario\r\n",
      "Extracted:  education and knowledge of the local procedures and clinical  scenario\r\n",
      "913 702\r\n",
      "Original :  udt results\r\n",
      "Extracted:  udt results\r\n",
      "914 734\r\n",
      "Original :  help identify active sud or possible diversion\r\n",
      "Extracted:  help identify active sud or possible diversion\r\n",
      "915 77\r\n",
      "Original :  udt\r\n",
      "Extracted:  udt\r\n",
      "916 824\r\n",
      "Original :  prior to initiating or continuing lot and periodically thereafter\r\n",
      "Extracted:  prior to initiating or continuing lot and periodically thereafter\r\n",
      "917 989\r\n",
      "Original :  close communication between the  sud and pain management providers\r\n",
      "Extracted:  close communication between the  sud and pain management providers\r\n",
      "918 1082\r\n",
      "Original :  interdisciplinary\r\n",
      "Extracted:  interdisciplinary\r\n",
      "919 0\r\n",
      "Original :  naloxone administration\r\n",
      "Extracted:  naloxone administration\r\n",
      "920 44\r\n",
      "Original :  as a life saving measure following opioid overdose\r\n",
      "Extracted:  as a life saving measure following opioid overdose\r\n",
      "921 96\r\n",
      "Original :  a  systematic review of 22 observational studies provided moderate quality evidence\r\n",
      "Extracted:  a  systematic review of 22 observational studies provided moderate quality evidence\r\n",
      "922 742\r\n",
      "Original :  prescription of naloxone rescue and accompanying education\r\n",
      "Extracted:  prescription of naloxone rescue and accompanying education\r\n",
      "923 936\r\n",
      "Original :  samhsa, the american medical association (ama), and other medical societies\r\n",
      "Extracted:  samhsa, the american medical association (ama), and other medical societies\r\n",
      "924 1041\r\n",
      "Original :  the va via pharmacy benefits management\r\n",
      "Extracted:  the va via pharmacy benefits management\r\n",
      "925 1137\r\n",
      "Original :  short-acting opioids\r\n",
      "Extracted:  short-acting opioids\r\n",
      "926 1182\r\n",
      "Original :  long-acting opioids such as methadone or  exceptionally potent opioids\r\n",
      "Extracted:  long-acting opioids such as methadone or  exceptionally potent opioids\r\n",
      "927 0\r\n",
      "Original :  synthetic opioids such as fentanyl analogs, potent opioid receptor agonists\r\n",
      "Extracted:  synthetic opioids such as fentanyl analogs, potent opioid receptor agonists\r\n",
      "928 26\r\n",
      "Original :  fentanyl analogs, potent opioid receptor agonists\r\n",
      "Extracted:  fentanyl analogs, potent opioid receptor agonists\r\n",
      "929 128\r\n",
      "Original :  fentanyl analogs that may be used to create counterfeit opioid analgesic pills\r\n",
      "Extracted:  fentanyl analogs that may be used to create counterfeit opioid analgesic pills\r\n",
      "930 218\r\n",
      "Original :  a toxidrome characterized by significant cns and profound respiratory depression requiring multiple  naloxone doses for reversal\r\n",
      "Extracted:  a toxidrome characterized by significant cns and profound respiratory depression requiring multiple  naloxone doses for reversal\r\n",
      "931 0\r\n",
      "Original :  those patients receiving opioid analgesics who do not meet dsm-5 criteria for oud\r\n",
      "Extracted:  those patients receiving opioid analgesics who do not meet dsm-5 criteria for oud\r\n",
      "932 99\r\n",
      "Original :  an  alternative management strategy: close follow-up and cbt\r\n",
      "Extracted:  an  alternative management strategy: close follow-up and cbt\r\n",
      "933 136\r\n",
      "Original :  close follow-up and cbt\r\n",
      "Extracted:  close follow-up and cbt\r\n",
      "934 20\r\n",
      "Original :  returning unused opioid medications\r\n",
      "Extracted:  returning unused opioid medications\r\n",
      "935 169\r\n",
      "Original :  70%\r\n",
      "Extracted:  70%\r\n",
      "936 88\r\n",
      "Original :  to reduce the amount of opioids in  the community\r\n",
      "Extracted:  to reduce the amount of opioids in  the community\r\n",
      "937 142\r\n",
      "Original :  it has been estimated that 70% of opioid prescriptions are left unused\r\n",
      "Extracted:  it has been estimated that 70% of opioid prescriptions are left unused\r\n",
      "938 233\r\n",
      "Original :  the national drug control strategy\r\n",
      "Extracted:  the national drug control strategy\r\n",
      "939 0\r\n",
      "Original :  take back programs\r\n",
      "Extracted:  take back programs\r\n",
      "940 300\r\n",
      "Original :  an effective tool\r\n",
      "Extracted:  an effective tool\r\n",
      "941 399\r\n",
      "Original :  3,633 containers containing 345  different prescription medications\r\n",
      "Extracted:  3,633 containers containing 345  different prescription medications\r\n",
      "942 550\r\n",
      "Original :  pain relievers\r\n",
      "Extracted:  pain relievers\r\n",
      "943 77\r\n",
      "Original :  80%\r\n",
      "Extracted:  80%\r\n",
      "944 187\r\n",
      "Original :  illicit use of injectable opioids\r\n",
      "Extracted:  illicit use of injectable opioids\r\n",
      "945 239\r\n",
      "Original :  an increased rate of human immunodeficiency virus (hiv) and hepatitis infection\r\n",
      "Extracted:  an increased rate of human immunodeficiency virus (hiv) and hepatitis infection\r\n",
      "946 0\r\n",
      "Original :  community-based needle exchange programs\r\n",
      "Extracted:  community-based needle exchange programs\r\n",
      "947 461\r\n",
      "Original :  sharing needles\r\n",
      "Extracted:  sharing needles\r\n",
      "948 380\r\n",
      "Original :  be an effective risk mitigation strategy for reducing high-risk behaviors (e.g., sharing needles) and infectious disease transmission among injection drug users\r\n",
      "Extracted:  be an effective risk mitigation strategy for reducing high-risk behaviors (e.g., sharing needles) and infectious disease transmission among injection drug users\r\n",
      "949 557\r\n",
      "Original :  patients who develop oud and progress to intravenous drug use\r\n",
      "Extracted:  patients who develop oud and progress to intravenous drug use\r\n",
      "950 659\r\n",
      "Original :  medication assisted treatment (mat) for oud\r\n",
      "Extracted:  medication assisted treatment (mat) for oud\r\n",
      "951 732\r\n",
      "Original :  patients who decline mat for oud\r\n",
      "Extracted:  patients who decline mat for oud\r\n",
      "952 794\r\n",
      "Original :  educating the patient regarding sterile injection techniques and community based needle exchange programs, if programs are available\r\n",
      "Extracted:  educating the patient regarding sterile injection techniques and community based needle exchange programs, if programs are available\r\n",
      "953 928\r\n",
      "Original :  the 2015 outbreak of hiv/hepatitis in rural  indiana and subsequent successful implementation of a needle exchange program\r\n",
      "Extracted:  the 2015 outbreak of hiv/hepatitis in rural  indiana and subsequent successful implementation of a needle exchange program\r\n",
      "954 1068\r\n",
      "Original :  the threat to rural communities from non-prescription opioid use and the potential benefits of needle exchange programs for use as a risk mitigation strategy\r\n",
      "Extracted:  the threat to rural communities from non-prescription opioid use and the potential benefits of needle exchange programs for use as a risk mitigation strategy\r\n",
      "955 13\r\n",
      "Original :  assessing suicide risk\r\n",
      "Extracted:  assessing suicide risk\r\n",
      "956 0\r\n",
      "Original :  opioid\r\n",
      "Extracted:  opioid\r\n",
      "957 46\r\n",
      "Original :  an assessment of current suicide risk should be made\r\n",
      "Extracted:  an assessment of current suicide risk should be made\r\n",
      "958 99\r\n",
      "Original :  at every phase of treatment\r\n",
      "Extracted:  at every phase of treatment\r\n",
      "959 128\r\n",
      "Original :  the va/dod suicide cpg\r\n",
      "Extracted:  the va/dod suicide cpg\r\n",
      "960 211\r\n",
      "Original :  patients considered to be at intermediate or high acute risk of suicide (determined by presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.)\r\n",
      "Extracted:  patients considered to be at intermediate or high acute risk of suicide (determined by presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.)\r\n",
      "961 298\r\n",
      "Original :  presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.\r\n",
      "Extracted:  presence and severity of suicidal ideation, level of intention to act, existence of risk factors, limited or absent protective factors, etc.\r\n",
      "962 454\r\n",
      "Original :  suicidality\r\n",
      "Extracted:  suicidality\r\n",
      "963 0\r\n",
      "Original :  a number of studies suggest\r\n",
      "Extracted:  a number of studies suggest\r\n",
      "964 28\r\n",
      "Original :  certain chronic pain conditions\r\n",
      "Extracted:  certain chronic pain conditions\r\n",
      "965 70\r\n",
      "Original :  an independent risk factor for suicide\r\n",
      "Extracted:  an independent risk factor for suicide\r\n",
      "966 119\r\n",
      "Original :  a recent large retrospective cohort study\r\n",
      "Extracted:  a recent large retrospective cohort study\r\n",
      "967 222\r\n",
      "Original :  suicide risk among veterans receiving ot for cncp\r\n",
      "Extracted:  suicide risk among veterans receiving ot for cncp\r\n",
      "968 195\r\n",
      "Original :  prescribed opioid dose\r\n",
      "Extracted:  prescribed opioid dose\r\n",
      "969 222\r\n",
      "Original :  suicide risk\r\n",
      "Extracted:  suicide risk\r\n",
      "970 333\r\n",
      "Original :  an individual’s risk of suicide at any given point in time\r\n",
      "Extracted:  an individual’s risk of suicide at any given point in time\r\n",
      "971 310\r\n",
      "Original :  many factors\r\n",
      "Extracted:  many factors\r\n",
      "972 278\r\n",
      "Original :  suicide risk is not static, and many factors influence an individual’s risk of suicide at any given point in time, as noted in the va/dod  suicide cpg.\r\n",
      "Extracted:  suicide risk is not static, and many factors influence an individual’s risk of suicide at any given point in time, as noted in the va/dod  suicide cpg.\r\n",
      "973 484\r\n",
      "Original :  whether one is initiating, maintaining,  or terminating lot\r\n",
      "Extracted:  whether one is initiating, maintaining,  or terminating lot\r\n",
      "974 0\r\n",
      "Original :  there is moderate quality evidence\r\n",
      "Extracted:  there is moderate quality evidence\r\n",
      "975 40\r\n",
      "Original :  intensification of monitoring\r\n",
      "Extracted:  intensification of monitoring\r\n",
      "976 76\r\n",
      "Original :  mitigate the risk of suicide among patients on lot\r\n",
      "Extracted:  mitigate the risk of suicide among patients on lot\r\n",
      "977 128\r\n",
      "Original :  im et al. (2015) found moderate quality evidence\r\n",
      "Extracted:  im et al. (2015) found moderate quality evidence\r\n",
      "978 484\r\n",
      "Original :  patients on long-acting opioids within the facilities providing more follow-up after new prescriptions\r\n",
      "Extracted:  patients on long-acting opioids within the facilities providing more follow-up after new prescriptions\r\n",
      "979 314\r\n",
      "Original :  decreased risk of suicide attempt\r\n",
      "Extracted:  decreased risk of suicide attempt\r\n",
      "980 0\r\n",
      "Original :  some patients on lot who suffer from chronic pain and co-occurring oud, depression, and/or personality disorders\r\n",
      "Extracted:  some patients on lot who suffer from chronic pain and co-occurring oud, depression, and/or personality disorders\r\n",
      "981 117\r\n",
      "Original :  threaten suicide when providers recommend discontinuation of opioid\r\n",
      "Extracted:  threaten suicide when providers recommend discontinuation of opioid\r\n",
      "982 197\r\n",
      "Original :  continuing lot to “prevent suicide” in someone with chronic pain\r\n",
      "Extracted:  continuing lot to “prevent suicide” in someone with chronic pain\r\n",
      "983 212\r\n",
      "Original :  to “prevent suicide” in someone with chronic pain\r\n",
      "Extracted:  to “prevent suicide” in someone with chronic pain\r\n",
      "984 284\r\n",
      "Original :  an appropriate response if suicide risk is high or increases\r\n",
      "Extracted:  an appropriate response if suicide risk is high or increases\r\n",
      "985 187\r\n",
      "Original :  however,  continuing lot to “prevent suicide” in someone with chronic pain is not recommended as an appropriate response if suicide risk is high or increases.\r\n",
      "Extracted:  however,  continuing lot to “prevent suicide” in someone with chronic pain is not recommended as an appropriate response if suicide risk is high or increases.\r\n",
      "986 380\r\n",
      "Original :  involve behavioral health to assess, monitor, and treat\r\n",
      "Extracted:  involve behavioral health to assess, monitor, and treat\r\n",
      "987 542\r\n",
      "Original :  further research\r\n",
      "Extracted:  further research\r\n",
      "988 569\r\n",
      "Original :  to identify strategies for safely managing patients at elevated risk of suicide who demand opioid medications or become further destabilized during tapering\r\n",
      "Extracted:  to identify strategies for safely managing patients at elevated risk of suicide who demand opioid medications or become further destabilized during tapering\r\n",
      "989 104\r\n",
      "Original :  at least every three months\r\n",
      "Extracted:  at least every three months\r\n",
      "990 24\r\n",
      "Original :  an individualized assessment of potential opioid-related harms relative to realistic treatment goals must be completed\r\n",
      "Extracted:  an individualized assessment of potential opioid-related harms relative to realistic treatment goals must be completed\r\n",
      "991 165\r\n",
      "Original :  frequent visits contribute to the appropriate use and adjustment of the planned therapy\r\n",
      "Extracted:  frequent visits contribute to the appropriate use and adjustment of the planned therapy\r\n",
      "992 291\r\n",
      "Original :  at least every three months or more frequently\r\n",
      "Extracted:  at least every three months or more frequently\r\n",
      "993 384\r\n",
      "Original :  due to the balance of benefits and harms\r\n",
      "Extracted:  due to the balance of benefits and harms\r\n",
      "994 756\r\n",
      "Original :  in order to increase the impact of risk mitigation strategies and enhance the delivery of comprehensive, biopsychosocial pain care\r\n",
      "Extracted:  in order to increase the impact of risk mitigation strategies and enhance the delivery of comprehensive, biopsychosocial pain care\r\n",
      "995 929\r\n",
      "Original :  based on risk stratification\r\n",
      "Extracted:  based on risk stratification\r\n",
      "996 1042\r\n",
      "Original :  within one to four weeks of starting ot or at any dose change, and at least every three months or more frequently if needed\r\n",
      "Extracted:  within one to four weeks of starting ot or at any dose change, and at least every three months or more frequently if needed\r\n",
      "997 21\r\n",
      "Original :  a clinician should re-examine the rationale for continuing the patient on ot\r\n",
      "Extracted:  a clinician should re-examine the rationale for continuing the patient on ot\r\n",
      "998 135\r\n",
      "Original :  changes in co-occurring conditions, diagnoses/medications, and functional status when conducting the risk/benefit analysis for lot\r\n",
      "Extracted:  changes in co-occurring conditions, diagnoses/medications, and functional status when conducting the risk/benefit analysis for lot\r\n",
      "999 267\r\n",
      "Original :  alcohol use, pregnancy, nursing of infants, and lab abnormalities\r\n",
      "Extracted:  alcohol use, pregnancy, nursing of infants, and lab abnormalities\r\n",
      "1000 423\r\n",
      "Original :  pharmacy review, informed consent, udts, and checking state pdmps\r\n",
      "Extracted:  pharmacy review, informed consent, udts, and checking state pdmps\r\n",
      "1001 528\r\n",
      "Original :  signs of diversion\r\n",
      "Extracted:  signs of diversion\r\n",
      "1002 623\r\n",
      "Original :  the longer the patient is on opioids, the greater the potential for change in patient status and development of opioid-related harms.\r\n",
      "Extracted:  the longer the patient is on opioids, the greater the potential for change in patient status and development of opioid-related harms.\r\n",
      "1003 49\r\n",
      "Original :  the lowest dose of opioids as indicated by patient-specific risks and benefits\r\n",
      "Extracted:  the lowest dose of opioids as indicated by patient-specific risks and benefits\r\n",
      "1004 167\r\n",
      "Original :  no\r\n",
      "Extracted:  no\r\n",
      "1005 267\r\n",
      "Original :  more frequent monitoring for adverse events including opioid use disorder and overdose\r\n",
      "Extracted:  more frequent monitoring for adverse events including opioid use disorder and overdose\r\n",
      "1006 394\r\n",
      "Original :  any\r\n",
      "Extracted:  any\r\n",
      "1007 416\r\n",
      "Original :  in a dose-dependent manner\r\n",
      "Extracted:  in a dose-dependent manner\r\n",
      "1008 501\r\n",
      "Original :  a range of 20-50 mg morphine equivalent daily dose\r\n",
      "Extracted:  a range of 20-50 mg morphine equivalent daily dose\r\n",
      "1009 627\r\n",
      "Original :  over 90 mg morphine equivalent daily dose\r\n",
      "Extracted:  over 90 mg morphine equivalent daily dose\r\n",
      "1010 835\r\n",
      "Original :  evaluate for tapering to reduced dose or to discontinuation\r\n",
      "Extracted:  evaluate for tapering to reduced dose or to discontinuation\r\n",
      "1011 0\r\n",
      "Original :  there is moderate quality evidence from retrospective cohort and retrospective case-control studies\r\n",
      "Extracted:  there is moderate quality evidence from retrospective cohort and retrospective case-control studies\r\n",
      "1012 303\r\n",
      "Original :  a daily dosage range of 20 to <50 mg medd\r\n",
      "Extracted:  a daily dosage range of 20 to <50 mg medd\r\n",
      "1013 396\r\n",
      "Original :  a range of 50 to <100 mg medd compared to risk at <20 mg medd\r\n",
      "Extracted:  a range of 50 to <100 mg medd compared to risk at <20 mg medd\r\n",
      "1014 268\r\n",
      "Original :  approximately 1.5 times\r\n",
      "Extracted:  approximately 1.5 times\r\n",
      "1015 368\r\n",
      "Original :  approximately 2.6 times\r\n",
      "Extracted:  approximately 2.6 times\r\n",
      "1016 295\r\n",
      "Original :  prescribed opioid dosage\r\n",
      "Extracted:  prescribed opioid dosage\r\n",
      "1017 0\r\n",
      "Original :  in a prospective cohort study (not included in the evidence review as it did not include information on  acute versus chronic pain in the patient population), dasgupta et al. (2015) compared residents of north  carolina who had received an opioid prescription in the last year to residents who had not.\r\n",
      "Extracted:  in a prospective cohort study (not included in the evidence review as it did not include information on  acute versus chronic pain in the patient population), dasgupta et al. (2015) compared residents of north  carolina who had received an opioid prescription in the last year to residents who had not.\r\n",
      "1018 0\r\n",
      "Original :  achieving an improved understanding of the factors contributing to prescription opioid-related overdose\r\n",
      "Extracted:  achieving an improved understanding of the factors contributing to prescription opioid-related overdose\r\n",
      "1019 202\r\n",
      "Original :  progressively higher doses of prescribed opioids result in correspondingly higher risks of opioid overdose\r\n",
      "Extracted:  progressively higher doses of prescribed opioids result in correspondingly higher risks of opioid overdose\r\n",
      "1020 536\r\n",
      "Original :  certain concomitant demographic factors, co-occurring medical or psychiatric conditions,  or interacting medications or substances\r\n",
      "Extracted:  certain concomitant demographic factors, co-occurring medical or psychiatric conditions,  or interacting medications or substances\r\n",
      "1021 0\r\n",
      "Original :  recognizing the lack of evidence of long-term benefit associated with lot used alone and the risks of  harms with use of opioids without risk mitigation, dosing determinations\r\n",
      "Extracted:  recognizing the lack of evidence of long-term benefit associated with lot used alone and the risks of  harms with use of opioids without risk mitigation, dosing determinations\r\n",
      "1022 500\r\n",
      "Original :  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "Extracted:  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "1023 500\r\n",
      "Original :  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "Extracted:  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "1024 500\r\n",
      "Original :  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "Extracted:  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "1025 500\r\n",
      "Original :  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "Extracted:  patients who require  higher doses of opioids, even in those who benefit from such therapy\r\n",
      "1026 626\r\n",
      "Original :  healthcare resources and patient adherence should be considered\r\n",
      "Extracted:  healthcare resources and patient adherence should be considered\r\n",
      "1027 104\r\n",
      "Original :  patients with co-occurring depression\r\n",
      "Extracted:  patients with co-occurring depression\r\n",
      "1028 361\r\n",
      "Original :  4.75, 5.47, 6.44, and 7.06, compared to those taking an opioid at the same dosage level without a diagnosis of depression\r\n",
      "Extracted:  4.75, 5.47, 6.44, and 7.06, compared to those taking an opioid at the same dosage level without a diagnosis of depression\r\n",
      "1029 499\r\n",
      "Original :  a history of or active sud\r\n",
      "Extracted:  a history of or active sud\r\n",
      "1030 984\r\n",
      "Original :  concurrent  prescribing of sedative-hypnotics and benzodiazepines\r\n",
      "Extracted:  concurrent  prescribing of sedative-hypnotics and benzodiazepines\r\n",
      "1031 51\r\n",
      "Original :  opioids taken prn (as needed) for chronic cancer pain versus regularly scheduled doses, or simultaneous prn plus regularly scheduled\r\n",
      "Extracted:  opioids taken prn (as needed) for chronic cancer pain versus regularly scheduled doses, or simultaneous prn plus regularly scheduled\r\n",
      "1032 68\r\n",
      "Original :  men\r\n",
      "Extracted:  men\r\n",
      "1033 63\r\n",
      "Original :  the impact of systematic reductions in medd in terms of  pain relief, specific pain and medical conditions, overdose morbidity and mortality as well as potential  adverse outcomes (e.g., the incidence of associated oud, infectious diseases related to intravenous drug  use disorder, and drug-related crime and diversion) and to determine whether/which conditions may be  appropriately treated with lot\r\n",
      "Extracted:  the impact of systematic reductions in medd in terms of  pain relief, specific pain and medical conditions, overdose morbidity and mortality as well as potential  adverse outcomes (e.g., the incidence of associated oud, infectious diseases related to intravenous drug  use disorder, and drug-related crime and diversion) and to determine whether/which conditions may be  appropriately treated with lot\r\n",
      "1034 0\r\n",
      "Original :  long-acting opioids\r\n",
      "Extracted:  long-acting opioids\r\n",
      "1035 217\r\n",
      "Original :  no single\r\n",
      "Extracted:  no single\r\n",
      "1036 60\r\n",
      "Original :  any specific opioid or opioid formulation,  specifically the following:  short-acting versus long-acting opioids (for lot for chronic pain), route of administration/delivery among alternatives such as transdermal, buccal, sublingual, or pumps, abuse deterrent formulations of opioids compared to non-abuse deterrent formulations, tramadol and other dual-mechanism opioids. buprenorphine for pain (compared to other opioids), methadone (with qt monitoring). \r\n",
      "Extracted:  any specific opioid or opioid formulation,  specifically the following:  short-acting versus long-acting opioids (for lot for chronic pain), route of administration/delivery among alternatives such as transdermal, buccal, sublingual, or pumps, abuse deterrent formulations of opioids compared to non-abuse deterrent formulations, tramadol and other dual-mechanism opioids. buprenorphine for pain (compared to other opioids), methadone (with qt monitoring). \r\n",
      "1037 107\r\n",
      "Original :  oxycodone/acetaminophen extended release [er] tablets\r\n",
      "Extracted:  oxycodone/acetaminophen extended release [er] tablets\r\n",
      "1038 9\r\n",
      "Original :  non-inferior\r\n",
      "Extracted:  non-inferior\r\n",
      "1039 358\r\n",
      "Original :  patients with cncp on long-acting ot\r\n",
      "Extracted:  patients with cncp on long-acting ot\r\n",
      "1040 369\r\n",
      "Original :  the concomitant use of oral and transdermal opioids or oral and intrathecal pumps\r\n",
      "Extracted:  the concomitant use of oral and transdermal opioids or oral and intrathecal pumps\r\n",
      "1041 34\r\n",
      "Original :  either transdermal or buccal\r\n",
      "Extracted:  either transdermal or buccal\r\n",
      "1042 34\r\n",
      "Original :  either transdermal or buccal\r\n",
      "Extracted:  either transdermal or buccal\r\n",
      "1043 421\r\n",
      "Original :  unique pharmacokinetic profile, continuous delivery, even after the patch is removed due to depot effect, increased rate of delivery, unpredictable variation in rate of delivery  - due to alterations in temperature due to external heat, skin integrity, and amount of  adipose tissue, among patients with fever, skin damage, or cachexia\r\n",
      "Extracted:  unique pharmacokinetic profile, continuous delivery, even after the patch is removed due to depot effect, increased rate of delivery, unpredictable variation in rate of delivery  - due to alterations in temperature due to external heat, skin integrity, and amount of  adipose tissue, among patients with fever, skin damage, or cachexia\r\n",
      "1044 413\r\n",
      "Original :  transdermal fentanyl should not be used in opioid-naïve patients; patients need to be informed that: heat (e.g., sun exposure, heating pad, febrile condition) can increase the rate and quantity  of absorption, proper application includes: being sure to take old patch off; never applying damaged patch  or a patch to non-intact skin; proper disposal to avoid exposure to children and pets, and precautions taken against possible diversion of remaining drug in used patch; adjusted dose (i.e., decreased patch size) should be used in patients with renal or hepatic  insufficiency and considered in elderly patients and those with febrile illness \r\n",
      "Extracted:  transdermal fentanyl should not be used in opioid-naïve patients; patients need to be informed that: heat (e.g., sun exposure, heating pad, febrile condition) can increase the rate and quantity  of absorption, proper application includes: being sure to take old patch off; never applying damaged patch  or a patch to non-intact skin; proper disposal to avoid exposure to children and pets, and precautions taken against possible diversion of remaining drug in used patch; adjusted dose (i.e., decreased patch size) should be used in patients with renal or hepatic  insufficiency and considered in elderly patients and those with febrile illness \r\n",
      "1045 89\r\n",
      "Original :  to present a physical barrier to prevent chewing,  crushing, cutting, grating, or grinding of the dosage form, or present a chemical barrier, such as a gelling  agent, that will resist extraction of the opioid with use of a common solvent\r\n",
      "Extracted:  to present a physical barrier to prevent chewing,  crushing, cutting, grating, or grinding of the dosage form, or present a chemical barrier, such as a gelling  agent, that will resist extraction of the opioid with use of a common solvent\r\n",
      "1046 344\r\n",
      "Original :  an opioid  antagonist (naloxone or naltrexone)\r\n",
      "Extracted:  an opioid  antagonist (naloxone or naltrexone)\r\n",
      "1047 652\r\n",
      "Original :  consumption  of a large number of intact capsules or tablets\r\n",
      "Extracted:  consumption  of a large number of intact capsules or tablets\r\n",
      "1048 3\r\n",
      "Original :  do not recommend for or against\r\n",
      "Extracted:  do not recommend for or against\r\n",
      "1049 0\r\n",
      "Original :  future research\r\n",
      "Extracted:  future research\r\n",
      "1050 0\r\n",
      "Original :  future research\r\n",
      "Extracted:  future research\r\n",
      "1051 55\r\n",
      "Original :  formulations of an opioid medication with a selective serotonin reuptake  inhibitor (ssri) or a serotonin-norepinephrine reuptake inhibitor (snri)\r\n",
      "Extracted:  formulations of an opioid medication with a selective serotonin reuptake  inhibitor (ssri) or a serotonin-norepinephrine reuptake inhibitor (snri)\r\n",
      "1052 228\r\n",
      "Original :  tramadol and tapentadol\r\n",
      "Extracted:  tramadol and tapentadol\r\n",
      "1053 253\r\n",
      "Original :  while both are dual-mechanism opioids, they differ in their affinity for the mu  opioid receptor, resulting in partial versus full agonist effects\r\n",
      "Extracted:  while both are dual-mechanism opioids, they differ in their affinity for the mu  opioid receptor, resulting in partial versus full agonist effects\r\n",
      "1054 205\r\n",
      "Original :  no long-term  evidence\r\n",
      "Extracted:  no long-term  evidence\r\n",
      "1055 13\r\n",
      "Original :  alternatives to opioids\r\n",
      "Extracted:  alternatives to opioids\r\n",
      "1056 95\r\n",
      "Original :  use of multimodal pain care including non-opioid medications as indicated\r\n",
      "Extracted:  use of multimodal pain care including non-opioid medications as indicated\r\n",
      "1057 274\r\n",
      "Original :  immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if  adjustments or continuing opioid therapy is indicated\r\n",
      "Extracted:  immediate-release opioids are used at the lowest effective dose with opioid therapy reassessment no later than 3-5 days to determine if  adjustments or continuing opioid therapy is indicated\r\n",
      "1058 486\r\n",
      "Original :  patient education about opioid risks and alternatives to opioid therapy\r\n",
      "Extracted:  patient education about opioid risks and alternatives to opioid therapy\r\n",
      "1059 116\r\n",
      "Original :  acute ot\r\n",
      "Extracted:  acute ot\r\n",
      "1060 58\r\n",
      "Original :  patients with mood disorders, those who refill  the initial prescription, higher prescribed dose (greater than 120 mg medd), and initiation using long acting opioids\r\n",
      "Extracted:  patients with mood disorders, those who refill  the initial prescription, higher prescribed dose (greater than 120 mg medd), and initiation using long acting opioids\r\n",
      "1061 309\r\n",
      "Original :  a  history of depression, sud, catastrophizing, higher preoperative total body pain, history of back pain, and  preoperative use of sedative-hypnotics or antidepressants\r\n",
      "Extracted:  a  history of depression, sud, catastrophizing, higher preoperative total body pain, history of back pain, and  preoperative use of sedative-hypnotics or antidepressants\r\n",
      "1062 43\r\n",
      "Original :  the use of opioids for acute pain\r\n",
      "Extracted:  the use of opioids for acute pain\r\n",
      "1063 160\r\n",
      "Original :  high prescribed dose, history of sud, and history of  mental health concerns\r\n",
      "Extracted:  high prescribed dose, history of sud, and history of  mental health concerns\r\n",
      "1064 260\r\n",
      "Original :  patient education, use of non-opioid adjunctive therapy, and  structured reassessment of opioid risks and benefits for all on acute ot. also, consider checking the pdmp and performing a udt.  \r\n",
      "Extracted:  patient education, use of non-opioid adjunctive therapy, and  structured reassessment of opioid risks and benefits for all on acute ot. also, consider checking the pdmp and performing a udt.  \r\n",
      "1065 178\r\n",
      "Original :  checking the pdmp, performing a  udt, placement in an inpatient setting or monitored environment, and/or providing oend\r\n",
      "Extracted:  checking the pdmp, performing a  udt, placement in an inpatient setting or monitored environment, and/or providing oend\r\n",
      "1066 111\r\n",
      "Original :  the setting, specifics of the painful insult, patient medical factors, and selected medication  potency/dose/route of administration/adjunct selection\r\n",
      "Extracted:  the setting, specifics of the painful insult, patient medical factors, and selected medication  potency/dose/route of administration/adjunct selection\r\n",
      "1067 209\r\n",
      "Original :  va and  dod healthcare practitioners including physicians, nurse practitioners, physician assistants, physical and  occupational therapists, psychologists, social workers, nurses, clinical pharmacists, chaplains, addiction  counselors, and others involved in the care of service members and their beneficiaries, retirees and their  beneficiaries, or veterans on or being considered for lot\r\n",
      "Extracted:  va and  dod healthcare practitioners including physicians, nurse practitioners, physician assistants, physical and  occupational therapists, psychologists, social workers, nurses, clinical pharmacists, chaplains, addiction  counselors, and others involved in the care of service members and their beneficiaries, retirees and their  beneficiaries, or veterans on or being considered for lot\r\n",
      "1068 0\r\n",
      "Original :  as with other cpgs, there are limitations, including significant evidence gaps. further, there is a need to  develop effective strategies for guideline implementation and evaluation of the effect of guideline  adherence on clinical outcomes.\r\n",
      "Extracted:  as with other cpgs, there are limitations, including significant evidence gaps. further, there is a need to  develop effective strategies for guideline implementation and evaluation of the effect of guideline  adherence on clinical outcomes.\r\n",
      "1069 407\r\n",
      "Original :  on the basis of all  clinical data available for an individual patient and are subject to change as scientific knowledge and  technology advance and patterns evolve\r\n",
      "Extracted:  on the basis of all  clinical data available for an individual patient and are subject to change as scientific knowledge and  technology advance and patterns evolve\r\n",
      "1070 342\r\n",
      "Original :  to serve as a standard of care\r\n",
      "Extracted:  to serve as a standard of care\r\n",
      "1071 594\r\n",
      "Original :  evidence available by december 2016\r\n",
      "Extracted:  evidence available by december 2016\r\n",
      "1072 745\r\n",
      "Original :  the use of a cpg must always be considered as a recommendation, within the context of a provider’s  clinical judgment and patient values and preferences, for the care of an individual patient\r\n",
      "Extracted:  the use of a cpg must always be considered as a recommendation, within the context of a provider’s  clinical judgment and patient values and preferences, for the care of an individual patient\r\n",
      "1073 27\r\n",
      "Original :  assist healthcare providers in managing or co-managing patients on or being  considered for lot\r\n",
      "Extracted:  assist healthcare providers in managing or co-managing patients on or being  considered for lot\r\n",
      "1074 163\r\n",
      "Original :  adults, including veterans as well as deployed and  non-deployed active duty service members, their beneficiaries, and retirees and their beneficiaries, with  chronic pain who are receiving care from the va or dod healthcare delivery systems\r\n",
      "Extracted:  adults, including veterans as well as deployed and  non-deployed active duty service members, their beneficiaries, and retirees and their beneficiaries, with  chronic pain who are receiving care from the va or dod healthcare delivery systems\r\n",
      "1075 440\r\n",
      "Original :  does not provide recommendations for the management of pain with lot in children or  adolescents, in patients with acute pain, or in patients receiving end-of-life care\r\n",
      "Extracted:  does not provide recommendations for the management of pain with lot in children or  adolescents, in patients with acute pain, or in patients receiving end-of-life care\r\n",
      "1076 427\r\n",
      "Original :  an empathetic and non-judgmental (versus a confrontational or adversarial)  \r\n",
      "Extracted:  an empathetic and non-judgmental (versus a confrontational or adversarial)  \r\n",
      "1077 566\r\n",
      "Original :  in order to build trust and facilitate frank discussions relating to the social, economic, emotional, and cultural factors that influence patients’  perceptions, behaviors, and decision making\r\n",
      "Extracted:  in order to build trust and facilitate frank discussions relating to the social, economic, emotional, and cultural factors that influence patients’  perceptions, behaviors, and decision making\r\n",
      "1078 351\r\n",
      "Original :  because a comprehensive review of the evidence related to lot was not feasible\r\n",
      "Extracted:  because a comprehensive review of the evidence related to lot was not feasible\r\n",
      "1079 92\r\n",
      "Original :  practice  recommendations for the care of populations with chronic pain already on or being considered for lot\r\n",
      "Extracted:  practice  recommendations for the care of populations with chronic pain already on or being considered for lot\r\n",
      "1080 305\r\n",
      "Original :  to  focus on the use of opioids for chronic pain rather than being comprehensive about all treatment options\r\n",
      "Extracted:  to  focus on the use of opioids for chronic pain rather than being comprehensive about all treatment options\r\n",
      "1081 453\r\n",
      "Original :  the multidisciplinary stakeholder involvement from its inception,  ensuring representation from the broad spectrum of clinicians engaged in the treatment and management  of patients with chronic pain on or being considered for lot\r\n",
      "Extracted:  the multidisciplinary stakeholder involvement from its inception,  ensuring representation from the broad spectrum of clinicians engaged in the treatment and management  of patients with chronic pain on or being considered for lot\r\n",
      "1082 113\r\n",
      "Original :  balancing desired outcomes with potential harms of treatment, equity of resource availability,  the potential for variation in patient values and preferences, and other considerations\r\n",
      "Extracted:  balancing desired outcomes with potential harms of treatment, equity of resource availability,  the potential for variation in patient values and preferences, and other considerations\r\n",
      "1083 193\r\n",
      "Original :  the va/dod  guideline for guidelines,[1] an internal document of the va and dod ebpwg\r\n",
      "Extracted:  the va/dod  guideline for guidelines,[1] an internal document of the va and dod ebpwg\r\n",
      "1084 414\r\n",
      "Original :  information regarding the process of developing guidelines, including the identification and  assembly of the guideline champions (“champions”) and other subject matter experts from within the va  and dod, known as the “work group,” and ultimately, the development and submission of an updated ot  cpg\r\n",
      "Extracted:  information regarding the process of developing guidelines, including the identification and  assembly of the guideline champions (“champions”) and other subject matter experts from within the va  and dod, known as the “work group,” and ultimately, the development and submission of an updated ot  cpg\r\n",
      "1085 33\r\n",
      "Original :  to use a patient-centered care approach that is tailored to the patient’s  capabilities, needs, goals, prior treatment experience, and preferences\r\n",
      "Extracted:  to use a patient-centered care approach that is tailored to the patient’s  capabilities, needs, goals, prior treatment experience, and preferences\r\n",
      "1086 261\r\n",
      "Original :  access to evidence-based interventions appropriate to that  patient\r\n",
      "Extracted:  access to evidence-based interventions appropriate to that  patient\r\n",
      "1087 380\r\n",
      "Original :  decrease patient anxiety, increase trust in  clinicians,[77] and improve treatment adherence\r\n",
      "Extracted:  decrease patient anxiety, increase trust in  clinicians,[77] and improve treatment adherence\r\n",
      "1088 478\r\n",
      "Original :  improved patient-clinician communication through  patient-centered care\r\n",
      "Extracted:  improved patient-clinician communication through  patient-centered care\r\n",
      "1089 65\r\n",
      "Original :  review the patient’s history including previous treatment approaches, their results, and any other outcomes with the patient\r\n",
      "Extracted:  review the patient’s history including previous treatment approaches, their results, and any other outcomes with the patient\r\n",
      "1090 219\r\n",
      "Original :  about his or her willingness to accept a referral to an addiction or other behavioral health specialist when appropriate\r\n",
      "Extracted:  about his or her willingness to accept a referral to an addiction or other behavioral health specialist when appropriate\r\n",
      "1091 83\r\n",
      "Original :  the foundation of a  patient-centered assessment of risks and benefits and a clinical synthesis performed by the provider\r\n",
      "Extracted:  the foundation of a  patient-centered assessment of risks and benefits and a clinical synthesis performed by the provider\r\n",
      "1092 263\r\n",
      "Original :  a patient-centered interview, and exploration of  patient values, goals, questions, concerns, and expectations\r\n",
      "Extracted:  a patient-centered interview, and exploration of  patient values, goals, questions, concerns, and expectations\r\n",
      "1093 0\r\n",
      "Original :  there are electronic tools\r\n",
      "Extracted:  there are electronic tools\r\n",
      "1094 140\r\n",
      "Original :  the opioid therapy risk report (otrr) and the stratification tool for  opioid risk mitigation (storm)\r\n",
      "Extracted:  the opioid therapy risk report (otrr) and the stratification tool for  opioid risk mitigation (storm)\r\n",
      "1095 252\r\n",
      "Original :  allows va providers to review clinical data related to opioid  pain treatment within the electronic medical record (emr), providing an efficient way of monitoring the  data\r\n",
      "Extracted:  allows va providers to review clinical data related to opioid  pain treatment within the electronic medical record (emr), providing an efficient way of monitoring the  data\r\n",
      "1096 441\r\n",
      "Original :  incorporates co-occurring medical and mental health conditions, sud, opioid dose,  co-prescribed sedatives, and information about prior adverse events and generates estimates of patients’  risk or hypothetical risk when considering initiation of opioid therapy. it quantifies risk for poisoning or  suicide-related events and for drug-related events, accidents, falls, and drug-induced conditions over a  three-year window. further, it provides suggestions as to what alternative treatments have not been tried  and what risk mitigation strategies need to be applied.\r\n",
      "Extracted:  incorporates co-occurring medical and mental health conditions, sud, opioid dose,  co-prescribed sedatives, and information about prior adverse events and generates estimates of patients’  risk or hypothetical risk when considering initiation of opioid therapy. it quantifies risk for poisoning or  suicide-related events and for drug-related events, accidents, falls, and drug-induced conditions over a  three-year window. further, it provides suggestions as to what alternative treatments have not been tried  and what risk mitigation strategies need to be applied.\r\n",
      "Unique Contexts: 190\r\n",
      " Ratio of QA Pair-to-Contexts: 5.773684210526316\r\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\r",
      "  0%|                                                  | 0/1097 [00:00<?, ?it/s]\r",
      "100%|████████████████████████████████████| 1097/1097 [00:00<00:00, 75719.18it/s]\r\n"
     ]
    }
   ],
   "source": [
    "!python csv_to_json.py"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b3af869d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.12"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
